Product Name | CAS | MF | MW | Synonyms |
---|---|---|---|---|
HJC-0123 | 1430420-02-2 | C24H16N2O3S | 412.46 | HJC-0123; HJC 0123; HJC0123 |
HIV-1 integrase inhibitor 2 | 957890-42-5 | C21H20ClNO2 | 353.84 | 3-Quinolineacetic acid, 6-chloro-2-methyl-4-phenyl-a-propyl- |
HIV-1 integrase inhibitor | 544467-07-4 | C11H9N3O4 | 247.21 | (Z)-4-(3-(azidomethyl)phenyl)-2-hydroxy-4-oxobut-2-enoic acid |
Hitachimycin | 77642-19-4 | C29H35NO5 | 477.598 | |
Histrelin Acetate | 220810-26-4 | C66H86N18O12.XC2H4O2 | 1383.58 | Supprelin LA. |
histapyrrodine | 493-80-1 | C19H24N2 | 280.413 | Histapyrrodine; UNII-0FYM61NG4D; 493-80-1; Calcistin; Domistan; Histapyrrodinehydrochloride |
Histamine Phosphate | 51-74-1 | C5H9N.2H3O4P | 307.14 | |
Histamine dihydrochloride | 56-92-8 | C5H9N3.2HCl | 184.07 | |
Histamine | 51-45-6 | C5H9N3 | 111.15 | 1h-imidazole-4-ethanamine;2-(4-IMIDAZOLYL)ETHYLAMINE;2-(1H-IMIDAZOL-4-YL)-ETHYLAMINE;4-(2-Aminoethyl)-1H-imidazole;HISTAMINE BASE;HISTAMIN |
Hispidulin | 1447-88-7 | C16H12O6 | 300.27 | Dinatin; Scutellarein 6-methyl ether; 4',5,7-Trihydroxy-6-methoxyflavone; 5,7-Dihydroxy-2-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; 6-Methoxyapigenin; 6-Methylscutellarein; Methoxyapigenin |
Hispidone | 73891-72-2 | C30H48O4 | 472.71 | |
Hispidol | 5786-54-9 | C15H10O4 | 254.24 | (2Z)-6-hydroxy-2-[(4-hydroxyphenyl)methylidene]-1-benzofuran-3-one; Hispidol; (Z)-4',6-Dihydroxyaurone; AC1NQYA9; 6,4' -dihydroxy aurone |
Hispidin | 555-55-5 | C13H10O5 | 246.2 | 6-(3,4-dihydroxystyrl)-4-hydroxy-2-pyrone; 6-[(E)-2-(3,4-dihydroxyphenyl)vinyl]-4-hydroxy-2H-pyran-2-one |
Hispidanin B | 1616080-84-2 | C42H56O6 | 656.89 | |
Hispanone | 82462-67-7 | C20H28O2 | 300.44 | (4aS,8aS)-4-[2-(furan-3-yl)ethyl]-3,4a,8,8-tetramethyl-5,6,7,8a-tetrahydro-1H-naphthalen-2-one |
HIRUDIN | 8001-27-2 | C287H440N80O110S6 | 7027 | hirudex; recombinanthirudin; HIRUDIN RECOMBINANT; DESULFATO-HIRUDIN; DESULFO-HIRUDIN; [63-TYROSINE]HIRUDIN (HV1), LEECH; NATIVE HIRUDIN; [TYR63]HIRUDIN (HV1), LEECH |
Hirsutine | 7729-23-9 | C22H28N2O3 | 368.47 | |
Hirsutide | 865368-30-5 | C34H40N4O4 | 568.71 | Cyclo-(L-NMe-Phe-L-Phe-L-NMe-Phe-L-Val); Cyclo(N-methyl-L-phenylalanyl-L-phenylalanyl-N-methyl-L-phenylalanyl-L-valyl) |
Hirsutenone | 41137-87-5 | C19H20O5 | 328.4 | (4E)-1,7-Bis(3,4-dihydroxyphenyl)-4-hepten-3-one |
Hirsuteine | 35467-43-7 | C22H26N2O3 | 366.461 | Methyl 2-(3-ethenyl-1,2,3,4,6,7,12,12b-octahydroindolo[2,3-a]quinolizin-2-yl)-3-methoxyprop-2-enoate |
Hirsutanonol | 41137-86-4 | C19H22O6 | 346.4 | (5S)-1,7-Bis(3,4-dihydroxyphenyl)-5-hydroxy-3-heptanone |
HIOC | 314054-36-9 | C16H19N3O3 | 301.34 | N-[2-(5-Hydroxy-1H-indol-3-yl)ethyl]-2-oxo-3-piperidinecarboxamide |
HINOKITIOL | 38094-79-0 | |||
Hinokiflavone | 19202-36-9 | C30H18O10 | 538.5 | 6-[4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy]-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-benzopyrone;2-(4-Hydroxyphenyl)-5,7-dihydroxy-6-[4-(5,7-dihydroxy-4-oxo-4H-1-benzopyran-2-yl)phenoxy]-4H-1-benzopyran-4-one; |
Hinesol | 23811-08-7 | C15H26O | 222.37 | (2R,5S,10S)-alpha,alpha,6,10-Tetramethylspiro[4.5]dec-6-ene-2-methanol |
HIF-2a Translation Inhibitor 76 | 882268-69-1 | C9H9N3O4S2 | 287.32 | |
HIF Phd Inhibitor 4 | 1227946-51-1 | C21H17ClN4O5S | 472.9 | N-(4-Chlorobenzyl)-3-(5,6-dimethoxy-2-pyridinyl)-2,4-dioxo-1 |
Hierochloe odorata,ext. | 91770-13-7 | |||
Hierochin D | 155759-02-7 | C19H20O6 | 344.4 | [2S-[2alpha,3beta,5(E)]]-2,3-Dihydro-7-hydroxy-2-(4-hydroxy-3-methoxyphenyl)-5-(3-hydroxy-1-propenyl)-3-benzofuranmethanol |
Hidrosmin Impurity | 120250-44-4 | C32H40O17.C30H36O16.C30H36O16 | ||
Hidrosmin | 115960-14-0 | C30H36O16 | 652.5984 | Hidrosmin; Venosmil; O-(beta-Hydroxyethyl)diosmin; F117; 4H-1-Benzopyran-4-one,7-((6-O-(6-deoxy-alpha-L-mannopyranosyl)-beta-D-glucopyranosyl)oxy)-5-(2-hydroxyethoxy)-2-(3-hydroxy-4-methoxyphenyl)-; AC1MJ8MV |
Hide–Remazol Brilliant Blue R | 37340-54-8 | Hide powder azure, Remazol Brilliant Blue R– Hide | ||
Hexaphenylcyclotrisilazane | 4570-25-6 | C36H33N3Si3 | 591.92 | 1,2,2,3,4,4-hexaphenyl-1,3,5,2,4,6-triazatrisilinane; 2,2,4,4,6,6-Hexaphenylcyclotrisilazane; Hexaphenylcyclotrisilazane |
Hexa-O-acetylmaltal | 67314-34-5 | C24H32O15 | 560.50 | 1,5-Anhydro-2-deoxy-4-O-(2,3,4,6-tetra-O-acetyl-a-D-glucopyranosyl)-D-arabino-hex-1-enitol diacetate; Maltal peracetate |
Hexanoic acid,3-amino-5-methyl-2-oxo-, (3S)- | 137041-31-7 | C7H13 N O3 | ||
Hexanoic acid,2-ethyl-, cerium(3+) salt (3:1) | 56797-01-4 | C8H16 O2 . 1/3 Ce | 569.7265 | |
Hexanoic acid,2-ethyl-, C16-18-alkyl esters | 90411-68-0 | |||
Hexanoic acid,2-ethyl-, 2-ethylhexyl ester | 7425-14-1 | C16H32 O2 | 256.48 | 2-ethylhexyl 2-ethylhexanoate; ETHYLHEXYL ETHYLHEXANOATE; 2-Ethylhexyl-2-ethylhexanoat; 2-Ethylhexanoic acid, 2-ethylhexyl ester; Dragoxate EH; Hexanoic acid, 2-ethyl-, 2-ethylhexyl ester; DRAGOXAT EH |
Hexakis(2,3,6-tri-O-methyl)cylomaltohexaose | 68715-56-0 | C54H96O30 | 1225.32 | Hexakis-(2,3,6-tri-O-methyl)-a-cyclodextrin; Permethyl-a-cyclodextrin; Octadeca-O-methyl-a-cyclodextrin |
HEXAKIS(2,2,3,3-TETRAFLUOROPROPOXY)PHOSPHAZINE | 58943-98-9 | C18H18F24N3O6P3 | 921.23 | HEXAKIS(2,2,3,3-TETRAFLUOROPROPOXY)PHOSPHAZENE; HEXAKIS(2,2,3,3-TETRAFLUOROPROPOXY)PHOSPHAZINE; Hexakis(1H,1H,3H-perfluoropropoxy)phosphazene; Hexakis(1H,1H,3H-perfluoropropoxy)phosphazene 97%; Hexakis(1H,1H,3H-perfluoropropoxy)phosphazene97% |
Hexahydro-cyclopenta[c]pyrrole-1,2-dicarboxylic acid di-tert-butyl ester | 402960-06-9 | C17H29 N O4 | 311.41646;g/mol | ditert-butyl(3S,3aS,6aR)-3,3a,4,5,6,6a-hexahydro-1H-cyclopenta[c]pyrrole-2,3-dicarboxylate;(1S,3aR,6aS)-Di-tert-butylhexahydrocyclopenta[c]pyrrole-1,2(1H)-dicarboxylate;402960-06-9;SCHEMBL15247679;MolPort-027-947-550;ZINC40435295 |
Hexahydrocurcumin | 36062-05-2 | C21H26O6 | 374.43 | (RS)-5-Hydroxy-1,7-bis(4-hydroxy-3-methoxyphenyl)-3-heptanone; 3-Oxolanosta-7,24Z-dien-26-oic acid; |
Hexahydro-3-methylphthalic anhydride | 57110-29-9 | C9H12O3 | 168.19 | 1,3-Isobenzofurandione, hexahydro-4-methyl-; 3-Isobenzofurandione, hexahydro-4-methyl-1; 3-Methylhexahydrophthalic anhydride; hexahydro-4-methyl-3-isobenzofurandione; HEXAHYDRO-4-METHYL 1,3-ISOBENZOFURANDIONE); 3-METHYL-1,2-CYCLOHEXANEDICARBOXLIC ANHYDRID |
Hexahydro-2-methyl-1H-1,4-diazepine | 65974-17-6 | C6H14N2 | 114.19 | Hexahydro-2-methyl-1H-1,4-diazepine; 2-Methyl-[1,4]diazepane |
Hexahydro-2'3a-dimethylspiro[1,3-dithiolo[4,5-b]furan-2,3'(2'H)-furan] | 38325-25-6 | C10H16O2S2 | 232.36 | hexahydro-2'3a-dimethylspiro[1,3-dithiolo[4,5-b]furan-2,3'(2'H)-furan]; Spiro[2,4-Dithia-1-methyl-8-oxabicyclo[3,3,0]octane-3,3'-(1'oxa-2'methyl)cyclopentane; Spiro1,3-dithiolo4,5-bfuran-2,3(2H)-furan, hexahydro-2,3a-dimethyl-; spiro{2,4-dithia-1-methy-8u |
Hexahydro-1H-azepine-1-carbaldehyde | 25114-81-2 | C7H13NO | 127.18 | hexahydro-1H-azepine-1-carbaldehyde |
Hexahydro-1-(4-piperidinyl)-5H-1,4-diazepin-5-one | 344779-09-5 | C10H19N3O | 197.28 | 1-(PIPERIDIN-4-YL)-1,4-DIAZEPAN-5-ONE; Hexahydro-1-(4-piperidinyl)-5H-1,4-diazepin-5-one |
Hexa-guluronic acid sodium salt | 183437-50-5 | C36H44O37Na6 | 1206.65 | |
Hexaglycerol | 36675-34-0 | C18H38O13 | 0 | POLYGLYCERIN-6 |
hexafluorozirconic acid | 12021-95-3 | H2ZrF6 | 207.23 | dihydrogen,(oc-6-11)-zirconate(2-hexafluoro-; fluorozirconic; Zirconate(2-),hexafluoro-,dihydrogen; DIHYDROGEN HEXAFLUOROZIRCONATE; FLUOROZIRCONIC ACID; HEXAFLUOROZIRCONIC ACID; Dihydrogen hexafluorozirconate solution; Hexafluorozirconic acid solution |
Hexafluorotitanic acid solution | 17439-11-1 | F6H2Ti | 163.87 | |
Hexafluoropropane:(HFC-236fa) | 690-39-1 | C3H2F6 | 152.04 | 1,1,1,3,3,3-hexafluoro-propan; 2,2-dihydroperfluoropropane; bis(trifluoromethyl)methane; Bistrifluoromethylmethane; R 236fa; r236fa; 1,1,1,3,3,3-HEXAFLUOROPROPANE; FC-236FA |
Hexafluoroisobutylene epoxide | 31898-68-7 | C4H2F6O | 180.05 | 2,2-BIS(TRIFLUOROMETHYL)OXIRANE; HEXAFLUOROISOBUTENE OXIDE; Oxirane, 2,2-bis(trifluoromethyl)- |
Hexafluorodisiloxane | 14515-39-0 | F6OSi2 | 186.1608192 | Hexafluorodisiloxane |
HEXAFLUOROCYCLOTRIPHOSPHAZENE | 15599-91-4 | F6N3P3 | 248.931805;g/mol | 2,2,4,4,6,6-hexafluoro-1,3,5-triaza-2$l^{5},4$l^{5},6$l^{5}-triphosphacyclohexa-1,3,5-triene; Hexafluorocyclotriphosphazene; 15599-91-4; Phosphonitrilicfluoridetrimer; AC1L3FXV; 1,3,5,2,4,6-Triazatriphosphorine,hexafluoro- |
Hexafluoro-2-methylisopropyl acrylate | 53038-41-8 | C7H6F6O2 | 236.11 | 1,1,1,3,3,3-HEXAFLUORO-2-METHYLISOPROPYL ACRYLATE; HEXAFLUORO-2-METHYLISOPROPANOL ACRYLATE; HEXAFLUORO-2-METHYLISOPROPYL ACRYLATE |
HEXAFLUORO-2-BUTYNE | 692-50-2 | C4F6 | 162.03 | 1,1,1,4,4,4-HEXAFLUORO-2-BUTYNE; HEXAFLUORO-2-BUTYNE; HEXAFLUOROBUT-2-YNE; 1,1,1,4,4,4-hexafluoro-2-butyn; 2-Butyne, hexafluoro-; Bis(trifluoromethyl)acetylene; butyne06; CF3CequivCCF3 |
Hexafluoro-1,3-butadiene | 685-63-2 | C4F6 | 162.03 | Hexafluoro-1,3-butadiene; Sifren 46 |
Hexafluorenium bromide | 317-52-2 | C36H42N2.2Br | 662.54008 | Mylaxen; 9H-fluoren-9-yl-[6-[9H-fluoren-9-yl(dimethyl)azaniumyl]hexyl]-dimethylazanium;dibromide; |
Hexaethylguanidium chloride | 69082-76-4 | C13H30ClN3 | 263.8504 | HEXAETHYL GUANIDINIUM CHLORIDE; Ethanaminium, N-(bis(diethylamino)methylene)-N-ethyl-, chloride; Ethanaminium, N-(bis(diethylamino)methylene)-N-ethyl-, chloride (1:1); Hexaethylguanidium Chloride |
Hexadecyl acetyl glycerol | 77133-35-8 | C21H42O4 | 358.6 | HAG; 1-O-Hexadecyl-2-acetyl-sn-glycerol; 1-Palmityl-2-acetylglycerol; (S)-1-(Hexadecyloxy)-3-hydroxypropan-2-yl acetate |
Hexadecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 115414-47-6 | C30H53NO9 | 571.74 | |
Hexadecyl 2-acetamido-2-deoxy-b-D-glucopyranoside | 115414-49-8 | C24H47NO6 | 445.63 | |
Hexadecanoyl-L-homoserine lactone | 87206-01-7 | C20H37NO3 | 339.5 | C16-HSL, N-Hexadecanoyl-L-homoserine lactone |
Hexadecanenitrile | 629-79-8 | C16H31N | 237.424 g/mol | |
Hexadecane | 544-76-3 | C16H34 | 226.44 | Cetane |
Hexadecanamide,N,N-bis(2-hydroxyethyl)- | 7545-24-6 | |||
Hexadecanal | 629-80-1 | C16H32O | 240.42468 | Palmitic acid aldehyde; palmitaldehyde,hexadecanal; Palmitinaldehyde |
Hexadecamethylheptasiloxane | 541-01-5 | C16H48O6Si7 | 533.147 g/mol | Heptasiloxane,hexadecamethyl-; HEXADECAMETHYLHEPTASILOXANE; 541-01-5; Heptasiloxane,1,1,1,3,3,5,5,7,7,9,9,11,11,13,13,13-hexadecamethyl-; Hepta(dimethylsiloxane); AC1L1W7Q |
Hexadecamethylcyclooctasiloxane | 556-68-3 | C16H48O8Si8 | 593.232 g/mol | |
Hexacosyl (E)-ferulate | 63034-29-7 | C36H62O4 | 558.9 | Hexacosyl (2E)-3-(4-hydroxy-3-methoxyphenyl)acrylate |
Hexacos-1-ene | 18835-33-1 | C26H52 | ||
Hexaconazole | 79983-71-4 | C14H17Cl2N3O | 314.21 | (±)-Hexaconazole; Contaf; Sitara; Anvil; 2-(2,4-dichlorophenyl)-1-(1,2,4-triazol-1-yl)hexan-2-ol |
Hetacillin potassium | 5321-32-4 | C19H22KN3O4S | 427.56 | potassium;(2S,5R,6R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylate; |
Hetacillin | 3511-16-8 | C19H23N3O4S | 389.47 | (2S,5R,6R)-6-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2-carboxylic acid; 6beta-[(4R)-2,2-Dimethyl-5-oxo-4-phenylimidazolidin-1-yl]penicillanic acid |
HET0016 | 339068-25-6 | C12H18N2O | 206.3 | HET 0016; HET0016; N-hydroxy-N'-(4-n-butyl-2-methylphenyl)Formamidine |
Hesperetin 5-O-glucoside | 69651-80-5 | C22H24O11 | 464.42 | Hesperetin 5-glucoside; Hesperetin 5-O-beta-D-glucoside; (2S)-7-hydroxy-2-(3-hydroxy-4-methoxy-phenyl)-5-[(2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy-chroman-4-one; 4H-1-Benzopyran-4-one, 5-(beta-D-glucopyranosyloxy)-2,3-dihydro-7-hyd |
Hesperidinase from Aspergillus niger | 37213-47-1 | Hesperidin--1,6-rhamnosidase | ||
Hesperidin | 520-26-3 | C28H34O15 | 610.56 | 3,5,7-Trihydroxy-4-methoxyflavanone-7-O-(6-O-a-L-rhamnopyranosyl)-b-D-glucopyranoside; Hesperetin-7-rutinoside; Cirmtin |
HESPERETIN DIHYDROCHALCONE | 35400-60-3 | C16H16O6 | 304.29 | 4-METHOXY-2',4',6',3-TETRAHYDROXYDIHYDROCHALCONE; HESPERETIN DIHYDROCHALCONE; HESPERIDINDIHYDROCHALCONE; 1-Propanone, 3-(3-hydroxy-4-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)-; 3-(3-Hydroxy-4-methoxyphenyl)-1-(2,4,6-trihydroxyphenyl)-1-propanone |
Hesperetin 7-O-glucoside | 31712-49-9 | C22H24O11 | 464.42 | |
Hesperetin 7-O-b-D-glucuronide | 1237479-09-2 | C22H22O12 | 478.40 | 3,4-Dihydro-5-hydroxy-2-(3-hydroxy-4-methoxyphenyl)-4-oxo-2H-1-benzopyran-7-yl b-D-glucopyranosiduronic acid |
Hesperetin 3-O-b-D-glucuronide | 1237479-05-8 | C22H22O12 | 478.40 | 5-(3,4-Dihydro-5,7-dihydroxy-4-oxo-2H-1-benzopyran-2-yl)-2-methoxyphenyl b-D-glucopyranosiduronic acid |
Hesperetin | 520-33-2 | C16H14O6 | 302.282 | Hesperitin; 3',5,7-Trihydroxy-4'-methoxyflavanone; Hesperin; YSO2; (2S)-5,7-dihydroxy-2-(3-hydroxy-4-methoxyphenyl)-2,3-dihydrochromen-4-one |
Hesperadin | 422513-13-1 | C29H32N4O3S | 516.65 | Hesperadin |
Herquline A | 71812-08-3 | C19H26N2O2 | 314.42 | Herqueline |
Herpetone | 951677-22-8 | C29H30O9 | 522.54 | |
Heronamide C | 1257083-94-5 | C29H39NO3 | 449.3 | |
Herboxidiene | 142861-00-5 | C25H42O6 | 438.601 | Herboxidiene |
Herbimycin C | 91700-92-4 | C29H40N2O9 | 560.6 | TAN 420D |
Herbimycin A | 70563-58-5 | C30H42N2O9 | 574.67 | (15r)-geldanamyci; antibiotictan420f; herbimycin; HERBIMYCIN A; HERBIMYCIN A, STREPTOMYCES HYGROSCOPICUS; HERBIMYCIN A, STREPTOMYCES SPECIES; herbimycin A from streptomyces hygros-copicus; herbimycin A from streptomyces*hygroscopicus |
Herbicidin A | 55353-31-6 | C23H29N5O11 | 551.5 | |
Herbarin | 36379-67-6 | C16H16O6 | 304.298 | dehydroherbarin; 3-hydroxy-7,9-dimethoxy-3-methyl-1,4-dihydrobenzo[g]isochromene-5,10-dione |
Herbaridine B | 1151511-05-5 | C17H20O6 | 320.341 | |
Herbacetin | 527-95-7 | C15H10O7 | 3,5,7,8-tetrahydroxy-2-(4-hydroxyphenyl)-4H-chromen-4-one | |
Heraclenol acetonide | 64790-68-7 | C19H20O6 | 344.4 | 9-{[(4R)-2,2,5,5-Tetramethyl-1,3-dioxolan-4-yl]methoxy}-7H-furo[3 ,2-g]chromen-7-one |
Heraclenol | 31575-93-6 | C16H16O6 | 304.3 | 9-[(2R)-2,3-dihydroxy-3-methylbutoxy]furo[3,2-g]chromen-7-one |
Heptyloxyethanol | 7409-44-1 | C9H20O2 | 160.25 | 2-(heptyloxy)-ethano; 2-(heptyloxy)ethanol; ethyleneglycolmonoheptylether; heptylcellosolve; HEPTYLOXYETHANOL; HEPTYLOXYETHANOL 90%; Heptyloxyethanol,90%; HeptyloxyethanolEthyleneglycol monoheptylether |
Heptakis(2,3,6-tri-O-methyl)cyclomaltoheptaose | 55216-11-0 | C63H112O35 | 1429.54 | Heneicosa-O-methyl-b-cyclodextrin; Heptakis-(2,3,6-tri-O-methyl)-b-cyclodextrin |
Heptakis(2,3,6-tri-O-ethyl)cyclomaltoheptaose | 111689-01-1 | C84H154O35 | 1724.10 | Heptakis-(2,3,6-tri-O-ethyl)-b-cyclodextrin |
Heptakis(2,3,6-tri-O-benzoyl)cyclomaltoheptaose | 23666-43-5 | C189H154O56 | 3321.21 | Heptakis-(2,3,6-tri-O-benzoyl)-b-cyclodextrin |
Heptafluoro-1-methoxypropane | 375-03-1 | C4H3F7O | 200.05 | HEPTAFLUOROPROPYL METHYL ETHER; HEPTAFLUORO-1-METHOXYPROPANE; 1,1,1,2,2,3,3-Heptafluoro-3-methoxypropane; 1,1,1,2,2,3,3-heptafluoro-3-methoxy-Propane; Heptafluoropropylmethylether98%; 1,1,1,2,2,3,3-heptafluoro-3-methoxy-Propan; Propane,1,1,1,2,2,3,3-hepta |
Heptadecyl mercaptan | 53193-22-9 | C17H36S | 272.53 | HEPTADECYL MERCAPTAN; 1-Heptadecanethiol; Heptadecane-1-thiol |
Heptadecyl 2-acetamido-3,4,6-tri-O-acetyl-2-deoxy-b-D-glucopyranoside | 262856-89-3 | C31H55NO9 | 585.77 | |
Heparin derived disaccharide sodium salt | 98797-50-3 | C12H15NO19S3 Na4 | 665.4 | 2-Deoxy-2-sulfoamino-6-O-sulfo-4-O-(2-O-sulfo-a-L-idopyranuronosyl)-a-D-glucopyranose; 4-O-(a-L-Idopyranosyluronic acid 2-sulfate)-D-glucosamine 2,6-disulfate |
Heparin calcium | 37270-89-6 | average molecular weight<8000 | ||
Heparin | 9005-49-6 | C26H42N2O37S5 | 1134.93 | [2-Deoxy-2-sulfoamino-6-O-sulfo-4-O-(2-O-sulfo-a-L-idopyranuronosyl)-a-D-glucopyranose]n |
Heparan Sulfate | 9050-30-0 | C12H19NO20S3 (monomer) | 593.47 (monomer) | Alpha-idosane; HHS 5; Heparan N-Sulfate; Heparan Sulfate; Heparan Sulphate; Heparitin; Heparitin Monosulfate; N-Acetylheparan Sulfate; Suleparoid; Tavidan |
Hennadiol | 20065-99-0 | C30H50O2 | 442.73 | 29-Hydroxylupeol;30-Hydroxylup-20(29)-en-3beta-ol;3beta,30-Dihydroxylup-20(29)-ene;Lup-20(29)-ene-3beta,30-diol;Wallichenol |
Henicosafluorodecanesulfonic acid | 335-77-3 | C10HF21O3S | 600.145 g/mol | |
Heneicosapentaenoic acid methyl ester | 65919-53-1 | C22H34O2 | 330.5 | HPA methyl ester; Methyl 6,9,12,15,18-heneicosapentaenoate; (all-Z)-6,9,12,15,18-heneicosapentaenoic acid methyl ester; (6Z,9Z,12Z,15Z,18Z)-6,9,12,15,18-henicosapentaenoic acid methyl ester |
Heneicosapentaenoic acid | 24257-10-1 | C21H32O2 | 316.5 | HPA; (all-Z)-6,9,12,15,18-heneicosapentaenoic acid; (6Z,9Z,12Z,15Z,18Z)-6,9,12,15,18-henicosapentaenoic acid |
Heneicosane, 2-methyl- | 1560-82-3 | C22H46 | 310.6 | 2-methylhenicosane; heneicosane,2-methyl-; 2-METHYLHENEICOSANE |
Henatinib | 1239269-51-2 | C25H29FN4O4 | 468.529 | Henatinib |
Henagliflozin | 1623804-44-3 | C22H24ClFO7 | 454.88 | UNII-21P2M98388; 21P2M98388; Henagliflozin; SHR3824; SHR-3824; (1R,2S,3S,4R,5R)-5-[4-chloro-3-[(4-ethoxy-3-fluorophenyl)methyl]phenyl]-1-(hydroxymethyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triol |
Hemp oil | 89958-21-4 | Hemp oil; Hemp oil, pressed | ||
Hemorphin-7 | 152685-85-3 | C49H64N12O11 | 997.11 | H-Tyr-Pro-Trp-Thr-Gln-Arg-Phe-OH; L-tyrosyl-L-prolyl-L-tryptophyl-L-threonyl-L-glutaminyl-L-arginyl-L-phenylalanine; (2S)-2-[[(2S)-2-[[(2S)-5-amino-2-[[(2S,3R)-2-[[(2S)-2-[[(2S)-1-[(2S)-2-amino-3-(4-hydroxyphenyl)propanoyl]pyrrolidine-2-carbonyl]amino]-3- |
Hemopressin (rat) | 568588-77-2 | C53H77N13O12 | 1088.27 | |
Hemopressin (human, mouse) | 1314035-51-2 | C50H79N13O12 | 1054.26 | |
HBED HCL H2O | 35369-53-0 | C20H27ClN2O7 | 442.89 | HBED 2HCL 2H2O; HBED HCL H2O; N,N'-DI(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID MONOHYDROCHLORIDE HYDRATE; N,N'-DI(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID DIHYDROCHLORIDE DIHYDRATE; N,N'-Di(2-hydroxybenzyl)ethylenediamine-N,N'-diacetic |
HBED | 35998-29-9 | C20H24N2O6 | 388.41 | HBED; N,N'-DI(2-HYDROXYBENZYL)ETHYLENEDIAMINE-N,N'-DIACETIC ACID HCL; N,N-BIS[2-HYDROXYBENZYL]ETHYLENEDIAMINE-N,N-DIACETIC ACID; chelii; n,n'-1,2-ethanediylbis(n-((2-hydroxyphenyl)methyl)-glycin; n,n'-1,2-ethanediylbis(n-((2-hydroxyphenyl)methyl)glycine) |
HBDDE | 154675-18-0 | C16H18O8 | 338.31 | hbdde; CHEMBL59451; 154675-18-0; 6,6'-bis(methoxymethyl)biphenyl-2,2',3,3',4,4'-hexol; 2,2',3,3',4,4'-Hexahydroxy-1,1'-biphenyl-6,6'-dimethanoldimethylether; CHEMBL437222 |
HAT Inhibitor II | 932749-62-7 | C20H16Br2O3 | 464.2 | Histone Acetyltransferase Inhibitor II; (2E,6E)-2,6-bis[(3-bromo-4-hydroxyphenyl)methylidene]cyclohexan-1-one |
H-Asn-OH | 70-47-3 | C4H10N2O3 | ||
HASMIGONE (HEXENYL CYCLOPENTANONE) | 34687-46-2 | C11H18O | 166.26 | 2-(2-Hexenyl) cyclopentanone, Cyclopentanone, 2-(2-hexenyl)-, HASMIGONE (HEXENYL CYCLOPENTANONE) |
Harzianum A | 156250-74-7 | C23H28O6 | 400.46 | 8-oxo-8-(1,2,5-trimethylspiro[8-oxatricyclo[7.2.1.02,7]dodec-5-ene-12,2'-oxirane]-11-yl)oxyocta-2,4,6-trienoic acid |
Harzianopyridone | 137813-88-8 | C14H19NO5 | 281.3 | (-)-Harzianopyridone; 4-Hydroxy-5,6-dimethoxy-3-[(2S,4E)-2-methyl-1-oxo-4-hexenyl]-2(1H)-pyridinone |
Harringtonine | 26833-85-2 | C28H37NO9 | 531.59 | 2'R-Harringtonine; Alkaloid C from cephalotaxus; Harringtonin; NSC 124147; Cephalotaxine, 4-methyl (2R)-2-hydroxy-2-(3-hydroxy-3-methylbutyl)butanedioate (ester) |
Harpagoside | 19210-12-9 | C24H30O11 | 494.50 | HARPAGOSIDE;8-O-E CINNAMOYL HARPAGIDE;8'-CINNAMOYLHARPAGIDE;Harpagosid;[1S-[1alpha,4aalpha,5alpha,7alpha(E),7aalpha]]-1,4a,5,6,7,7a-hexahydro-4a,5-dihydroxy-7-methyl-7-[(allyl-1-oxo-3-phenyl)oxy]cyclopenta[c]pyran-1-yl-beta-D-glucopyranoside;Harpogoside;H |
Harpagide | 6926-08-5 | C15H24O10 | 364.35 | (1S-(1a,4aa,5a,7a,7a))-1,4a,5,6,7,7a-Hexahydro-4a,5,7-trihydroxy-7-methylcyclopenta[c]pyran-1-yl beta-D-glucopyranoside |
Harmine | 442-51-3 | C13H12N2O | 212.25 | 7-Methoxy-1-methyl-9H-beta-carbolin; 7-Methoxy-1-methyl-9H-beta-carboline |
Harman | 486-84-0 | C12H10N2 | 182.22 | 1-Methyl-9H-pyrido[3,4-b]indole; Harman; Aribine; Locuturine |
H-Arg-Lys-OH | 40968-46-5 | C12H26N6O3 | 362.43 | H-ARG-LYS-OH ACETATE SALT; H-ARG-LYS-OH ACOH; arg-lys acetate; H-Arg-Lys-OH |
Halobetasol Propionate Impurity D | 66852-61-7 | C25H31Cl2FO5 | 501.43 | |
Halobetasol Propionate Impurity C | 181527-42-4 | C25H31ClF2O5 | 484.97 | |
Halobetasol Propionate Impurity B | 79861-38-4 | C27H34F2O7 | 508.56 | |
Halobetasol Propionate | 66852-54-8 | C25H31ClF2O5 | 484.96 | Vitamin B1 |
Halobetasol Dipropionate | 886204-51-9 | C28H35ClF2O6 | 541.04 | |
Halobetasol | 98651-66-2 | C22H27ClF2O4 | 428.901 | Halobetasol; Ulobetasol |
Halicloic acid A | 1393581-27-5 | C38H56O5 | 592.85 | Halicloic Acid A; CHEMBL2087614; BDBM50421038; 4-(4'-(2''-methoxy-4''-hydroxy-3'',6''-dimethylbenzoyloxy)-3',5',6'-trimethyl-2'-methoxybenzoyloxy)-2-methoxy-3,6-dimethylbenzoic acid |
Halcinonide | 3093-35-4 | C24H32ClFO5 | 454.96 | Halcinonide |
HAC-Y6 | 1331959-78-4 | C23H22N2O4 | 390.432 | HAC-Y6; HACY6; HAC Y6 |
Guanosine 5'-O-(2-Thiodiphosphate) Trilithium Salt | 97952-36-8 | C10H12Li3N5O10P2S | 477.07 | |
Guanosine 5-monophosphomorpholidate | 7361-07-1 | C31H52N9O9P | 725.8 | |
Guanosine 5'-Diphosphate Triammonium Salt | 79441-34-2 | C10H16N6O11P2 | 458.22 | Guanosine 5'-(Trihydrogen Diphosphate), Triammonium Salt; Triammonium Guanosine 5'-Diphosphate |
guanosine 5'-diphosphate disodium salt | 7415-69-2 | C10H13N5Na2O11P2 | 487.165 | 5'-GDP; 5'-GDP 2Na; Guanosine-5,-diphosphate disodium |
Guanosine 5'-(tetrahydrogen triphosphate) Sodium Salt (>80%) | 24905-71-3 | 523.18 | 5'-GTP Sodium Salt; Sodium GTP | |
Guanosine 3'-diphosphate 5'-triphosphate | 38918-96-6 | C10H18N5O20P5 | 683.14 g/mol | |
Guanosine 3',5'-Diphosphate Tetralithium Salt | 55612-39-0 | C10H11Li4N5O11P2 | 466.93 | Guanosine 3',5'-Bis(dihydrogen Phosphate) Tetralithium Salt; 3',5'-Diphosphoguanosine Tetralithium Salt |
Guanosine 3'-(trihydrogen diphosphate), 5'-(trihydrogen diphosphate) | 32452-17-8 | C10H17N5O17P4 | 0 | Guanosine 3'-(trihydrogen diphosphate), 5'-(trihydrogen diphosphate); GUANOSINE TETRAPHOSPHONATE |
Guanosine-2'(3')-monophosphate disodium salt | 70347-42-1 | C10H12N5O8PNa2 | 407.18 | Guanylic acid disodium salt; Guanosine 2'-3'-monophosphate disodium salt mixed Isomers; 2'-Guanylic acid, disodium salt; (2R,3R,4R,5R)-2-(2-amino-6-hydroxypurin-9-yl)-4-hydroxy-5-(hydroxymethyl)oxola n-3-yl dihydrogen phosphate, sodium salt, sodium salt |
Guanosine 2',3'-Cyclic Monophosphate Triethylamine Salt | 73647-09-3 | C16H27N6O7P | 446.4 | Guanosine Cyclic 2',3'-(Hydrogen Phosphate) N,N-Diethylethanamine |
Guanosine | 118-00-3 | C10H13N5O5 | 283.24 | Guanosine; NSC 19994; NSC19994; NSC-19994 |
Guanoclor | 5001-32-1 | C9H12Cl2N4O | 263.12 | 2-(2-(2,6-dichlorophenoxy)ethyl)hydrazine-1-carboximidamide; Guanoclor; VATENSOL. |
Guanine-15N5 | 168566-53-8 | C5H5[15N]5O | 156.09 | 2-Amino-1,9-dihydro-6H-purin-6-one-4,8-15N5; 2-Amino-6-hydroxy-1H-purine-15N5; 2-Amino-6-hydroxypurine-15N5; 2-Aminohypoxanthine-15N5; 9H-Guanine-15N5; 2-Amino-hypoxanthine-15N5 |
GT1b-Oligosaccharide | 75663-36-4 | C59H96N4O45 | 1581.39 | |
GUANIDINOSUCCINIC ACID | 6133-30-8 | C5H9N3O4 | 175.14 | |
Guanidinoethyl sulfonate | 543-18-0 | C3H9N3O3S | 167.2 | NSC 667063; Taurocyamine; 2-[(aminoiminomethyl)amino]-ethanesulfonic acid |
Guanidinium dihydrogen phosphate | 5423-22-3 | CH5N3.H3O4P | 157.06 | guanidinium phosphate (1:1); GUANIDINUM MONOHYDROGEN PHOSPHATE; GUANIDINE DIHYDROGEN PHOSPHATE; GUANIDINE PHOSPHATE, DIBASIC; GUANIDINE PHOSPHATE, MONOBASIC; Guanidinium dihydrogen phosphate; GUPHOS; DIGUANIDINE PHOSPHATE |
GUANIDINE-13C HYDROCHLORIDE | 286013-04-5 | CH6ClN3 | 96.54 | guanidine; hydrochloride; Guanidine-13Chydrochloride; 286013-04-5; 492701_ALDRICH; GUANIDINE-13CHYDROCHLORIDE |
Guanidine, N,N-diethyl- | 18240-93-2 | C5H13 N3 | 115.18 | N,N-DIETHYL-GUANIDINE; 1,1-DIETHYLGUANIDINE |
Guanidine thiocyanate | 593-84-0 | CN3H5.HSCN | 118.16 | GITC; Guanidinium rhodanide; Guanidinium thiocyanate |
Guanidine phosphate | 1763-07-1 | CH5N3.x(H3PO4) | 157.07 | |
Guanidine hydrochloride | 50-01-1 | CH5N3.HCl | 95.53 | Guanidine HCl; Guanidinium chloride; GuHCl; GdnHCl; GdmCl |
guanidine | 113-00-8 | CH5N3 | 59.0706 | Guanidinebase; Carbamidine; carbamamidine; imidourea; Diaminomethanimine |
GUANIDINE | 90332-86-8 | CH3N3O | 73.05402 | GUANIDINE; iminourea; aminoformamidine; aminomethanamidine |
Guangxitoxin 1E | 1233152-82-3 | C178H248N44O45S7 | 3948.61 | |
Guan-fu base G | 78969-72-9 | C26H33NO7 | 471.5 | |
Guan-fu base A | 1394-48-5 | C24H31NO6 | 429.5 | guanfu base A |
Guanfacine-13C-15N3 | 1189924-28-4 | C8H9Cl2O[13C][15N]3 | 250.07 | N-(Aminoiminomethyl)-2,6-dichlorobenzeneacetamide-13C, 15N3; N-Amidino-2-(2,6-dichlorophenyl)acetamide-13C, 15N3; [(2,6-Dichlorophenyl)acetyl]guanidine-13C,15N3 |
Guanfacine Methyl Ester Impurity | 54551-83-6 | C9H8Cl2O2 | 219.07 | 2,6-Dichlorobenzeneacetic acid methyl ester; Methyl 2,6-dichlorophenylacetate; Methyl 2-(2,6-Dichlorophenyl)Ethanoate; St5406080 |
Guanfacine Hydrochloride | 249-443-3 | C9H10Cl3N3O | 282.55 | N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide;hydrochloride; Guanfacine Hydrochloride; BS 100 141; BS-100-141; BS100141; Estulic; Guanfacine; Guanfacine Hydrochloride; Guanfacine Monohydrochloride; Hydrochloride, Guanfacine; Lon798; Monohydrochl |
Guanfacine hydrochloride | 29110-48-3 | C9H10Cl3N3O | 282.56 | BS 100-141; Tenex; Estulic; Guanfacine HCl; N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide hydrochloride |
Guanfacine | 29110-47-2 | C9H9Cl2N3O | 246.10 | N-(diaminomethylidene)-2-(2,6-dichlorophenyl)acetamide BS 100 141 BS-100-141 BS100141 Estulic Guanfacine Guanfacine Hydrochloride Guanfacine Monohydrochloride Hydrochloride, Guanfacine Lon798 Monohydrochloride, Guanfacine Tenex |
Guajadial B | 1414455-03-0 | C30H34O5 | 474.6 | |
Goniodiol 8-acetate | 144429-71-0 | C15H16O5 | 276.3 | |
Goniodiol | 96422-52-5 | C13H14O4 | 234.3 | (6R)-6-[(1R,2R)-1,2-Dihydroxy-2-phenylethyl]-5,6-dihydro-2H-pyran-2-one |
Gonadorelin diacetate | 71447-49-9 | C55H75N17O13.2(C2H4O2) | 1302.41 | LUTEINIZING HORMONE RELEASING HORMONE (HUMAN) (PORCINE, RAT) 2ACOH 4H2O; GONADOTROPIN-RELEASING HORMONE (PORCINE, RAT) 2ACOH 4H2O; GNRH (PORCINE, RAT) 2ACOH 4H2O; LH-RH (HUMAN) (PORCINE, RAT) 2ACOH 4H2O; LH-RH HUMAN DIACETATE SALT; gonadorelindiacetate; l |
Gonadorelin Acetate Hydrate (1:x:x) | 52699-48-6 | C55H75N17O12.xC2H4O2.xH2O | 1166.31 (free base) | |
Gonadorelin acetate | 34973-08-5 | C57H79N17O15 | 1242.34 | Luprolite acetate; H-Pyr-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly-NH2.CH3CO2H |
Gonadorelin | 33515-09-2 | C55H75N17O13 | 1182.29 | Luliberin; LH-Releasing hormone; AY-24031; AY 24031; AY24031; Relisorm L; Synthetic gonadoliberin |
Gomisin U | 135095-46-4 | C23H30O7 | 418.48 | |
Gomisin S | 119239-49-5 | C23H30O7 | 418.5 | (6S,7S,8S,12aS)-5,6,7,8-Tetrahydro-1,2,10,11,12-pentamethoxy-6,7-dimethyldibenzo[a,c]cyclooctene-3,8-diol |
Gomisin O | 72960-22-6 | C23H28O7 | 416.46 | |
GOMISIN N | 69176-52-9 | C23H28O6 | 400.46 | GOMISIN N; Benzo(3,4)cycloocta(1,2-F)(1,3)benzodioxole, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, (6R,7S,13as)- |
Gomisin L2 | 82425-44-3 | C22H26O6 | 386.44 | (-)-Gomisin L2 |
Gly-Pro-Glu | 32302-76-4 | C12H19N3O6 | 301.30 | GPE, Glycyl-prolyl-glutamic acid |
Glyphosate-sodium | 34494-03-6 | C3H7NNaO5P | 191.05 | Glyphosate-sodium; N-(Phosphonomethyl)glycine monosodium salt |
Glyphosate-ammonium | 40465-66-5 | C3H7NO5P.NH4 | 186.10 | N-(Phosphonomethyl)glycine monoammonium salt; Glyphosate-ammonium |
Glyphosate isopropylamine salt | 38641-94-0 | C3H9N.C3H8NO5P | 228.18 | n-(phosphonomethyl)-glycincompd.with2-propanamine(1:1); n-(phosphonomethyl)glycineisopropylaminesalt; n-(phosphonomethyl)glycineisopropylammoniumsalt; nitosorg; rattler; utal; glifosatoestrella; glyphosate,isopropylaminesalt |
Glipizide | 29094-61-9 | C21H27N5O4S | 445.54 | CP-28720; CP 28720; CP28720 |
Gliotoxin | 67-99-2 | C13H14N2O4S2 | 326.0 | Aspergillin, SN 12879, SN 12870 |
Gliorosein | 4373-40-4 | C10H14O4 | 198.22 | 2,3-dimethoxy-5S,6S-dimethyl-2-cyclohexene-1,4-dione |
Glimepiride-d4 | 1131981-29-7 | C24H30D4N4O5S | 494.65 | 3-ethyl-4-methyl-2-oxo-N-(2-{4-[({[(1r,4r)-4-methylcyclohexyl]carbamoyl}amino)sulfonyl]phenyl}(1,1,2,2-D4)ethyl)-2,5-dihydro-1H-pyrrole-1-carboxamide |
Glimepiride Impurity I | 878480-70-7 | C24H34N4O5S | 490.63 | ortho-Glimepiride Impurity; 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[2-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide; Glimepride 2-Isomer; Glimepiride ortho isomer |
Glimepiride Impurity D | 791104-62-6 | C24H34N4O5S | 490.63 | 1-[[m-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea; 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[3-[[[[(trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxami |
Glimepiride Impurity C | 119018-30-3 | C18H23N3O6S | 409.46 | N-[[4-[2-[[(3-Ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrol-1-yl)carbonyl]amino]ethyl]phenyl]sulfonyl]carbamic acid methyl ester; Methyl ((4-(2-(3-ethyl-4-methyl-2-oxo-2,5-dihydro-1H-pyrrole-1-carboxamido)ethyl)phenyl)sulfonyl)carbamate; [[4-[2-[[(3-Ethyl-2, |
Fluticasone propionate | 80474-14-2 | C25H31F3O5S | 500.57 | Fluticasone Propionate, Cutivate, Flixonase, Flixotide, Flonase, Flovent; DSSTox_CID_25511; DSSTox_RID_80922; DSSTox_GSID_45511; NCGC00016943-01 |
Floctafenine | 23779-99-9 | C20H17F3N2O4 | 406.3553 | floctafenine; Idarac; 23779-99-9; Novodolan; Idalon; Diralgan |
FloCoumafen | 90035-08-8 | C33H25F3O4 | 542.54 | 2h-1-benzopyran-2-one,4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-((4-(trifluoromethy; 4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-((4-(trifluoromethyl)phenyl)methoxy)phenyl)-1-naphthalenyl)-2h-1-benzopyran-2-on; 4-hydroxy-3-(1,2,3,4-tetrahydro-3-(4-(4-trifluoromethylb |
FLLL32 | 1226895-15-3 | C28H32O6 | 464.558 | FLLL-32; BCP28141; (E)-3-(3,4-dimethoxyphenyl)-1-[1-[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]cyclohexyl]prop-2-en-1-one |
FLLL31 | 52328-97-9 | C25H28O6 | 424.493 | FLLL31; FLLL 31; FLLL-31. |
Flindokalner | 187523-35-9 | C16H10ClF4NO2 | 359.7 | (3S)-3-(5-chloro-2-methoxyphenyl)-3-fluoro-6-(trifluoromethyl)-1H-indol-2-one; (5-chloro-2-methoxyphenyl)-1,3-dihydro-3-fluoro-6-(trifluoromethyl)-2H-indol-2-one; BMS 204352; BMS-204352; BMS204352; MaxiPost |
Ethyl Tropic Acid | 3979-14-4 | C11H14O3 | 194.23 | |
Guajadial | 959860-49-2 | C30H34O5 | 474.6 | (2aR,4aR,10R,10aS,13aS)-7,9-Dihydroxy-2,2,4a-trimethyl-13-methyle ne-10-phenyl-1,2,2a,3,4,4a,10,10a,11,12,13,13a-dodecahydrocyclobu ta[6,7]cyclonona[1,2-b]chromene-6,8-dicarbaldehyde |
Guaifenesin-D5 | 1329563-41-8 | C10H9O4D5 | 203.25 | rac Guaifenesin-d5; 3-(o-Methoxyphenoxy)-1,2-propanediol-d5; Guaiacol Glyceryl-d5 Ether; Robitussin-d5 |
Guaifenesin-d3 | 1189924-85-3 | C10H11O4D3 | 201.24 | rac Guaifenesin-d3; 3-(o-Methoxyphenoxy)-1,2-propanediol-d3; Guaiacol Glyceryl Ether-D3; Robitussin-d3 |
Guaifenesin Impurity D | 16929-60-5 | C17H20O5 | 304.35 | 1,3-Bis(2-methoxyphenoxy)-2-propanol; 1,3-Bis(2-methoxyphenoxy)propan-2-ol; NSC 142122 |
Guaifenesin Impurity B | 14007-09-1 | C10H14O4 | 198.22 | 2-(2-methoxyphenoxy)propane-1,3-diol; 1,3-Propanediol, 2-(o-methoxyphenoxy)-; 2-(o-Methoxyphenoxy)-1,3-propanediol; Brn 2049374; 1,3-Propanediol,2-(2-Methoxyphenoxy)-; 2-(2-Methoxyphenoxy)-1,3-propanediol |
GUAIENE | 88-84-6 | C15H24 | 204.35 | 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethylidene)-,(1S-cis)-Azulene; 1,2,3,4,5,6,7,8-octahydro-1,4-dimethyl-7-(1-methylethylidene)-azulen(1s-ci; 1,2,3,4,5,6,7,8-Octahydro-1,4-dimethyl-7-(1-methylethylidene)-azulene; 1,2,3,4,5,6,7,8-octahydro-1 |
GT1b-Ganglioside | 59247-13-1 | C95H165N5O48 xNa | 2145.33 (free acid basis) | Cer-Glc-Gal(NeuAc-NeuAc)-GalNAc-Gal-NeuAc; GT1b-Ganglioside |
GT 949 | 460330-27-2 | C30H37N7O2 | 527.66 | 3-((4-Cyclohexylpiperazin-1-yl)(1-phenethyl-1H-tetrazol-5-yl)methyl)-6-methoxyquinolin-2(1H)-one |
GT 2016 | 152241-24-2 | C19H31N3O | 317.47 | 5-Cyclohexyl-1-[4-(1H-imidazol-5-yl)-1-piperidinyl]-1-pentanone |
GQ-16 | 870554-67-9 | C19H16BrNO3S | 418.3 | 5Z-[(5-bromo-2-methoxyphenyl)methylene]-3-[(4-methylphenyl)methyl]-2,4-thiazolidinedione |
GSK-LSD1 2HCl | 1431368-48-7 | C14H22Cl2N2 | 289.24 | GSK LSD1 2HCl; GSK-LSD1 Dihydrochloride |
GSK-J2 sodium salt | 2108665-15-0 | C22H23N5O2·Na | 412.4 | 3-((6-(4,5-dihydro-1H-benzo[d]azepin-3(2H)-yl)-2-(pyridin-3-yl)pyrimidin-4-yl)amino)propanoic acid, monosodium salt |
GSK-J2 | 1394854-52-4 | C22H23N5O2 | 389.45 | SK-J2; GSK J2; 1394854-52-4; SCHEMBL15937902; 3705AH |
GSK963 | 2049868-46-2 | C14H18N2O | 230.31 | 2,2-dimethyl-1-[(3S)-3-phenyl-3,4-dihydropyrazol-2-yl]propan-1-one |
GSK-923295 | 1088965-37-0 | C32H38ClN5O4 | 592.137 | GSK-923295; GSK 923295; GSK923295. |
GSK894490A | 1012035-06-1 | C24H30ClN3O4S | 492.03 | Benzenesulfonamide, N-(5-((3R,5S)-3,5-dimethyl-1-piperazinyl)-2-methoxyphenyl)-4-(5-methyl-2-furanyl)-, hydrochloride (1:1), rel-;N-[5-[(3R,5S)-3,5-dimethylpiperazin-1-yl]-2-methoxyphenyl]-4-(5-methylfuran-2-yl)benzenesulfonamide hydrochloride;GSK-894490A |
GSK'872 | 1346546-69-7 | C19H17N3O2S2 | 383.49 | N-(6-propan-2-ylsulfonylquinolin-4-yl)-1,3-benzothiazol-5-amine |
GSK864 | 1816331-66-4 | C30H31FN6O4 | 558.6 | (7S)-1-[(4-fluorophenyl)methyl]-3-N-(4-methoxy-3,5-dimethylphenyl)-7-methyl-5-(1H-pyrrole-2-carbonyl)-4,6-dihydropyrazolo[4,3-c]pyridine-3,7-dicarboxamide; GSK 864; GSK-864 |
GSK-8573 | 1693766-04-9 | C20H21NO3 | 323.392 | GSK8573; 1-[1-(3-Methoxyphenyl)-7-propoxyindolizin-3-yl]ethanone |
GSK837149 | 13616-29-0 | C23H22N8O5S2 | 554.6 | 1,3-bis[4-[(4-methylpyrimidin-2-yl)sulfamoyl]phenyl]urea |
GSK-7975A | 1253186-56-9 | C18H12F5N3O2 | 397.31 | SCHEMBL705705; AOB4124; CPYTVBALBFSXSH-UHFFFAOYSA-N;2,6-difluoro-N-[1-[[4-hydroxy-2-(trifluoromethyl)phenyl]methyl]pyrazol-3-yl]benzamide |
GSK7227 | 1067214-81-6 | C25H22N2O6S | 478.52 | 2-[[3-(5-Methoxy-4-methylindol-1-yl)sulfonylbenzoyl]amino]-5-methylbenzoic acid;GSK-7227;Benzoic acid, 2-((3-((5-methoxy-4-methyl-1H-indol-1-yl)sulfonyl)benzoyl)amino)-5-methyl- |
GSK-690693 | 937174-76-0 | C21H27N7O3 | 425.48418 | GSK-690693; GSK690693. |
GSK6853 | 1910124-24-1 | C22H27N5O3 | 409.49 | N-[1,3-dimethyl-6-[(2R)-2-methylpiperazin-1-yl]-2-oxobenzimidazol-5-yl]-2-methoxybenzamide; GSK6853; GSK-6853; GSK-6853 |
GSK650394 | 890842-28-1 | C25H22N2O2 | 382.45 | GSK650394; GSK-650394; GSK 650394 |
GSK-626616 | 1025821-33-3 | C18H10Cl2N4OS | 401.26 | (5Z)-2-(2,6-Dichloroanilino)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazolone;GSK626616;(5Z)-2-(2,6-dichloroanilino)-5-(quinoxalin-6-ylmethylidene)-1,3-thiazol-4-one |
GSK621 | 1346607-05-3 | C26H20ClN3O5 | 489.91 | GSK-621; GSK 621. |
GSK-598809 | 1310803-30-5 | C23H25F4N5OS | 495.54 | NII-Y5OZ63HC3V;5-(5-((3-((1S,5R)-1-(2-Fluoro-4-(trifluoromethyl)phenyl)-5-methyl-3-azabicyclo(3.1.0)hexan-3-yl)propyl)thio)-4-methyl-4H-1,2,4-triazol-3-yl)-4-methyloxazole |
GSK5959 | 901245-65-6 | C22H26N4O3 | 394.47 | N-(1,3-dimethyl-2-oxo-6-piperidin-1-ylbenzimidazol-5-yl)-2-methoxybenzamide;GSK-5959 |
GSK481 | 1622849-58-4 | C21H19N3O4 | 377.39 | 5-benzyl-N-[(3S)-5-methyl-4-oxo-2,3-dihydro-1,5-benzoxazepin-3-yl]-1,2-oxazole-3-carboxamide |
GSK466317A | 864082-48-4 | C21H16ClF3N4O2 | 448.83 | N-(7-chloro-1H-indazol-5-yl)-6-methyl-2-oxo-4-[4-(trifluoromethyl)phenyl]-3,4-dihydro-1H-pyridine-5-carboxamide |
GSK-461364 | 929095-18-1 | C27H28F3N5O2S | 543.609 | GSK 461364; 5-[6-[(4-Methyl-1-piperazinyl)methyl]-1h-benzimidazol-1-yl]-3-[(1r)-1-[2-(trifluoromethyl)phenyl]ethoxy]-2-thiophenecarboxamide |
GSK429286A | 864082-47-3 | C21H16F4N4O2 | 432.37 | GSK 429286A; GSK-429286A |
GSK4112 | 1216744-19-2 | C18H21ClN2O4S | 396.89 | GSK4112;SR6452;CHEMBL1961795;1216744-19-2;MLS006010708;GTPL2903 |
GSK4027 | 2079896-25-4 | C17H21BrN4O | 377.3 | 4-bromo-2-methyl-5-[[(3R,5R)-1-methyl-5-phenyl-3-piperidinyl]amino]-3(2H)-pyridazinone |
GSK-3787 | 188591-46-0 | C15H12ClF3N2O3S | 392.78059 | GSK-3787; GSK3787; GSK 3787. |
GSK376501A | 1010412-80-2 | C32H37NO6 | 531.64 | GSK-376501A;GSK376501;GSK-376501;1-[[3,5-bis(2-methoxyethoxy)phenyl]methyl]-3-(4-tert-butylphenyl)indole-2-carboxylic acid;1H-Indole-2-carboxylic acid, 1-((3,5-bis(2-methoxyethoxy)phenyl)methyl)-3-(4-(1,1-dimethylethyl)phenyl)- |
GSK369796 Dihydrochloride | 1010411-21-8 | C20H24Cl3N3O | 428.78 | 2-[(tert-Butylamino)methyl]-5-[(7-chloroquinolin-4-yl)amino]phenol Dihydrochloride; GSK369796 Dihydrochloride; GSK 369796; GSK-369796; GSK369796; N-tert-Butyl isoquine. |
GSK-356278 | 720704-34-7 | C21H25N7O2S | 439.54 | 5-(5-((2,4-dimethyl-5-thiazolyl)methyl)-1,3,4-oxadiazol-2-yl)-1-ethyl-n-(tetrahydro-2H-pyran-4-yl)-1H-Pyrazolo(3,4-b)pyridin-4-amine |
GSK-345931A sodium | 869499-38-7 | C22H19ClNNaO3 | 403.83 | 869534-13-4(Free); 6-(5'-chloro-2'-(2-methylpropoxy)(1,1'-biphenyl)-2-yl)- 2-Pyridinecarboxylic acid sodium salt |
GSK-345931A | 869534-13-4 | C22H20ClNO3 | 381.86 | 869499-38-7(sodium); 6-(5'-chloro-2'-(2-methylpropoxy)(1,1'-biphenyl)-2-yl)- 2-Pyridinecarboxylic acid |
GSK343 | 1346704-33-3 | C31H39N7O2 | 541.7 | GSK343; GSK-343; GSK 343. |
GSK321 | 1816331-63-1 | C28H28FN5O3 | 501.56 | (7R)-1-[(4-fluorophenyl)methyl]-N-[3-[(1S)-1-hydroxyethyl]phenyl]-7-methyl-5-(1H-pyrrole-2-carbonyl)-6,7-dihydro-4H-pyrazolo[4,3-c]pyridine-3-carboxamide; (7R)-1-[(4-fluorophenyl)methyl]-N-[3-[(1S)-1-hydroxyethyl]phenyl]-7-methyl-5-(1H-pyrrole-2-carbonyl) |
GSK317354A | 874119-13-8 | C25H18F4N6O | 494.45 | 4-(4-fluorophenyl)-N-(1H-indazol-5-yl)-6-methyl-2-(6-(trifluoromethyl)pyridin-3-yl)-1,4-dihydropyrimidine-5-carboxamide |
GSK-2881078 | 1539314-06-1 | C14H13F3N2O2S | 330.33 | GSK-2881078; SCHEMBL15421613; SKDVMPZQJMZEAC-SECBINFHSA-N; CS-5736; (R)-1-(1-(methylsulfonyl)propan-2-yl)-4-(trifluoromethyl)-1H-indole-5-carbonitrile |
GSK2879552 | 1401966-69-5 | C23H28N2O2 | 364.48 | GSK2879552; UNII-GT77Z6Y09Z; GSK-2879552; GT77Z6Y09Z; 1401966-69-5; 4-((4-((((1R,2S)-2-Phenylcyclopropyl)amino)methyl)piperidin-1-yl)methyl)benzoic acid |
GSK2838232 | 1443461-21-9 | C48H73ClN2O6 | 809.57 | GSK2838232; GSK-2838232; GSK 2838232. |
GSK2838232 | 1443460-91-0 | C48H73ClN2O6 | 809.56 | 4-[[(3aR,5aR,5bR,7aR,9S,11aR,11bR,13aS)-3a-[(1R)-2-[(4-chlorophenyl)methyl-[2-(dimethylamino)ethyl]amino]-1-hydroxyethyl]-5a,5b,8,8,11a-pentamethyl-2-oxo-1-propan-2-yl-4,5,6,7,7a,9,10,11,11b,12,13,13a-dodecahydro-3H-cyclopenta[a]chrysen-9-yl]oxy]-2,2-dime |
GSK2837808A | 1445879-21-9 | C31H25F2N5O7S | 649.62 | 3-[[3-(cyclopropylsulfamoyl)-7-(2,4-dimethoxypyrimidin-5-yl)quinolin-4-yl]amino]-5-(3,5-difluorophenoxy)benzoic acid |
GSK2830371 | 1404456-53-6 | C23H29ClN4O2S | 461.02 | |
GSK2801 | 1619994-68-1 | C20H21NO4S | 371.45 | GSK2801; GSK-2801; GSK 2801. |
Gold(III) chloride trihydrate | 16961-25-4 | AuCl4H7O3 | 393.83 | TETRACHLOROGOLD(III) ACID TRIHYDRATE; TETRACHLOROAURIC (III) ACID, TRIHYDRATE; TETRA-CHLOROAURIC ACID TRIHYDRATE; TETRACHLORAURIC(III) ACID TRIHYDRATE; aurate(1-),tetrachloro-,hydrogen,trihydrate; Auricchloride,hydrochloride,trihydrate; goldacidchloride; |
Gold(I) trisodium disulphite | 19153-98-1 | Na3Au.(SO3)2 | 426.06 | Gold(I) trisodium disulphite; gold(1+) trisodium disulphite; sodium gold sulfite |
Gold sodium thiosulfate | 10233-88-2 | Au.3Na.2O3S2.H2O | 490.18 | Gold sodium thiosulfate; Gold sodium thiosulfate 5-hydrate |
GLY-GLY-GLY-GLY-GLY-GLY | 3887-13-6 | C12H20N6O7 | 360.32 | H-GLY-GLY-GLY-GLY-GLY-GLY-OH; GLY-GLY-GLY-GLY-GLY-GLY; HEXAGLYCINE; 2-[[2-[[2-[[2-[[2-(glycylamino)acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino]acetic acid; 2-[[2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]acetyl]amino |
Glafenine | 3820-67-5 | C19H17ClN2O4 | 372.80 | 2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate; 1-Glyceryl N-(7-chloro-4-quinolyl)anthranilate |
Glabrone | 60008-02-8 | C20H16O5 | 336.34 | Morusin hydroperoxide |
Glabrol | 59870-65-4 | C25H28O4 | 392.49 | |
Glabridin | 59870-68-7 | C20H20O4 | 324.37 | 4-[(3R)-8,8-Dimethyl-3,4-dihydro-2H-pyrano[6,5-f]chromen-3-yl]benzene-1,3-diol; 4-((R)-8,8-Dimethyl-3,4-dihydro-2H,8H-benzo[1,2-B:4,3-B']dipyran-3-yl)-benzene-1,3-diol; Aids096010; Aids-096010; 4-(8,8-DiMethyl-3,4-dihydro-2H,8H-pyrano[2,3-f]chroMen-3-yl)- |
Glabrene | 60008-03-9 | C20H18O4 | 322.35 | 2',2'-Dimethyl-3,6'-bi[2H-1-benzopyran]-5',7-diol;2',2'-Dimethyl-[3,8'-bi-2H-1-benzopyran]-5',7-diol |
Glabredelphinine | 132160-37-3 | C22H33NO6 | 407.507 | |
Glabratine | 142750-47-8 | C27H34N2O9 | 530.575 | |
Glabranin | 41983-91-9 | C20H20O4 | 324.4 | 5,7-Dihydroxy-8-prenylflavanone; :4H-1-Benzopyran-4-one,2,3-dihydro-5,7-dihydroxy-8-(3-methyl-2-butenyl)-2- phenyl-, (2S)- |
Glabralide C | 2170388-85-7 | C29H40O4 | 452.634 | |
Glabralide B | 2170388-84-6 | C21H26O3 | 326.436 | |
Glabralide A | 1969289-10-8 | C27H32O5 | 436.00 | |
GL3 | 60037-39-0 | C48H64O27 | 1073.02 | |
GKT137831 | 1218942-37-0 | C21H19ClN4O2 | 394.85 | N/A |
GKA 50 | 851884-87-2 | C26H28N2O6 | 464.51 | 6-[[3-[(1S)-2-Methoxy-1-methylethoxy]-5-[(1S)-1-methyl-2-phenylethoxy]benzoyl]amino-3-pyridinecarboxylic acid |
GDP-D-mannose disodium salt | 103301-73-1 | C16H23N5O16P2Na2 | 649.3 | Guanosine 5-diphospho-a-D-mannose disodium salt; GDP-Man |
Geranylfarnesol | 22488-05-7 | C25H42O | 358.61 | 3,7,11,15,19-Pentamethyleicosa-2E,6E,10E,14E,18-pentaen-1-ol; (2E,6E,10E,14E)-3,7,11,15,19-pentamethylicosa-2,6,10,14,18-pentaen-1-ol; All-E-geranylfarnesol |
Geranylacetone | 3796-70-1 | C13H22O | 194.318 | (E)-Geranylacetone; (E)-6,10-Dimethylundeca-5,9-dien-2-one; Trans-Geranylacetone; (5E)-6,10-dimethylundeca-5,9-dien-2-one |
GSK-270822A | 64082-23-5 | C24H20N4O2 | 396.45 | GSK270822A;N-(1H-Indazol-5-yl)-2-methyl-4-(2-naphthyl)-6-oxo-1,4,5,6-tetrahydro-3-pyridinecarboxamide |
GSK2656157 | 1337532-29-2 | C23H21FN6O | 416.46 | GSK2656157; GSK 2656157; GSK-2656157. |
GSK2636771 | 1372540-25-4 | C22H22F3N3O3 | 433.431 | GSK2636771; GSK-2636771; GSK 2636771 |
GSK2578215A | 1285515-21-0 | C24H18FN3O2 | 399.42 | N/A |
GSK256471 | 1133706-08-7 | C29H29N3O3S | 499.63 | N-[(S)-cyclopropyl(phenyl)methyl]-3-[[methyl(methylsulfonyl)amino]methyl]-2-phenylquinoline-4-carboxamide |
GSK256066 2,2,2-trifluoroacetic acid | 1415560-64-3 | C29H27F3N4O7S | 632.61 | GSK-256066; GSK 256066 |
GSK256066 | 801312-28-7 | C27H26N4O5S | 518.58 | |
GSK-239512 | 720691-69-0 | C23H27N3O2 | 377.48 | 1-(6-((3-cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-3-pyridinyl)-2-Pyrrolidinone |
GSK2334470 | 1227911-45-6 | C25H34N8O | 462.602 | GSK2334470; GSK2334470; GSK2334470 |
GSK2330672 | 1345982-69-5 | C28H38N2O7S | 546.68 | CHEMBL2387408; UNII-386012Z45S; GSK2330672; GSK-2330672; SCHEMBL2586025; CZGVOBIGEBDYTP-VSGBNLITSA-N |
GSK J4 HCl | 1373423-53-0 | C24H27N5O2.HCl | 453.96 | |
GSK J1 | 1373422-53-7 | C22H23N5O2 | 389.45 | GSKJ1; GSKJ 1; GSKJ-1. |
GSK 962040 hydrochloride | 923565-22-4 | C25H34ClFN4O | 461.02 | Camicinal hydrochloride;GSK-962040 hydrochloride;2-[4-(3-Fluoroanilino)piperidin-1-yl]-1-[4-[[(3S)-3-methylpiperazin-1-yl]methyl]phenyl]ethanone hydrochloride |
GSK 962040 | 923565-21-3 | C25H33FN4O | 424.55 | GSK-962040;Camicinal;1-[4-(3-fluoroanilino)piperidin-1-yl]-2-[4-[[(3S)-3-methylpiperazin-1-yl]methyl]phenyl]ethanone |
GSK 9311 hydrochloride | 1923851-49-3 | C24H31N5O3·HCl | 474 | N-[2,3-Dihydro-1,3-dimethyl-6-[(2R)-2-methyl-1-piperazinyl]-2-oxo-1H-benzimidazol-5-yl]-N-ethyl-2-methoxybenzamide hydrochloride |
GSK 9027 | 1229096-88-1 | C27H19F4N3O2S | 525.52 | N-[4-[1-(4-Fluorophenyl)-1H-indazol-5-yl-3-(trifluoromethyl)phenyl]benzenesulfonamide |
GSK 789472 hydrochloride | 1257326-24-1 | C15H21N3O.HCl | 295.81 | 4,5-Dihydro-1-phenyl-3-(2-piperidinyl)methylimidazol-2(1H)-one hydrochloride; 1-phenyl-3-(piperidin-2-ylmethyl)imidazolidin-2-one hydrochloride |
GSK 525768A | 1260530-25-3 | C22H22ClN5O2 | 423.90 | GSK 525768A; GSK-525762A; CHEMBL2153435; SCHEMBL12966358; DTXSID50680634 |
GSK 4716 | 101574-65-6 | C17H18N2O2 | 282.34 | 4-Hydroxy-2-[(1E)-[4-(1-methylethyl)phenyl]methylene]hydrazide |
GSK 461364 analogue II | 929095-22-7 | C27H27F3N4O3S | 544.59 | 5-[6-(1-methylpiperidin-4-yl)oxybenzimidazol-1-yl]-3-[(1R)-1-[2-(trifluoromethyl)phenyl]ethoxy]thiophene-2-carboxamide |
GSK 461364 analogue I | 929095-23-8 | C26H27ClN4O3S | 511.04 | GSK579289A; Compound 25 [PMID 19237286]; 3-[(1R)-1-(2-chlorophenyl)ethoxy]-5-[6-(1-methylpiperidin-4-yl)oxybenzimidazol-1-yl]thiophene-2-carboxamide |
GSK 269962 | 850664-21-0 | C29H30N8O5 | 570.60 | GSK-269962A; N-[3-[2-(4-amino-1,2,5-oxadiazol-3-yl)-1-ethylimidazo[4,5-c]pyridin-6-yl]oxyphenyl]-4-(2-morpholin-4-ylethoxy)benzamide |
GSK 264220A | 685506-42-7 | C17H21N3O4S | 363.43 | N-[2-Methyl-5-(1-piperidinylsulfonyl)-3-furanyl]-N'-phenylurea; 3-[2-methyl-5-(piperidine-1-sulfonyl)furan-3-yl]-1-phenylurea; 1-(2-methyl-5-piperidin-1-ylsulfonylfuran-3-yl)-3-phenylurea |
GSK 2606414 | 1337531-36-8 | C24H20F3N5O | 451.453 | GSK-2606414; 1-(5-(4-Amino-7-methyl-7H-pyrrolo[2,3-d]pyrimidin-5-yl)-indolin-1-yl)-2-(3-(trifluoromethyl)phenyl)ethanone |
GSK 2250665A | 1246030-96-5 | C26H29N5OS | 459.61 | trans-4-[[4-[(6-Ethyl-2-benzothiazolyl)amino]-6-(phenylmethyl)-2-pyrimidinyl]amino]cyclohexanol |
GSK 189254A | 720690-73-3 | C21H25N3O2 | 351.44 | 6-((3-Cyclobutyl-2,3,4,5-tetrahydro-1H-3-benzazepin-7-yl)oxy)-N-methyl-3-Pyridinecarboxamide, |
GSK 1702934A | 924377-85-5 | C22H25N3O2S | 395.52 | 1,3-Dihydro-1-[1-[(5,6,7,8-tetrahydro-4H-cyclohepta[b]thien-2-yl)carbonyl]-4-piperidinyl]-2H-benzimidazol-2-one; 3-[1-(5,6,7,8-tetrahydro-4H-cyclohepta[b]thiophene-2-carbonyl)piperidin-4-yl]-1H-benzimidazol-2-one; GSK-2934A |
GSK 1562590 hydrochloride | 1003878-07-6 | C30H30Cl2N4O4.HCl | 617.95 | N-[(1R)-1-[3'-(Aminocarbonyl)[1,1'-biphenyl]-4-yl]-2-(1-pyrrolidinyl)ethyl]-6,7-dichloro-2,3-dihydro-N-methyl-3-oxo-4H-1,4-benzoxazine-4-acetamide hydrochloride; 3-[4-[(1R)-1-[[2-(6,7-dichloro-3-oxo-1,4-benzoxazin-4-yl)acetyl]-methylamino]-2-pyrrolidin-1- |
GSI-136 | 443989-01-3 | C11H18ClNO3S2 | 311.83 | (S)-5-chloro-N-(3-ethyl-1-hydroxypentan-2-yl)thiophene-2-sulfonamide; |
GSA 10 | 300833-95-8 | C26H30N2O5 | 450.53 | GSA-10; propyl 4-[(1-hexyl-4-hydroxy-2-oxoquinoline-3-carbonyl)amino]benzoate |
GS967 | 1262618-39-2 | C14H7F6N3O | 347.22 | GS967; GS-967; GS 967; GS458967; GS 458967; GS-458967. |
GS9667 | 618380-90-8 | C21H24FN5O4S | 461.51 | GS-9667;CVT-3619;CVT3619;(2S,3S,4R,5R)-2-[(2-fluorophenyl)sulfanylmethyl]-5-[6-[[(1R,2R)-2-hydroxycyclopentyl]amino]purin-9-yl]oxolane-3,4-diol |
GS-9219 | 859209-74-8 | C21H35N8O6P | 526.535 | GS 9219; GS-9219; GS9219. |
GS-7340 fumarate | 379270-38-9 | C25H33N6O9P | 592.54 | (S)-isopropyl 2-(((S)-((((R)-1-(6-amino-9H-purin-9-yl)propan-2-yl)oxy)methyl)(phenoxy)phosphoryl)amino)propanoate fumarate; TAF; GS734; GS-734; GS 7340; Tenofovir alafenamide fumarate; trade name: Genvoya |
GS-441524 | 1191237-69-0 | C12H13N5O4 | 291.26 | (2R,3R,4S,5R)-2-(4-aminopyrrolo[2,1-f][1,2,4]triazin-7-yl)-3,4-dihydroxy-5-(hydroxymethyl)tetrahydrofuran-2-carbonitrile; EVO984; EVO 984; EVO-984; GS441524; GS 441524; GS-441524; CHEMBL2016757; SCHEMBL10120689; EX-A3056; Remdesivir-metabolite; GS-5734-me |
GS-283 | 149440-36-8 | C17H17NO3 | 283.33 | GS-283; GS 283; 6,7-Isoquinolinediol, 3,4-dihydro-1-((4-methoxyphenyl)methyl)-; 7-hydroxy-1-[(4-methoxyphenyl)methyl]-3,4-dihydro-2H-isoquinolin-6-one |
GS 9620 | 1228585-88-3 | C22H30N6O2 | 410.51 | 4-amino-2-butoxy-8-[[3-(pyrrolidin-1-ylmethyl)phenyl]methyl]-5,7-dihydropteridin-6-one; GS-9620; GS9620; Vesatolimod |
GS 6201 | 752222-83-6 | C21H21F3N6O2 | 446.43 | CVT 6883; 3-Ethyl-3,9-dihydro-1-propyl-8-[1-[[3-(trifluoromethyl)phenyl]methyl]-1H-pyrazol-4-yl]-1H-purine-2,6-dione |
GS 39783 | 39069-52-8 | C15H23N5O2S | 337.44 | N,N'-Dicyclopentyl-2-(methylthio)-5-nitro-4,6-pyrimidinediamine;4-N,6-N-dicyclopentyl-2-methylsulfanyl-5-nitropyrimidine-4,6-diamine; |
GS 389 | 41498-37-7 | C19H23NO3 | 313.39 | 6,7-dimethoxy-1-[(4-methoxyphenyl)methyl]-1,2,3,4-tetrahydroisoquinoline; |
GS 143 | 916232-21-8 | C28H19FN2O4 | 466.46 | 4-[4-[[5-(2-Fluorophenyl)-2-furanyl]methylene]-4,5-dihydro-5-oxo-3-(phenylmethyl)-1H-pyrazol-1-yl]benzoic acid |
Grubbs Catalyst, 2ndGeneration | 246047-72-3 | C46H65Cl2N2PRu | 848.97 | (1,3-Bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene)dichloro(phenylmethylene)(tricyclohexylphosphine)ruthenium, Benzylidene[1,3-bis(2,4,6-trimethylphenyl)-2-imidazolidinylidene]dichlo |
Grubbs Catalyst, 1st Generation | 172222-30-9 | C44H38Cl2P2Ru | 822.96 | Benzylidene-bis(tricyclohexylphosphine)dichlororuthenium, Bis(tricyclohexylphosphine)benzylidine ruthenium(IV) dichloride |
GRP (porcine) | 74815-57-9 | C126H198N38O31S2 | 2805.31 | Gastrin Releasing Peptide porcine |
Grosvenorine | 156980-60-8 | C33H40O19 | Grosvenorin | |
Groenlandicine | 38691-95-1 | C19H16NO4+ | 322.33464 | 11,12-Dihydro-8-methoxy-9-hydroxybenzo[a]-1,3-benzodioxolo[4,5-g]quinolizinium; 11,12-Dihydro-9-hydroxy-8-methoxybenzo[a]-1,3-benzodioxolo[4,5-g]quinolizinium; Groenlandicine; Tetrahydricheilanthifolinium; Tetrahydrocheilanthifoline; Tetradehydrocheilanth |
GRK2i | 148505-03-7 | C153H256N50O41S | 3484.08 | |
Griseofulvin-d3 | 1279033-22-5 | C17H14ClO6D3 | 355.79 | (1'S,6'R)-7-Chloro-2',4,6-trimethoxy-d3-6'-methyl-spiro[benzofuran-2(3H),1'-[2]cyclohexene]-3,4'-dione; Amudane-d3; Fulcin-d3; Grisovi-d3; (+)-Griseofulvin-d3; Spirofulvin-d3; Sporostatin-d3; Xuanjing-d3 |
Griseofulvin-13CD3 | 1329612-29-4 | |||
Griseofulvin | 126-07-8 | C17H17ClO6 | 352.77 | Curling factor; Fulvicin; Gris PEG; GrisPEG; Gris-PEG; Grisactin; Amudane; 7-Chloro-2',4,6-trimethoxy-6'beta-methylspiro(benzofuran-2(3H), 1'-(2)cyclohexene)-3,4'-dione; (2S-trans)-7-Chloro-2',4,6-trimethoxy-6'-methylspiro(benzofuran-2(3H), 1'-(2)cyclohex |
Griseofulvic Acid | 469-54-5 | C16H15ClO6 | 338.75 | (1'S,6'R)-7-Chloro-4,6-dimethoxy-6'-methyl-,Spiro[benzofuran-2(3H),1'-cyclohexane]-2',3,4'-trione; trans-7-Chloro-4,6-dimethoxy-6'-methylspiro[benzofuran-2(3H),1'- cyclohexane]-2',3,4'-trione; (+/-)-Griseofulvic Acid |
Grifolin monomethyl ether | 64432-04-8 | C23H34O2 | 342.523 | 3-Methoxy-5-methyl-2-[(2E,6E)-3,7,11-trimethyl-2,6,10-dodecatrienyl]phenol |
Grifolin | 6903-07-7 | C22H32O2 | 328.496 | |
GQ1b-Ganglioside | 68652-37-9 | C106H182N6O56 4H3N | 2504.71 | Tetrasialoganglioside 1b |
GR 125487 sulfamate | 859502-43-5 | C19H26FN3O5S.H2NSO3H | 524.58 | 5-Fluoro-2-methoxy-[1-[2-[(methylsulfonyl)amino]ethyl]-4-piperidinyl]-1H-indole-3-methylcarboxylate sulfamate |
Grepafloxacin Hydrochloride | 161967-81-3 | C19H22FN3O3.HCl | 395.86 | GREPAFLOXACIN HCL; OPC-17116; 1-Cyclopropyl-6-fluoro-1,4-dihydro-5-methyl-7-(3-methyl-1-piperazinyl)-4-oxo-3-quinolinecarboxylic acid hydrochloride (1:1);Grepafloxacin hydrochloride;D02178;Gpfx;Grepafloxacin hydrochloride (jan/usan);Raxar;Raxar (tn) |
Grepafloxacin | 119914-60-2 | C19H22FN3O3 | 359.401 | Raxar; 1-cyclopropyl-6-fluoro-5-methyl-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid |
Green sensitizing dye SG4# | 97631-91-9 | |||
Grayanotoxin III hemi(ethyl acetate) adduct | 4678-45-9 | (C20H34O6)2 . C4H8O2 | 370.48 | 4,8-tetramethyl-,(2s,3as,4r,4ar,7r,8r,9as,11r,11ar,12r)-1; 6,10,14,16-hexol,(3-beta,6-beta,14r)-grayanotoxane-5; andromedol; deacetylandromedotoxin; deacylasebotoxini; GRAYANOTOXIN 3.1/2 ETHYL ACETATE ADDUCT; GRAYANOTOXIN III; GRAYANOTOXIN III HEMI(ETHYL |
Grayanotoxin I | 4720-09-6 | C22H36O7 | 412.52 | Asebotoxin; Acetylandromedol; Andromedotoxin; Rhodotoxin |
Grapiprant (CJ-023423) | 415903-37-6 | C26H29N5O3S | 491.61 | CJ-023423; CJ 023423; CJ023423; CAS#415903-37-6; RQ-00000007; RQ 00000007; RQ00000007; AAT-007; AAT007; AAT 007; Grapiprant |
Graphislactone A | 52179-44-9 | C16H14O6 | 302.3 | Graphislactone S1 |
Grapefruit | 90045-43-5 | |||
Grape seed extract | 84929-27-1 | C32H30O11 | 590.574 | BIBW2992 Dimaleate; BIBW 2992 Dimaleate; BIBW-2992 Dimaleate |
Granotapide | 594842-13-4 | C39H37F3N2O8 | 718.73 | JTT130;JTT-130;Diethyl 2-[[2-[3-(dimethylcarbamoyl)-4-[[2-[4-(trifluoromethyl)phenyl]benzoyl]amino]phenyl]acetyl]oxymethyl]-2-phenylpropanedioate |
Granisetron-d3 | 1224925-76-1 | C18H21N4OD3 | 315.44 | |
Granisetron Impurity C HCl | 1364645-74-8 | C17H23N4OCl | 334.85 | |
Granisetron Impurity B | 107007-95-4 | C17H22N4O | 298.39 | N-[(1R,3r,5S)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide; N-[(3-endo)-9-Methyl-9-azabicyclo[3.3.1]non-3-yl]-1H-indazole-3-carboxamide; 1-Desmethyl Granisetron; endo-N-(9-Methyl-9-azabicyclo[3.3.1]non-3-yl)-1H-indazole-3-carboxamide |
Granisetron Impurity 1 | 1363173-34-5 | C18H4N4O3 | 334.34 | 1-Methyl-1H-Indazole-3-Carboxylic Acid Anhydride; 1-Methyl-1H-indazole-3-carboxylic Acid 3,3'-Anhydride |
Granisetron hydroChloride | 107007-99-8 | C18H24N4O.HCl | 348.87 | N/A |
Granisetron | 109889-09-0 | C18H24N4O | 312.42 | 1-methyl-n-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-indazole-3-carboxamide; 1H-Indazole-3-carboxamide, 1-methyl-N-(9-methyl-9-azabicyclo[3.3.1]non-3-yl)-, endo-; BRL 43694 |
Grandiflorenic acid | 22338-67-6 | C20H28O2 | 300.44 | (+)-Kaura-9(11),16-diene-18-oic acid;Kaura-9(11),16-dien-18-oic acid |
Granatcin-A | 19879-06-2 | C22H20O10 | ||
Gramicidin, USP | 1393-88-0 | Gramicidina; Gramicidine; Gramicidinum; Gramoderm; GRAMICIDIN; Gramicidine[INN-French] | ||
Gramicidin S | 113-73-5 | C60H92N12O10 | 1141.46 | |
Gramicidin complex | 1405-97-6 | C99H139N19O18 (for Gramicidin A1) | 1883.3 | |
Gramicidin A | 11029-61-1 | C99H140N20O17 | 1882.30 | (R)-2-((2S,5R,8S,11R,14S,17R,20S,26S)-2-((1H-indol-3-yl)methyl)-17-isobutyl-5,8,11,26-tetraisopropyl-14,20-dimethyl-4,7,10,13,16,19,22,27,28-nonaoxo-3,6,9,12,15,18,21,24,25-nonaazaoctacosanamido)-N-((5S,8R,11S,14R,17S)-5,11-bis((1H-indol-3-yl)methyl)-1-hy |
GRA Ex-25 | 307983-31-9 | C29H36F3N3O5 | 563.61 | 3-(4-((1-(4-(tert-butyl)cyclohexyl)-3-(4-(trifluoromethoxy)phenyl)ureido)methyl)benzamido)propanoic acid; GRA Ex-25; GRA Ex 25; GRA Ex25; GRAEx-25; GRAEx 25; GRAEx25. |
GR 94800 | 141636-65-9 | C49H61N9O8 | 904.08 | GR-94800 |
GR 89696 fumarate | 126766-32-3 | C19H25Cl2N3O3.C4H4O4 | 530.4 | 4-[(3,4-Dichlorophenyl)acetyl]-3-(1-pyrrolidinylmethyl)-1-piperazinecarboxylic acid methyl ester fumarate |
GR 82334 | 129623-01-4 | C69H91N15O16 | 1386.57 | GR-82334; Physalaemin(1-11), D-pro(9)(spiro-gamma-lactam)leu(10)-trp(11)-; Physalemin, 9-deglycine-10-((5S)-6-oxo-L-alpha-(2-methylpropyl)-1,7-diazaspiro(4.4)nonane-7-acetic acid)-11-L-tryptophanamide- |
GR 79236 | 124555-18-6 | C15H21N5O5 | 351.36 | N-[(1S, trans)-2-Hydroxycyclopentyl]adenosine |
GR 73632 | 133156-06-6 | C40H59N7O6S | 766.01 | GR-73632; Delta-Aminovaleryl-9-pro-10-meleu-substance P (7-10); Substance P (7-10), delta-aminovaleryl-pro(9)-N-meleu(10)-; Substance P (7-10), delta-aminovaleryl-prolyl(9)-N-methylleucine(10)- |
GR 55562 dihydrochloride | 159533-25-2 | C23H25N3O2.2HCl | 448.39 | 3-[3-(Dimethylamino)propyl]-4-hydroxy-N-[4-(4-pyridinyl)phenyl]benzamide dihydrochloride |
GR 46611 | 185259-85-2 | C23H27N3O2 | 377.49 | 3-[3-(2-Dimethylaminoethyl)-1H-indol-5-yl]-N-(4-methoxybenzyl)acrylamide |
GR 231118 | 158859-98-4 | C110H170N34O24 | 2352.77 | GR-231118 |
GR 203040 | 168398-02-5 | C20H24N6O·2HCl | 437.37 | (2S,3S)-N-[[2-Methoxy-5-(1H-tetrazol-1-yl)phenyl]methyl]-2-phenyl-3-piperidinamine dihydrochloride |
GR 159897 | 158848-32-9 | C23H27FN2O2S | 414.54 | 5-Fluoro-3-[2-[4-methoxy-4-[[(R)-phenylsulphinyl]methyl]-1-piperidinyl]ethyl]-1H-indole |
GR 144053 trihydrochloride | 1215333-48-4 | C18H27N5O2.3HCl | 454.83 | 4-[4-[4-(Aminoiminomethyl)phenyl]-1-piperazinyl]-1-piperidineacetic acid trihydrochloride |
GR 135531 | 190277-13-5 | C14H17N3O3 | 275.31 | 5-Methoxycarbonylamino-N-acetyltryptamine; 5-MCA-NAT; methyl N-[3-(2-acetamidoethyl)-1H-indol-5-yl]carbamate |
GR 127935 hydrochloride | 148642-42-6 | C29H31N5O3.HCl | 534.06 | N-[4-Methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-4'-(5-methyl-1,2,4-oxadiazol-3-yl)-1,1'-biphenyl-4-carboxamide hydrochloride |
GPR120 modulator 2 | 1050506-87-0 | C20H18ClNO3S | 387.88 | |
GPR120 modulator 1 | 1050506-75-6 | C19H16ClNO4S | 389.85 | |
GP 2a | 919077-81-9 | C24H23Cl2N3O | 440.36 | N-Cyclohexyl-1-(2,4-dichlorophenyl)-1,4-dihydro-6-methylindeno[1,2-c]pyrazole-3-carboxamide |
GPP 78 | 1202580-59-3 | C27H29N5O | 439.6 | CAY10618; NMPRTase Inhibitor; N-[1,1'-biphenyl]-2-yl-4-(3-pyridinyl)-1H-1,2,3-triazole-1-octanamide |
GPI-15427 | 805242-85-7 | C20H20N4O2 | 348.406 | GPI-15427; GPI 15427; GPI15427. |
GPi 688 | 918902-32-6 | C19H18ClN3O4S | 419.88 | 2-Chloro-N-[1-[(2R)-2,3-dihydroxypropyl]-1,2,3,4-tetrahydro-2-oxo-3-quinolinyl]-6H-thieno[2,3-b]pyrrole-5-carboxamide |
GP 1a | 511532-96-0 | C23H22Cl2N4O | 441.35 | N-(Piperidin-1-yl)-1-(2,4-dichlorophenyl)-1,4-dihydro-6-methylindeno[1,2-c]pyrazole-3-carboxamide; 1-(2,4-dichlorophenyl)-6-methyl-N-(1-piperidinyl)-4H-indeno[1,2-c]pyrazole-3-carboxamide |
Gossypin | 652-78-8 | C21H20O13 | 480.38 | 3,3,4,5,7,8-Hexahydroxy flavone-8-glucoside; Gossypetin 8-glucoside |
Gossypetin | 489-35-0 | C15H10O8 | 318.237 | Articulatidin; Equisporol; 3,5,7,8,3',4'-Hexahydroxyflavone; 2-(3,4-dihydroxyphenyl)-3,5,7,8-tetrahydroxychromen-4-one |
Gosogliptin | 869490-23-3 | C17H24F2N6O | 366.42 | UNII-GI718UO477; PF-00734200; PF-734200; CHEMBL515387;(3,3-difluoropyrrolidin-1-yl)-[(2S,4S)-4-(4-pyrimidin-2-ylpiperazin-1-yl)pyrrolidin-2-yl]methanone;89490-47-1(dihydrochloride) |
Goserelin Acetate | 145781-92-6 | C61H88N18O16 | 1329.49 | ICI118630; ICI-118630; ICI 118630; Goserelin Acetate; brand name: Zoladex. |
Goserelin Acetate | 65807-02-5 | C59H84N18O14 | 1269.433 | Zoladex. ZDX. ICI-118630 |
Gopherenediol | 916236-79-8 | C20H34O2 | 306.483 | (1R,2R,3R,3a'S,6R,7'R,7a'R)-7'-Isopropyl-2,6-dimethyl-4'-methyleneoctahydrospiro[cyclohexane-1,1'-indene]-2,3-diol |
Goniotriol | 96405-62-8 | C13H14O5 | 250.3 | (+)-6-(1,2-Dihydroxy-2-phenylethyl)-5,6-dihydro-5-hydroxy-2H-pyran-2-one;(7R)-2,3-Dideoxy-7-C-phenyl-D-xylohept-2-enonic acid delta-lactone |
Goniopypyrone | 129578-07-0 | C13H14O5 | 250.3 | 3,7-Anhydro-2-deoxy-7-C-phenyl-D-gulo-heptonic acid delta-lactone |
Goniodiol diacetate | 136778-40-0 | C17H18O6 | 318.32 | [(1S,2R)-2-acetyloxy-1-[(2R)-6-oxo-2,3-dihydropyran-2-yl]-2-phenylethyl] acetate |
Gomisin K1 | 75629-20-8 | C23H30O6 | 402.48 | (-)-Gomisin K1 |
Gomisin J | 66280-25-9 | C22H28O6 | (6R,7S)-1,2,11,12-tetramethoxy-6,7-dimethyl-5,6,7,8-tetrahydrodibenzo[a,c][8]annulene-3,10-diol | |
Gomisin H | 66056-20-0 | C23H30O7 | 418.5 | |
Gomisin G | 62956-48-3 | C30H32O9 | 536.6 | Benzo(3,4)cycloocta(1,2-f)(1,3)benzodioxole-7,8-diol, 5,6,7,8-tetrahydro-1,2,3,13-tetramethoxy-6,7-dimethyl-, 8-benzoate, (6S,7S,8S,13aS)-; |
Gomisin E | 72960-21-5 | C28H34O9 | 514.57 | 5R,6S,7S,13aS,16R,17R)-5,6,7,8-Tetrahydro-17-hydroxy-1,2,3-trimethoxy-6,7,16,17-tetramethyl-5,13-(epoxybutanoxy)benzo[3,4]cycloocta[1,2-f][1,3]benzodioxol-18-one |
Gomisin D | 60546-10-3 | C28H34O10 | 530.56 | |
Gomisin A | 58546-54-6 | C23H28O7 | 416.46 | Gomisin-A; Besigomsin; TJN-101; Wuweizi alcohol-B; Wuweizichun-B |
Golvatinib | 928037-13-2 | C33H37F2N7O4 | 633.701 | E7050; E-7050; E 7050; Golvatinib. |
Golotimod | 229305-39-9 | C16H19N3O5 | 333.344 | SCV-07; Gamma-D-Glu-L-trp; SCV07; Gamma-D-Glutamyl-L-tryptophan; (2R)-2-amino-5-[[(1S)-1-carboxy-2-(1H-indol-3-yl)ethyl]amino]-5-oxopentanoic acid |
Golgicide A | 1139889-93-2 | C17H14F2N2 | 284.3 | N/A |
Golgicide A | 1005036-73-6 | C17H14F2N2 | 284.30 | 6,8-Difluoro-4-pyridin-3-yl-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinoline, CID 25113626, GCA |
Gold, powder, -60 Mesh | 7440-57-5 | Au | 196.967 | |
Goitrin | 13190-34-6 | C5H7NOS | 129.18 | DL-Goitrin; 5-Vinyloxazolidine-2-thione |
Go6983 | 133053-19-7 | C26H26N4O3 | 442.519 | Go-6983; 3-[1-[3-(dimethylamino)propyl]-5-methoxyindol-3-yl]-4-(1H-indol-3-yl)pyrrole-2,5-dione |
GO-6976 | 136194-77-9 | C24H18N4O | 378.435 | GO-6976; GO 6976; PD-406976; PD 406976; PD406976 |
GNF179 Metabolite | 1310455-86-7 | C14H16FN3 | 245.3 | GNF 179 Metabolite; GNF-179 Metabolite |
G-NGA2F N-Glycan | 84825-26-3 | C62H104N4O46 | 1641.49 | Monogalactosylated, core fucosylated, asialo, bi-antennary N-linked glycan |
G-NGA2 N-Glycan | 103584-68-5 | C56H94N4O41 | 1479.35 | Monogalactosylated, asialo, bi-antennary N-linked glycan |
GNF-7 | 839706-07-9 | C28H24F3N7O2 | 547.54 | GNF-7; GNF7; GNF 7. |
GNF-6231 | 1243244-74-7 | C25H28N6O2 | 444.54 | N-(5-(4-acetylpiperazin-1-yl)pyridin-2-yl)-2-(2',3-dimethyl-[2,4'-bipyridin]-5-yl)acetamide |
GNF-6231 | 1243245-18-2 | C24H25FN6O2 | 448.502 | N-[5-(4-acetylpiperazin-1-yl)pyridin-2-yl]-2-[6-(2-fluoropyridin-4-yl)-5-methylpyridin-3-yl]acetamide |
GNF-5 | 778277-15-9 | C20H17F3N4O3 | 418.38 | |
GNF179 | 1261114-01-5 | C22H23ClFN5O | 427.9 | GNF 179; GNF-179 |
GNF1331 | 603101-22-0 | C20H20N6O2S2 | 440.54 | N-(6-methoxy-1,3-benzothiazol-2-yl)-2-[(4-propyl-5-pyridin-4-yl-1,2,4-triazol-3-yl)sulfanyl]acetamide;GNF-1331 |
GNF 5837 | 1033769-28-6 | C28H21F4N5O2 | 535.503 | GNF-5837; 1-[2-fluoro-5-(trifluoromethyl)phenyl]-3-[4-methyl-3-[[(3Z)-2-oxo-3-(1H-pyrrol-2-ylmethylidene)-1H-indol-6-yl]amino]phenyl]urea |
Gnetol | 86361-55-9 | C14H12O4 | 244.246 | (E)-2-(3,5-Dihydroxystyryl)benzene-1,3-diol |
Gnetofuran B | 526214-79-9 | C16H14O5 | 286.283 | |
GNE-9822 | 1557232-32-2 | C24H32N6O | 420.56 | GNE-9822; GNE 9822; GNE9822; (S)-N-[1-[3-(Dimethylamino)-1-phenylpropyl]-1H-pyrazol-4-yl]-6,6-dimethyl-4,5,6,7-tetrahydro-1H-indazole-3-carboxamide |
GNE-9605 | 1536200-31-3 | C17H20ClF4N7O | 449.839 | GNE9605; GNE 9605 |
GNE-900 | 1200126-26-6 | C23H21N5 | 367.456 | GNE-900; GNE900; GNE 900. |
GNE-8525 | 1196546-33-4 | C31H30FN7O | 535.63 | (R)-1-(6-(6-(2-(3-fluorophenyl)pyrrolidin-1-yl)imidazo[1,2-b]pyridazin-3-yl)-[2,4'-bipyridin]-2'-yl)piperidin-4-ol |
GNE-7915 | 1351761-44-8 | C19H21F4N5O3 | 443.403 | |
GNE-6776 | 2009273-71-4 | C20H20N4O2 | 348.406 | GNE 6776; 5-[6-amino-4-ethyl-5-(4-hydroxyphenyl)-3-pyridyl]-N-methyl-pyridine-2-carboxamide |
GNE-6468 | 1677668-27-7 | C23H16ClN3O4 | 433.85 | GNE-6468; GNE 6468; GNE6468; 4-(6-(2-chloro-6-cyclopropylbenzoyl)imidazo[1,5-a]pyrimidin-8-yl)-2-hydroxybenzoic acid |
GNE-617 | 1362154-70-8 | C21H15F2N3O3S | 427.42 | GNE617; GNE 617 |
GNE-4997 | 1705602-02-3 | C25H27F2N5O3S | 515.58 | GNE-4997; GNE-4997; GNE-4997; (4aS,5aR)-N-(1-((R)-((R)-1,1-dioxidotetrahydro-2H-thiopyran-2-yl)(phenyl)methyl)-1H-pyrazol-4-yl)-5,5-difluoro-5a-methyl-1,4,4a,5,5a,6-hexahydrocyclopropa[f]indazole-3-carboxamide |
GNE-495 | 1449277-10-4 | C22H20FN5O2 | 405.43 | 8-amino-N-(1-(cyclopropanecarbonyl)azetidin-3-yl)-2-(3-fluorophenyl)-1,7-naphthyridine-5-carboxamide |
GNE-493 | 1033735-94-2 | C17H20N6O2S | 372.44 | |
GNE-477 | 1032754-81-6 | C21H28N8O3S2 | 504.63 | |
GNE-3511 | 1496581-76-0 | C23H26F2N6O | 440.50 | GNE-3511; CHEMBL3393333; SCHEMBL15602439; BDBM50059190; 2-[[6-(3,3-difluoropyrrolidin-1-yl)-4-[1-(oxetan-3-yl)piperidin-4-yl]pyridin-2-yl]amino]pyridine-4-carbonitrile |
GNE-3500 | 1537859-24-7 | C24H30FN3O3S | 459.58 | GNE-3500; GNE 3500; GNE3500; 1-(4-(3-fluoro-4-(((3S,6R)-3-methyl-1,1-dioxido-6-phenyl-1,2-thiazinan-2-yl)methyl)phenyl)piperazin-1-yl)ethan-1-one |
GNE-317 | 1394076-92-6 | C19H22N6O3S | 414.48 | GNE-317; GNE 317; GNE317. |
GNE-272 | 1936428-93-1 | C22H25FN6O2 | 424.4804 | (S)-1-(3-((2-fluoro-4-(1-methyl-1H-pyrazol-4-yl)phenyl)amino)-1-(tetrahydrofuran-3-yl)-1,4,6,7-tetrahydro-5H-pyrazolo[4,3-c]pyridin-5-yl)ethan-1-one |
GNE-0877 | 1374828-69-9 | C14H16F3N7 | 339.326 | |
GNE 9278 | 901230-11-3 | C21H27N5O3S | 429.54 | 4-Cyclohexyl-N-(7-hydroxy-5-methyl-2-propyl[1,2,4]triazolo[1,5-a]pyrimidin-6-yl)benzenesulfonamide |
GNE 2861 | 1394121-05-1 | C22H26N6O2 | 406.48 | 1-[2-[1-(2-Amino-4-pyrimidinyl)-2-[(2-methoxyethyl)amino]-1H-benzimidazol-6-yl]ethynyl]cyclohexanol; 1-[2-[3-(2-aminopyrimidin-4-yl)-2-(2-methoxyethylamino)benzimidazol-5-yl]ethynyl]cyclohexan-1-ol |
Gnaphaline | 33803-42-8 | C17H14O6 | 314.30 | 4H-1-Benzopyran-4-one,5,7-dihydroxy-3,8-dimethoxy-2-phenyl-; 5,7-Dihydroxy-3,8-Dimethoxyflavon |
GN 44028 | 1421448-26-1 | C18N15N3O2 | 305.33 | N-(2,3-Dihydro-1,4-benzodioxin-6-yl)-1,4-dihydroindeno[1,2-c]pyrazol-3-amine |
GMQ hydrochloride | 5361-15-9 | C10H11N5.HCl | 237.69 | N-(4-Methyl-2-quinazolinyl)-guanidine hydrochloride; 1-(4-methylquinazolin-2-yl)guanidine hydrochloride |
GM-CSF | 83869-56-1 | C639H1006N168O196S8 | 211.2178 | RMGM-CSF; RMLFN-ALPHARMM-CSF; RMM-CSF; RECOMBINANT MOUSE GM-CSF; REC GM-CSF (MURINE); REC GRANULOCYTE-MACROPHAGE-COLONY STIMULATING FACTOR (MURINE); MOUSE M-CSF; MOUSE GRANULOCYTE MACROPHAGE-COLONY STIMULATING FACTOR |
GMC 61-39 | 234113-94-1 | C19H18ClF3N4O3S | 474.88 | [3-chloro-6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepin-8-yl] trifluoromethanesulfonate |
GMC 3-15 | 691846-63-6 | C27H30N4O3 | 458.55 | 4-[4-[[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]carbamoyl]phenyl]-3-methylbenzamide |
GMC 2-83 | 183140-98-9 | C19H18F3N3O4S | 441.42 | [6-(4-methylpiperazin-1-yl)benzo[b][1,4]benzoxazepin-8-yl] trifluoromethanesulfonate |
GMC 2-29 | 148672-15-5 | C29H31N5O3 | 497.59 | N-[4-methoxy-3-(4-methylpiperazin-1-yl)phenyl]-4-[2-methyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide |
GMC 2-118 | 256227-78-8 | C29H31N5O5S | 561.65 | [4-[[4-[2-methyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzoyl]amino]-2-(4-methylpiperazin-1-yl)phenyl] methanesulfonate |
GMC 2-113 | 256227-77-7 | C28H29N5O3 | 483.56 | BDBM50084961; ZINC13805066; N-[4-hydroxy-3-(4-methylpiperazin-1-yl)phenyl]-4-[2-methyl-4-(5-methyl-1,3,4-oxadiazol-2-yl)phenyl]benzamide |
GMC 15-27 | 256227-71-1 | C27H31N5O2 | 457.57 | 4'-(Aminoiminomethyl)-N-[4-methoxy-3-(4-methyl-1-piperazinyl)phenyl]-2'-methyl-[1,1'-biphenyl]-4-carboxamide |
GMC 1-169 | 183140-97-8 | C19H19F3N4O3S | 440.44 | [6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepin-8-yl] trifluoromethanesulfonate |
GMC 1-165 | 156632-07-4 | C18H20N4O | 308.38 | 11-(4-Methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepin-2-ol; 6-(4-methylpiperazin-1-yl)-11H-benzo[b][1,4]benzodiazepin-8-ol |
GMC 1-116 | 63687-94-5 | C18H20N4O | 308.38 | 11-(4-Methyl-piperazin-1-yl)-5H-dibenzo[b,e][1,4]diazepin-8-ol; 8-Hydroxyclozapine; AC1L9SL1; 6-(4-methylpiperazin-1-yl)-5H-benzo[b][1,4]benzodiazepin-3-ol |
GM4-Ganglioside | 66456-69-7 | C57H106N2O17 xNa | 1091.45 (free acid basis) | |
GM3-Ganglioside | 54827-14-4 | C59H111N3O21 xNa | 1198.52 (free acid basis) | aNeu5Ac(2-3)bDGalp(1-4)bDGlcp(1-1)Cer |
GM1-Pentasaccharide | 52659-37-7 | C37H62N2O29 | 998.88 | GM1-oligosaccharide |
GM1-Lysoganglioside | 171483-40-2 | C55H97N3O30 xNa | 1280.36 (free acid basis) | lyso-Monosialoganglioside GM1 |
GM1-Ganglioside | 37758-47-7 | C73H131N3O31 xNa | 1546.82 (free acid basis) | Gal(b1-3)GalNAc(b1-4)[Neu5Ac(a2-3)]Gal(b1-4)Glc(b1-1)Cers; Monosialoganglioside GM1; prototype ganglioside; monosialotetrahexosylganglioside |
GM 1489 | 171347-75-4 | C27H33N3O4 | 463.57 | (3R)-3-[[(2S)-3-(1H-indol-3-yl)-1-oxo-1-[[(1S)-1-phenylethyl]amino]propan-2-yl]carbamoyl]-5-methylhexanoic acid |
Glyurallin A | 199331-36-7 | C21H20O5 | 352.386 | 3,9-Dihydroxy-1-methoxy-2-prenylpterocarpene |
Glyphosate | 1071-83-6 | C3H8NO5P | 169.07 | N-(Phosphonomethyl)glycine; ACIGATE |
Glyparamide | 5581-42-0 | C15H16ClN3O3S | 353.82 | |
Glyoxalbis(2-hydroxyanil) | 1149-16-2 | C14H12N2O2 | 240.26 | CALCIUM RED; GBHA; GLYOXAL BIS(2-HYDROXYANIL); glyoxal-bis-hydroxyanil; GLYOXALBIS-(O-HYDROXYANIL); DI-(2-HYDROXYPHENYLIMINO)ETHANE; 1,2-BIS(2-HYDROXYPHENYLIMINO)ETHANE; 2,2-BIBENZOXAZOLINE |
Glyoxal trimer dihydrate | 4405-13-4 | C6H10O8 | 210.14 | Ethanedial |
glymidine sodium | 3459-20-9 | C13H14N3NaO4S | 331.327 | |
Glymidine | 339-44-6 | C13H15N3O4S | 309.08 | 2-Benzenesulfonamido-5-(2-methoxyethoxy)pyrimidine; Glidiazine; Glymidine; N-[5-(2-Methoxyethoxy)-2-pyrimidinyl]benzenesulfonamide |
GlyH-101 | 328541-79-3 | C19H15Br2N3O3 | 493.15 | GlyH 101; GlyH101 |
Glycyl-L-histidyl-L-lysine | 49557-75-7 | C14H24N6O4 | 340.384 | Prezatide; GHK; Glycylhistidyllysine; Glycyl-histidyl-lysine; Liver cell growth factor |
Glycyl-L-glutamine monohydrate | 13115-71-4 | 221.21 | BETA-LIPOTROPIN (90-91) (CAMEL); BETA-ENDORPHIN (30-31) (CAMEL); GLYCYL-L-GLUTAMINE; GLY-GLN; GLY-GLU; H-GLY-GLN-OH | |
Glycyl-H 1152 dihydrochloride | 913844-45-8 | C18H24N4O3S.2HCl | 449.4 | (S)-(+)-4-Glycyl-2-methyl-1-[(4-methyl-5-isoquinolinyl)sulfonyl]-hexahydro-1H-1,4-diazepine dihydrochloride; 2-amino-1-[(3S)-3-methyl-4-(4-methylisoquinolin-5-yl)sulfonyl-1,4-diazepan-1-yl]ethanone dihydrochloride |
Glycyl-glycine-15N2 | 108451-47-4 | [15N]H2CH2CO[15N]HCH2COOH | 134.1 | 2-(2-aminoacetamido)acetic acid-15N2 |
GLYCYLGLYCINE ETHYL ESTER HCL REAG | 627-74-7 | C6H12N2O3 | 160.18 | Ethyl [(aminoacetyl)amino]acetate; Glycylglycine ethyl ester; GLY-GLY ETHYL ESTER HYDROCHLORIDE; GLYCYLGLYCINE ETHYL ESTER HYDROCHLORIDE; H-GLY-GLY-OET HCL; glycylglycineethylesterHCl; 2-(glycylamino)acetic acid ethyl ester; ethyl 2-(2-azanylethanoylamino |
Ganciclovir-d5 | 1189966-73-1 | C9H8N5O4D5 | 260.27 | 2-Amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy-d5]methyl]-6H-purin-6-one; 2'-NDG-d5; 2'-Nor-2'-deoxyguanosine-d5; 9-(1,3-Dihydroxy-2-propoxymethyl) guanine-d5; BW 759-d5; BW 759U-d5; BW-B 759U-d5; Biolf 62-d5; DHPG-d5; Denosine-d5; Ganguard-d5; |
Ganciclovir Sodium | 107910-75-8 | C9H12N5NaO4 | 277.21 | 2-Amino-1,9-dihydro-9-[[2-hydroxy-1-(hydroxymethyl)ethoxy]methyl]-6h-purin-6-one sodium salt;9-[[1-(Hydroxymethyl)-2-hydroxyethoxy]methyl]-2-amino-9H-purine-6(1H)-one/sodium,(1:1) salt;Ganciclovir monosodium salt;6H-Purin-6-one, 1,9-dihydro-2-amino-9-((2- |
Ganciclovir Monopropionate | 194159-18-7 | C12H17N5O5 | 311.30 | Ganciclovir Mono-O-propionate; Ganciclovir Impurity B; 2-Amino-1,9-dihydro-9-[[1-(hydroxymethyl)-2-(1-oxopropoxy)ethoxy]methyl]-6H-purin-6-one |
Ganciclovir Monoacetate | 88110-89-8 | C11H15N5O5 | 297.27 | Ganciclovir mono-O-acetate; 9-[[2-(Acetyloxy)-1-(hydroxymethyl)ethoxy]methyl]-2-amino-1,9-dihydro-6H-purin-6-one |
Ganciclovir Impurity N | 1401562-16-0 | C15H25N6O5Cl | 404.86 | Ganciclovir mono-N-methyl valinate; 2-(RS)-[(Guanin-9-yl)methoxy]-3-hydroxypropyl N-methyl-L-valinate hydrochloride; N-Methyl-L-valine 2-(2-amino-6-oxo-1,6-dihydropurin-9-ylmethoxy)-3-hydroxypropyl ester monohydrochloride; N-Methylvalganciclovir hydrochlo |
Ganciclovir Impurity D | 1346598-14-8 | C10H15N5O5 | 285.26 | 2-AMino-1,9-dihydro-9-[[[2-hydroxy-1-(hydroxyMethyl)ethoxy]Methoxy]Methyl]- |
Ganciclovir Impurity A | 1797982-93-4 | C9H10ClN5O2 | 255.67 | 9-[[2-Chloroprop-2-en-1-yl)oxy]methyl]guanine; 2-amino-9-[[(2-chloroprop-2-en-yl)oxy]methyl]-1,9-dihydro-6H-purin-6-one |
Fluorescent brightener BBU | 16470-24-9 | C40H40N12Na4O16S4 | 1165.03 | tetrasodium 4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-(4-sulphonatoanilino)-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate]; PHORWHITE BBU; 2,2'-(1,2-ethenediyl)bis(5-((4-(bis(2-hydroxyethyl)amino)-6-((4-sulfophenyl)amino)-1,3,5-triazin-2-yl)amino)-be |
Fluorescent brightener BA (C.I.113) | 12768-92-2 | C40H42N12Na2O10S2 | 90.0779 | Fluorescent Brightener 113; Blankophor BA; Fluorescent brightening agent 113; C.I. Fluorescent Brightener 113 |
Fluorescent brightener 9 | 133-66-4 | C44H34N12Na2O6S2 | 936.943 | disodium 4,4'-bis[(4,6-dianilino-1,3,5-triazin-2-yl)amino]stilbene-2,2'-disulphonate; cellu-brite; Benzenesulfonic acid, 2,2'-(1,2-ethenediyl)bis[5-[4,6-bis(phenylamino)-1,3,5-triazin-2-yl]amino]-, disodium salt; Fluorescent brightening agent 9 (C.I. 4062 |
Fluorescent Brightener 87 | 12768-91-1 | C40H40N12Na4O16S4 | 1165.03 | Kayaphor S; fluorescent brightener 87; Fluorescent brightening agent 87 |
Fennel Oil | 8006-84-6 | |||
Fenmetozole Tosylate | 83474-08-2 | C17H18Cl2N2O4S | 417.31 | 2-[(3,4-dichlorophenoxy)methyl]-4,5-dihydro-1H-imidazole;4-methylbenzenesulfonic acid; Fenmetozole (Tosylate) |
Fenitrooxone | 2255-17-6 | C9H12NO6P | 261.17 | 3-Methyl-4-nitrophenyl dimethyl phosphate;3-methyl-4-nitrophenyldimethylphosphate;4-nitro-m-cresodimethylphosphate; Accothion O-analog; accothiono-analog; BAY 42247; bay42247; Dimethyl 3-methyl-4-nitrophenyl phosphate |
Fenirofibrate O-b-D-glucuronide | 168844-26-6 | C23H25ClO10 | 496.90 | |
Fadrozole | 102676-31-3 | C14H14ClN3 | 259.737 | CGS-16949A |
Fadolmidine HCl | 189353-32-0 | C13H15ClN2O | 250.726 | Fadolmidine; MPV-2426. |
Fluorobexarotene | 1190848-23-7 | C24H27FO2 | 366.47 | 2-Fluoro-4-[1-(5-,6,7,8-tetrahydro-3,5,5,8,8-pentamethyl-2-naphthalenyl)ethenyl]benzoic acid |
Fluorobenzene-d5 | 1423-10-5 | C6D5F | 101.13 | Fluoro(2H5)benzene; 1,2,3,4,5-pentadeuterio-6-fluorobenzene |
Fluoroacetyl chloride | 359-06-8 | C2H2ClFO | 96.48 | acetylchloride,fluoro-; acetylchloride,fluoro-[qr]; chloridkyselinyfluoroctove; fluoro-acetylchlorid; fluoroacetylchloride[qr]; fluoroacetylchloride101 |
Fluoroacetic anhydride | 407-33-0 | C4H4F2O3 | 138.07 g/mol | Fluoroaceticanhydride; 407-33-0; 2-fluoroaceticanhydride; Aceticacid,fluoro-,anhydride; (2-fluoroacetyl)2-fluoroacetate; Aceticacid,2-fluoro-,1,1'-anhydride |
Fluorfolpet | 719-96-0 | C9H4Cl2FNO2S | 280.106 | FLUOROFOLPET; N-(dichlorofluoromethylthio)phthalimide; Fluorfolpet; 1H-Isoindole-1,3(2H)-dione, 2-(dichlorofluoromethyl)thio-; FLUORODICHLOROMETHYLTHIOPHTHALIMIDE; 2-[(dichlorofluoromethyl)thio]-1h-isoindole-3(2h)-dione; 3-(2H)-dione, 2-[(dichlorofluorome |
Fluoresone | 2924-67-6 | C8H9FO2S | 188.219 g/mol | |
Fluorescent Brightening Agent 24 | 12224-02-1 | C40H40N12Na4O16S2 | 1100.90 | Fluorescent brightener 24; tetrasodium 4,4'-bis[[4-[bis(2-hydroxyethyl)amino]-6-[(3-sulphonatophenyl)amino]-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate; Benzenesulfonic acid, 2,2-(1,2-ethenediyl)bis5-4-bis(2-hydroxyethyl)amino-6-(3-sulfophenyl)a |
Glycyl-D-proline | 71884-56-5 | C7H12N2O3 | 172.18 | (R)-1-(2-Aminoacetyl)pyrrolidine-2-carboxylic acid; Glycyl-D-proline |
Glycycoumarin | 94805-82-0 | C21H20O6 | 368.38 | 3-(2,4-Dihydroxyphenyl)-7-hydroxy-5-methoxy-6-(3-methyl-2-butenyl)-2H-1-benzopyran-2-one |
Glycozolinine | 5257-08-9 | C13H11NO | 197.2 | 6-Methyl-9H-carbazol-3-ol; Glycozolinol |
Glycoursodeoxycholic Acid | 64480-66-6 | C26H43NO5 | 449.64 | N-[(3.alpha.,5.beta.,7.beta.)-3,7-dihydroxy-24-oxocholan-24-yl]Glycine; 3.alpha.,7.beta.-Dihydroxy-5.beta.-cholanoylglycine; Glycylursodeoxycholic acid; N-(3.alpha.,7.beta.-Dihydroxy-5.beta.-cholan-24-oyl)glycine; N-[(3.alpha.,5.beta.,7.beta.)-3,7-Dihydro |
Glycosylceramide | 497155-61-0 | C40H75NO9 | 714.02 | Ceramide b-D-glucoside; Glucocerebrosides; GlcCer |
Glycosolone | 67879-81-6 | C16H19NO3 | 273.332 | 2(1H)-Quinolinone, 8-hydroxy-4-methoxy-1-methyl-3-(3-methyl-2-butenyl)-; 8-hydroxy-4-methoxy-1-methyl-3-(3-methylbut-2-enyl)quinolin-2-one |
Glycosmisic Acid | 443908-19-8 | C20H20O7 | 372.37 | spicatolignan B |
Glycoside O-4 | 94898-61-0 | C39H62O15S | ||
Glycopyrrolate Impurity I | 1404453-68-4 | C19H27ClNO3Br | 432.78 | 3-[[2-(4-Chlorophenyl)-2-cyclopentyl-2-hydroxyacetyl]oxy]-1,1-dimethyl pyrrolidinium Bromide |
Glycopyrrolate Impurity (1,1-Dimethyl-3-Hydroxy-pyrrolidinium Bromide) | 51052-74-5 | C6H14NOBr | 196.08 | |
Glyco-Obeticholic Acid | 863239-60-5 | C28H47NO5 | 477.68 | |
Glycodeoxycholic acid | 360-65-6 | C26H43NO5 | 449.632 | Glycodeoxycholate; Deoxycholylglycine; Glycodesoxycholic acid; Deoxycholic acid glycine conjugate |
Glycocholic acid-(glycyl-1-13C) monohydrate | 64431-95-4 | [13C]C25H43NO6·H2O | 484.63 | |
Glycine-2-13C,15N | 91795-59-4 | H2[15N][13C]H2COOH | 77.05 | 2-azanylacetic acid-2-13C,15N |
Glycocholic acid sodium salt hydrate | 207614-05-9 | C26H42NO6.Na.2H2O | 523.638 | SODIUM GLYCOCHOLATE HYDRATE, 98 |
Glycochenodeoxycholic acid | 640-79-9 | C26H43NO5 | 449.62 | 2-[[(4R)-4-[(3R,5S,7R,8R,9S,10S,13R,14S,17R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]pentanoyl]amino]acetic acid; Acid, Glycochenodeoxycholic; Chenodeoxycholate, Glycine; Chenodeoxych |
Glycoborinine | 233279-39-5 | C18H17NO2 | 279.339 | 3,3,10-Trimethyl-7H-pyrano[3,2-g]carbazol-9-ol |
Glycitin | 40246-10-4 | C22H22O10 | 446.40 | 7-(b-D-Glucopyranosyloxy)-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; Glycitein-7-O-b-D-glucoside |
Glycitein | 40957-83-3 | C16H12O5 | 284.26 | 7-Hydroxy-3-(4-hydroxyphenyl)-6-methoxy-4H-1-benzopyran-4-one; 7,4'-Dihydroxy-6 methoxyisoflavone; |
Glyciphosphoramide | 7568-40-3 | C12H24Cl2N3O5P | 392.214 | BRN 2012594; M 25; LS-72312; Z-6202; M 256202; M-25,6202. |
Glycin-tert-butyl ester | 6456-74-2 | C6H13NO2 | 131.17300 | |
Glycinexylidide-d6 | 1217098-46-8 | C10H8N2OD6 | 184.27 | 2-Amino-N-(2,6-dimethylphenyl)acetamide-d6 |
Glycinexylidide HCl | 18865-38-8 | C10H15ClN2O | 214.69 | 2-Amino-N-(2,6-dimethylphenyl)acetamide Hydrochloride; |
Glycine-N,N,O-d3 | 4896-76-8 | D2NCH2COOD | 78.09 | Aminoacetic Acid-d3; H-Gly-OH-d3; Glycine-D3; deuterio 2-(dideuterioamino)acetate |
Glycine-d5 | 4896-77-9 | D2NCD2COOD | 80.1 | Aminoacetic Acid-d5; H-Gly-OH-d5; (2H5)Glycine; Perdeuterioglycine; Perdeuteroglycine; deuterio 2,2-dideuterio-2-(dideuterioamino)acetate |
Glycinecarbonatesodiumsalt | 50610-34-9 | C3H4NNa3O5 | 203.03687 | Glycine carbonate sodium salt; Glycine sodium salt carbonate; Sodium glycine carbonate |
Glycine-2-13C | 20220-62-6 | H2N[13C]H2COOH | 76.06 | 2-aminoacetic acid-2-13C |
Glycine-2,2-d2-N-t-BOC | 42492-65-9 | HOOCCD2NH-t-BOC | 177.2 | BOC-Glycine-d2; BOC-Gly-OH-d2; N-(tert-Butoxycarbonyl)glycine-2,2-d2; 2,2-dideuterio-2-[(2-methylpropan-2-yl)oxycarbonylamino]acetic acid |
Glycine-2,2-d2-N-FMOC | 284665-11-8 | HOOCCD2NH-FMOC | 299.32 | FMOC-Glycine-d2; FMOC-Gly-OH-d2; 2,2-dideuterio-2-(9H-fluoren-9-ylmethoxycarbonylamino)acetic acid |
Glycine-2,2-d2 | 4896-75-7 | H2NCD2COOH | 77.08 | Aminoacetic Acid-d2; H-Gly-OH-d2; 2-amino-2,2-dideuterioacetic acid |
Glycine-15N | 7299-33-4 | H2[15N]CH2COOH | 76.06 | 2-azanylacetic acid-15N |
Glycine-13C2,15N | 211057-02-2 | H2[15N][13C]H2[13C]OOH | 78.05 | Aciport-13C2,15N; Glicoamin-13C2,15N; Glycocoll-13C2,15N |
Glycine-1-13C,15N | 112898-03-0 | H2[15N]CH2[13C]OOH | 77.05 | 2-azanylacetic acid-1-13C,15N |
Glycine-1-13C | 20110-59-2 | H2NCH2[13C]OOH | 76.06 | 2-aminoacetic acid-1-13C |
Glycine-1,2-13C2 | 67836-01-5 | H2N[13C]H2[13C]OOH | 77.05 | 2-aminoacetic acid-1,2-13C2 |
Glycine,N-methyl-N-(1-oxo-9-octadecen-1-yl)- | 16693-85-9 | C21H39 N O3 | 353.5393 | |
Glycine,N-formyl-N-hydroxy- | 689-13-4 | C3H5NO4 | 119.07600 | |
Glycine,N-[2-[bis(carboxymethyl)amino]ethyl]-N-(2-hydroxyethyl)-, sodium salt (1:3) | 139-89-9 | C10H18 N2 O7 . 3 Na | 344.2 | HEDTA-NA3; HEDTA TRISODIUM SALT; HEEDTA TRISODIUM SALT; N-(CARBOXYMETHYL)-N'-2-HYDROXYETHYL-N,N-ETHYLENEDIGLYCINE TRISODIUM SALT; N-CARBOXYMETHYL-N'-(2-HYDROXYETHYL)-N,N'-ETHYLENEDIGLYCINE TRISODIUM SALT; N-HYDROXYETHYLETHYLENEDIAMINETRIACETIC ACID TRISOD |
Glycine,N-[2-[bis(carboxymethyl)amino]-3-(4-ethoxyphenyl)propyl]-N-[2-[bis(carboxymethyl)amino]ethyl]- | 135306-78-4 | C23H33 N3 O11 | 527.52162;g/mol | Caloxeticacid; Caloxeticacid[INN]; AC1L9OPT; SCHEMBL92689; CHEMBL2110606; AM015093 |
Glycine,N-[[bis[4-(dimethylamino)phenyl]amino]carbonyl]-, sodium salt (1:1) | 115871-19-7 | C19H24 N4 O3 . Na | 378.39 | DA-64; N-(Carboxymethylaminocarbonyl)-4,4'-bis(dimethylamino)diphenylamine Sodium Salt; Sodium N-(Carboxymethylaminocarbonyl)-4,4'-bis(dimethylamino)diphenylamine |
Glycine,N,N-bis[2-(2,6-dioxo-4-morpholinyl)ethyl]- | 23911-26-4 | C14H19 N3 O8 | 357.32 | N,N-BIS[2-(2,6-DIOXOMORPHOLINO)ETHYL]GLYCINE; DIETHYLENETRIAMINEPENTAACETIC ACID ANHYDRIDE; DIETHYLENETRIAMINEPENTAACETIC ANHYDRIDE; DIETHYLENETRIAMINEPENTAACETIC DIANHYDRIDE; DIETHYLENETRIAMINE-N,N,N',N'',N''-PENTAACETIC ACID ANHYDRIDE; DIETHYLENETRIAMIN |
Glycine Bisphosphonate | 41003-10-5 | C2H9NO7P2 | 221.04 | 2-Amino-1-hydroxyethylene-1,1-bisphosphonic Acid; Ethane-1-hydroxy-2-amino-1,1-diphosphonic Acid |
Glycine anhydride;oxiracetaM related substance ISF3890 | 106-57-0 | |||
Glycine | 56-40-6 | C2H5NO2 | Aminoacetic acid; H-Gly-OH; | |
Glycidyl ether 100 | 90529-77-4 | C6H12O4.(C3H4O)0-2 | 148.160003662109 | Glycidyl ether 100; 1,2,3-Propanetriol glycidyl ethers |
GLYCIDYL AZIDE POLYMER | 80044-10-6 | |||
Glychionide A | 119152-50-0 | C21H18O11 | 446.36 | |
GLYCERYLPOLYMETHACRYLATE | 37310-95-5 | |||
Glyceryl tripalmitate | 555-44-2 | C51H98O6 | 807.32 | Glycerol tripalmitate, Tripalmitin |
Glycerone phosphate dilithium salt | 102783-56-2 | C3H5Li2O6P | 181.92 | Dihydroxyacetone phosphate dilithium salt; 1-Hydroxy-3-(phosphonooxy)-2-propanone dilithium salt; DHAP.2Li |
Glycerone phosphate | 57-04-5 | C3H7O6P | 170.06 | |
GLYCEROL-D8 | 7325-17-9 | C3D8O3 | 100.14 | GLYCEROL (U-D8); GLYCEROL-D8; GLYCEROL-D8, 98 ATOM% D, 98% CHEMICAL PURITY; 1,2,3-Propane-1,1,2,3,3-d5-triol-d3 |
Glutathione reduced ethyl ester | 92614-59-0 | 335.38 | Glu-Cys-Gly-OEt, GSH-MEE | |
Glutathione Monoethyl Ester | 118421-50-4 | C12H21N3O6S | 335.38 | L-GLUTATHIONE REDUCED ETHYL ESTER; L-GAMMA-GLUTAMYL-L-CYSTEINYL ETHYL GLYCINATE; GAMMA-L-GLUTAMYL-L-CYSTEINYL-GLYCINE ETHYL ESTER; GAMMA-GCE; GAMMA-GLU-CYS-GLY-OET; GLU(CYS-GLY-OET); GSH-MEE; GLUTATHIONE MONOETHYL ESTER |
Glutathione Impurity C | 27025-41-8 | C20H32N6O12S2 | 612.626 | NOV 002; NOV002; Gluthoxim; Glutoxim; Oxiglutatione; Glutathione disulfide; GSSG; Oxidized glutathione; Glutathione disulphide |
Glutathione Disulfide-13C4-15N2 | 1416898-83-3 | [13C]4C16H32[15N]2N4O12S2 | 618.58 | N,N'-[Dithiobis[1-[(carboxymethyl)carbamoyl]ethylene]]diglutamine-13C4,15N2; GSSG-13C4,15N2; Glutathione Disulphide-13C4,15N2; Glutathione Oxidized-13C4,15N2; Glutathione-S-S-glutathione-13C4,15N2; Glutathione-SSG-13C4,15N2; Oxidized L-Glutathione-13C4,15 |
Glutathione (reduced) sodium salt | 20167-21-9 | C10H16N3NaO6S | 329.31 | GLUTATHIONE, MONOSODIUM SALT; GLUTATHIONE (REDUCED), SODIUM SALT |
Glutathione (1S, 2R)-Isomer | 274260-05-8 | C10H17N3O6S | 307.33 | |
Glutaryl-glycyl-L-arginine 7-amido-4-methylcoumarin hydrochloride | 103213-40-7 | C23H31ClN6O7 | 538.98 | Glutaryl-Gly-Arg-AMC.HCl |
GLUTARYL COENZYME A LITHIUM SALT | 103192-48-9 | C26H41LiN7O19P3S | 887.57 | GLUTARYL COENZYME A LITHIUM SALT; GLUTARYL COENZYME A LITHIUM; 5-[2-[3-[4-[[[5-(6-aminopurin-9-yl)-4-hydroxy-3-phosphonooxy-oxolan-2-yl]methoxy-hydroxy-phosphoryl]oxy-hydroxy-phosphoryl]oxy-2-hydroxy-3,3-dimethyl-butanoyl]aminopropanoylamino]ethylsulfanyl |
Glutaric acid sodium salt | 13521-83-0 | C5H6Na2O4 | 176.08 | GLUTARIC ACID SODIUM SALT; Glutaricacid,disodiumsalt; Pentanedioicacid,disodiumsalt; disodium glutarate; SODIUM GLUTARATE |
Glutaraldehydic acid | 5746-02-1 | C5H8O3 | 116.1152 | |
Glutapyrone | 92236-42-5 | C19H24N2Na2O9 | 470.38 | (S)-4-[[(1,3-Dicarboxypropyl)amino]carbonyl]-1,4-dihydro-2,6-dimethyl-3,5-pyridinedicarboxylic acid 3,5-diethyl ester disodium salt |
Glutaminase C-IN-1 | 311795-38-7 | C27H27BrN2O | 475.42 | 5-[3-bromo-4-(dimethylamino)phenyl]-2,2-dimethyl-1,3,5,6-tetrahydrobenzo[a]phenanthridin-4-one 5-(3-bromo-4-(dimethylamino)phenyl)-2,2-dimethyl-2,3,5,6-tetrahydrobenzo(a)phenanthridin-4(1H)-one |
GLUTAMATE CAGED | 239135-34-3 | C16H19N3O7 | 365.34 | |
Glumetinib | 1642581-63-2 | C21H17N9O2S | 459.48 | SCC244; 6-(1-methyl-1H-pyrazol-4-yl)-1-[[6-(1-methyl-1H-pyrazol-4-yl)imidazo[1,2-a]pyridin-3-yl]sulfonyl]-1H-pyrazolo[4,3-b]pyridine |
Glu-Leu | 2566-39-4 | C11H20N2O5 | 260.29 | (2S)-2-[[(4S)-4-amino-4-carboxybutanoyl]amino]-4-methylpentanoicacid; gamma-Glu-leu; L-gamma-Glu-L-Leu; gamma-Glutamylleucine; 2566-39-4; L-gamma-glutamyl-L-leucine |
Glufosfamide | 132682-98-5 | C10H21Cl2N2O7P | 383.16 | N,N-Bis(2-chloroethyl)phosphorodiamidic acid beta-D-glucopyranosyl ester |
Gludapein | 76490-22-7 | C20H33N5O11 | 519.50300 | |
Glucuronidase from bovine liver | 9001-45-0 | -D-Glucuronide glucuronosohydrolase | ||
Glucovanillin | 494-08-6 | C14H18O8 | 314.29 | 4-(b-D-Glucopyranosyloxy)-3-methoxybenzaldehyde; Vanillin 4-O-b-D-glucoside |
Glucotropaeolin | 499-26-3 | C14H17NO10S2 | 423.417 | glucotropeolin |
Glucotropaeolin | 5115-71-9 | C14H18KNO9S2 | 447.5 | Glucotropaeolin Potassium Salt; Benzyl glucosinolate |
Glucosyl-vitexin | 76135-82-5 | C27H30O15 | 4-[8-(beta-D-Glucopyranosyloxy)-5,7-dihydroxy-4-oxo-4H-chromen-2-yl]phenyl beta-D-glucopyranoside; 4H-1-benzopyran-4-one, 8-(beta-D-glucopyranosyloxy)-2-[4-(beta-D-glucopyranosyloxy)phenyl]-5,7-dihydroxy-; Glucosylvitexin | |
Glucosyl-C18-sphingosine | 52050-17-6 | C24H47NO7 | 461.63 | Glucosylsphingosine; 2-Amino-3-hydroxy-4-octadecenyl b-D-glucopyranoside; (2S,3R,4E)-2-Amino-3-hydroxy-4-octadecenyl b-D-glucopyranoside |
Glucosulfone | 554-18-7 | C24H34N2O18S3.2Na | 780.707 | |
Glucosibarin potassium salt | 144491-25-8 | C15H20KNO10S2.H2O | 477.55 | Glucosibarin |
Glucosepane | 257290-23-6 | C18H32N6O6 | 428.48 | (2S)-2-Amino-6-((6R,7S)-2-(((S)-4-amino-4-carboxybutyl)amino)-6,7-dihydroxy-6,7,8,8a-tetrahydroimidazo[4,5-b]azepin-4(5H)-yl)hexanoic acid |
Glucose Pentasulfate, Potassium Salt, Technical Grade | 359435-44-2 | C6H7O21S5K5 | 770.94 | |
GLUCOSE GLUTAMATE | 113114-16-2 | C11H19NO9 | 309.26986 | |
Glucose dehydrogenase from Pseudomonas sp. | 9028-53-9 | |||
Glucoraphanin | 21414-41-5 | C12H23NO10S3 | 437.5 | Glucorafanin; Sulforaphane glucosinolate; 4-methylsulfinylbutyl glucosinolate |
Glucoprotamin | 178037-31-5 | |||
Glucopiericidin A | 108073-65-0 | C31H47NO9 | 577.71 | |
Gluconate Calcium | 299-28-5 | C6H11O7 Ca | 215.19 | Calcium D-gluconate; 2,3,4,5,6-Pentahydroxycaproic acid hemicalcium salt |
Gluconasturtiin Potassium Salt | 1454839-39-4 | C15H20KNO9S2 | 461.55 | |
Gluconapin | 19041-09-9 | C11H19NO9S2 | 373.401 | 3-BUTENYLGLUCOSINOLATE; 1-Thio-beta-D-glucopyranose 1-(N-(sulfooxy)-4-pentenimidate); beta-D-Glucopyranose, 1-thio-, 1-(N-(sulfooxy)-4-pentenimidate); GLUCONAPIN(RG) |
Glucomannan | 11078-31-2 | (C35H49O29)n | 1000000 | GALACTOMANNANE; GLUCOMANNAN; GLUCOMANNAN MAYO; GUM XANTHAN; RHODOPOL 23; XANTEMPO(TM); XANTHAN; XANTHAN GUM FOOD GRADE |
Glucodigifucoside | 2446-63-1 | C35H54O13 | 682.804 | 3-[(3S,5R,8R,9S,10S,13R,14S,17R)-3-[(3S,4S,6S)-3,4-dihydroxy-6-methyl-5-[(2S,3R,4S,5S,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxyoxan-2-yl]oxy-14-hydroxy-10,13-dimethyl-1,2,3,4,5,6,7,8,9,11,12,15,16,17-tetradecahydrocyclopenta[a]phenanthren-17-yl] |
Glucocorticoid receptor agonist | 1245526-82-2 | C20H20F4N2O2 | 396.38 | 4-fluoro-2-[(4R)-5,5,5-trifluoro-4-hydroxy-2-methyl-4-(1H-pyrrolo[2,3-c]pyridin-2-ylmethyl)pentan-2-yl]phenol;Glucocorticoidreceptoragonist;CHEMBL1253898;1245526-82-2;C20H20F4N2O2;3695AH |
Glucagon-like peptide 1 (1-37) (human, rat) | 87805-34-3 | C186H275N51O59 | 4169.52 | GLP-1 |
glucagon receptor antagonists-4 | 1393124-08-7 | C26H28F3N3O4 | 503.51 | |
glucagon receptor antagonists-3 | 202917-17-7 | C22H30FNO2 | 359.48 | 3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-, (aR,4R)-rel- (9CI);(aphlaR,4R)-4-(4-Fluoro-2-hydroxyphenyl)-alpha-methyl-2,6-bis(1-methylethyl)-5-propyl-3-pyridinemethanol |
glucagon receptor antagonists-2 | 202917-18-8 | C22H30FNO2 | 359.48 | (6E)-3-fluoro-6-[3-[(1R)-1-hydroxyethyl]-2,6-di(propan-2-yl)-5-propyl-1H-pyridin-4-ylidene]cyclohexa-2,4-dien-1-one 3-Pyridinemethanol, 4-(4-fluoro-2-hydroxyphenyl)-a-methyl-2,6-bis(1-methylethyl)-5-propyl-, (aR)- |
Glucagon receptor antagonists 1 | 503559-84-0 | C29H34FNO2 | 447.59 | 1-(4-(2-(Benzyloxy)-4-fluorophenyl)-2,6-diisopropyl-5-(prop-1-en-1-yl)pyridin-3-yl)ethanol; 1-[4-(4-fluoro-2-phenylmethoxyphenyl)-2,6-di(propan-2-yl)-5-[(E)-prop-1-enyl]pyridin-3-yl]ethanol; |
Glucagon Receptor Antagonist Inactive Control | 362482-00-6 | C21H23BrN2OS | 431.4 | GCGR Inactive Control; 4-bromo-N-[3-cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-benzamide; hGCGR Antagonist, Control |
Glucagon Receptor Antagonist I | 438618-32-7 | C20H30N2OS | 346.5 | GCGR Antagonist I; hGCGR Antagonist; N-[3-cyano-6-(1,1-dimethylpropyl)-4,5,6,7-tetrahydrobenzo[b]thien-2-yl]-2-ethyl-butanamide |
Glucagon (swine) | 16941-32-5 | C153H225N43O49S | 3482.75 | Glucagonum; Glucagone; HG-Factor; His-ser-glu(nh2)-gly-thr-phe-thr-ser-asp-tyr-ser-lys-tyr-leu-asp-ser-arg-arg-ala-glu(NH2)-asp-phe-val-glu(NH2)-trp-leu-met-asp(NH2)-thr; Glucagon-like-immunoreactivity; Glucaton |
Glubionate Calcium | 12569-38-9 | C18H34CaO20 | 610.528 | Calcium glubionate; Neocalglucon |
GLPG1837 | 1654725-02-6 | C16H20N4O3S | 348.42 | ABBV-974; N-[3-(aminocarbonyl)-4,7-dihydro-5,5,7,7-tetramethyl-5H-thieno[2,3-c]pyran-2-yl]-1H-pyrazole-3-carboxamide |
GLPG-1690 | 1628260-79-6 | C30H33FN8O2S | 588.71 | GLPG-1690; GLPG 1690; GLPG1690; 2-((2-ethyl-6-(4-(2-(3-hydroxyazetidin-1-yl)-2-oxoethyl)piperazin-1-yl)-8-methylimidazo[1,2-a]pyridin-3-yl)(methyl)amino)-4-(4-fluorophenyl)thiazole-5-carbonitrile |
GLPG0634 analogue | 1206101-20-3 | C23H18N6O2 | 410.43 | GLPG0634 analog; N-[5-[4-[(6-cyanopyridin-3-yl)methoxy]phenyl]-[1,2,4]triazolo[1,5-a]pyridin-2-yl]cyclopropanecarboxamide |
GLPG0492 R enantiomer | 1215085-93-0 | C19H14F3N3O3 | 389.33 | GLPG-0492 R enantiomer |
GLPG0492 | 1215085-92-9 | C19H14F3N3O3 | 389.33 | GLPG0492; SCHEMBL2021011; CHEMBL2178100; GLPG 0492; GLPG-0492; VAJGULUVTFDTAS-GOSISDBHSA-N |
GLPG-0187 | 1320346-97-1 | C29H37N7O5S | 595.719 | GLPG0187; UNII-43A5P87Z4T; 43A5P87Z4T; SCHEMBL2372722; CHEMBL3319236; (2S)-3-[[2,5-dimethyl-6-[4-(5,6,7,8-tetrahydro-1,8-naphthyridin-2-yl)piperidin-1-yl]pyrimidin-4-yl]amino]-2-[(4-methoxyphenyl)sulfonylamino]propanoic acid |
GLPG 0974 | 1391076-61-1 | C25H25ClN2O4S | 485 | 4-[[[(2R)-1-(Benzo[b]thien-3-ylcarbonyl)-2-methyl-2-azetidinyl]carbonyl][(3-chlorophenyl)methyl]amino]butanoic acid |
GLP-2 (rat) | 195262-56-7 | C166H256N44O56S | 3796.17 | Glucagon-like Peptide 2 (rat) |
GLP-2 (human) | 223460-79-5 | C165H254N44O55S | 3766.14 | Glucagon-like peptide 2 (human) |
GLP-1R agonist DMB | 281209-71-0 | C13H15Cl2N3O2S | 348.25 | N-(tert-Butyl)-6,7-dichloro-3-(methylsulfonyl)quinoxalin-2-amine |
GLP-1 antagonist | 475466-57-0 | C28H37N3O3 | 463.61 | N-[[4,5-dimethyl-1-[(2-methylphenyl)methyl]imidazol-2-yl]methyl]-2,4-dimethoxy-N-(3-methylbutyl)benzamide |
GLP-1 (9-36) amide | 161748-29-4 | C140H214N36O43 | 3089.44 | Glucagon-like peptide-1 (9-36) amide |
Glomeratose A | 202471-84-9 | C24H34O15 | 562.52 | |
Glochidonol | 23963-54-4 | C30H48O2 | 440.7 | 1-Hydroxy-20(29)-lupen-3-one |
Glochidone | 6610-55-5 | C30H46O | 422.7 | Lupa-1,20(29)-dien-3-one |
Glochicoccin D | 927812-23-5 | C21H24O10 | 436.4 | (2S,3aR,4S,4'S,5'R,6S,7aR)-3a,4-Dihydroxy-4'-[(4-hydroxybenzoyl)o xy]-5'-methyl-3-oxodecahydro-3H-spiro[1-benzofuran-2,2'-pyran]-6- carboxylic acid |
Globulol | 489-41-8 | C15H26O | 222.372 | (-)-Globulol; (1aR,4R,4aR,7R,7aS,7bS)-1,1,4,7-tetramethyl-2,3,4a,5,6,7,7a,7b-octahydro-1aH-cyclopropa[e]azulen-4-ol |
Globo H pentenyl glycoside | 284663-02-1 | |||
Globotriose | 66580-68-5 | C18H32O16 | 504.44 | Gal-a-1,4-Gal-b-1,4-Glc; pk-Antigen; Globotriaose |
Globosuxanthone A | 917091-74-8 | C15H12O7 | 304.25 | (1R,2R)-2,9-dihydro-1,2,8-trihydroxy-9-oxo-1H-xanthene-1-carboxylic acid, methyl ester |
Globoside | 11034-93-8 | C56H102N2O23 | 1171.41 | Globotetraosylceramide; Cytolipins; GlcNAc (b1-3)Gal (a1-4) Gal (b1-4) Glc b1-1 Cer |
Globopentaose | 71937-76-3 | C32H55NO26 | 869.77 | Gal-b-1,3-GalNAc-b-1,3-Gal-a-1,4-Gal-b-1,4-Glc; SSEA-3a |
Globo-N-tetraose | 75660-79-6 | C26H45NO21 | 707.63 | GalNAc-b-1,3-Gal-a-1,4-Gal-b-1,4-Glc |
Globalide | 34902-57-3 | C15H26O2 | 238.37 | OXACYCLOHEXADECEN-2-ONE; habanolid; HABANOLIDE 947.303; Oxacyclohexadecen-2-on |
Gliquidone | 33342-05-1 | C27H33N3O6S | 527.63 | Glurenorm |
Glipizide-d11 | 1189426-07-0 | C21H16N5O4SD11 | 456.60 | N-[2-[4[[[(Cyclohexylamino-d11)carbonyl]amino]sulfonyl]phenyl]ethyl]-5-methylpyrazinecarboxamide; 1-(Cyclohexyl-d11)-3-[[p-[2-(5-methylpyrazinecarboxamido) ethyl]phenyl]sulfonyl]urea; Aldiab-d11; Digrin-d11; Dipazide-d11; Glibenese-d11; Glibetin-d11; Glic |
Glipizide EP Impurity H | 10080-05-4 | C15H23N3O3S | 325.43 | 1-Cyclohexyl-3-(p-sulfaMoylphenethyl)urea; 4-[2-[[(CyclohexylaMino)carbonyl]aMino]ethyl]benzenesulfonaMide |
Glipizide EP Impurity F | 192118-08-4 | C11H16N2O4S | 272.33 | [2-[4-(AMinosulfonyl)phenyl]ethyl]carbaMic Acid Ethyl Ester |
Glipizide EP Impurity E | 66375-96-0 | C21H27N5O4S | 445.54 | 1-Cyclohexyl-3-{{4-{2-{[(6-methylpyrazin-2-yl)carbonyl]amino}ethyl}phenyl}sulfonyl}urea; 5-Desmethyl-6-methyl Glipizide; N-[2-[4-[[[(Cyclohexylamino)carbonyl]amino]sulfonyl]phenyl]ethyl]-6-methyl-2-pyrazinecarboxamide |
Glimepiride Impurity B | 119018-29-0 | C16H21N3O4S | 351.43 | 4-{2-[(3-Ethyl-4-methyl-2-oxo-3-pyrrolin-1-yl)carboxamido]ethyl}benzenesulfonamide; Glimepiride sulfonamide; N-[2-[4-(Aminosulfonyl)phenyl]ethyl]-3-ethyl-2,5-dihydro-4-methyl-2-oxo-1H-pyrrole-1-carboxamide; Des[(trans-4-methylcyclohexyl)amino]carbonyl Gli |
Glimepiride Impurity A | 684286-46-2 | C24H34N4O5S | 490.63 | 1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(cis-4-methylcyclohexyl)urea; 3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[(cis-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole-1-carboxamide; |
Glimepiride | 93479-97-1 | C24H34N4O5S | 490.62 | 1-[[p-[2-(3-Ethyl-4-methyl-2-oxo-3-pyrroline-1-carboxamido)ethyl]phenyl]sulfonyl]-3-(trans-4-methylcyclohexyl)urea; Amary; trans-3-Ethyl-2,5-dihydro-4-methyl-N-[2-[4-[[[[trans-4-methylcyclohexyl)amino]carbonyl]amino]sulfonyl]phenyl]ethyl]-2-oxo-1H-pyrrole |
Gliflumide | 35273-88-2 | C25H29FN4O4S | 500.592 | Gliflumide; N-[(S)-1-(5-Fluoro-2-methoxyphenyl)ethyl]-4-[[(5-isobutylpyrimidin-2-yl)amino]sulfonyl]benzeneacetamide; SH-31168; ZK-28200; Benzeneacetamide, N-((1S)-1-(5-fluoro-2-methoxyphenyl)ethyl)-4-(((5-(2-methylpropyl)-2-pyrimidinyl)amino)sulfonyl)-; B |
Glaucogenin C mono-D-thevetoside | 849201-84-9 | C28H40O9 | 520.61 | Glaucogenin C O-beta-D-thevetopyranoside |
Glaucocalyxin B | 80508-81-2 | C22H30O5 | 374.47 | |
glaucocalyxin A | 79498-31-0 | C20H28O4 | 332.43 | LeukaMenin F; Wangzaozin B; Leucamenin F |
Glaucine | 475-81-0 | C21H25NO4 | 355.43 | (s)-5,6,6a7-tetrahydro-1,2,9,10-tetramethoxy-6-methyl-4h-dibenzo(de,g)quinol; (S)-1,2,9,10-Tetramethoxy-6-methyl-5,6,6a,7-tetrahydro-4H-dibenzo[de,g]quinoline |
Glaucin B | 115458-73-6 | C28H32O10 | 528.6 | (4aS,6aR,7S,8aR,8bR,9aS,12R,12aS,14aR,14bR)-12-(3-Furyl)-6,6,8a,1 2a-tetramethyl-3,8,10-trioxotetradecahydro-3H-oxireno[d]pyrano[4' ,3':3,3a][2]benzofuro[5,4-f]isochromen-7-yl acetate |
Gibberellin A4+7 (GA4:GA7=65:35) | 668-44-0 | C5H3F3N4O3 | 224.09800 | |
Glatiramer acetate | 147245-92-9 | C25H45N5O13 | 623.65 | L-Alanine polymer with L-Glutamic Acid L-Lysine L-Tyrosine Acetate; L-Tyrosine polymer with L-Alanine L-Glutamic Acid L-Lysine Acetate; Copaxone; Copolymer 1; L-Glutamic Acid peptide with L-Alanine L-Lysine L-Tyrosine Acetate Salt; Protiramer; TV 5010 |
glass spheres | 65997-17-3 | O2Si | 0 | Sodiumzincpolyphosphate; Sodiumzincpotassiumpolyphosphate; SILANIZED GLASS WOOL; GLASS BEADS, ACID WASHED; GLASS POWDER; GLASS WOOL; GLASS WOOL, SILANIZED; GLASS SPHERES |
Glasdegib | 1095173-27-5 | C21H22N6O | 374.44 | PF-04449913; PF 04449913; 1-[(2R,4R)-2-(1H-benzimidazol-2-yl)-1-methylpiperidin-4-yl]-3-(4-cyanophenyl)urea |
Glafenine hydrochloride | 65513-72-6 | C19H18Cl2N2O4 | 409.26 | 2,3-dihydroxypropyl 2-[(7-chloroquinolin-4-yl)amino]benzoate;hydrochloride; Glafenine (hydrochloride) |
GK921 | 1025015-40-0 | C21H20N4O | 344.41 | |
GK187 | 1071001-50-7 | C14H15F5O2 | 310.26 | 1,1,1,2,2-pentafluoro-7-(4-methoxyphenyl)-3-heptanone |
Givinostat hydrochloride monohydrate | 732302-99-7 | C24H27N3O4.HCl.H2O | 475.97 | [6-(diethylaminomethyl)naphthalen-2-yl]methyl N-[4-(hydroxycarbamoyl)phenyl]carbamate;hydrate;hydrochloride; givinostat hydrochloride; ITF 2357; ITF2357; ITF-2357; ITF2357 HCl; ITF2357 hydrochloride |
Givinostat hydrochloride | 199657-29-9 | C24H28ClN3O4 | 457.95 | (6-((diethylamino)methyl)naphthalen-2-yl)methyl (4-(hydroxycarbamoyl)phenyl)carbamate hydrochloride; ITF2357; ITF-2357; ITF 2357; ITF2357 HCl; ITF2357 hydrochloride; Givinostat HCl gavinostat, |
Givinostat | 497833-27-9 | C24H27N3O4 | 421.497 | Givinostat; gavinostat; ITF-2357; ITF 2357; ITF2357. |
Gitogenin | 511-96-6 | C27H44O4 | (2alpha,3beta,5alpha,22xi,25R)-spirostan-2,3-diol | |
GIT 27 | 6501-72-0 | C11H11NO3 | 205.21 | 5-Dihydro-3-phenyl-5-isoxazoleacetic acid; (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid; 3-phenyl-4,5-dihydro-5-isoxazole acetic acid; GIT27; VGX-1027 |
Gisadenafil besylate | 334827-98-4 | C23H33N7O5S.C6H6O3S | 677.79 | UK 369003; 5-[2-Ethoxy-5-[(4-ethyl-1-piperazinyl)sulfonyl]-3-pyridinyl]-3-ethyl-2,6-dihydro-2-(2-methoxyethyl)-7H-pyrazolo[4,3-d]pyrimidin-7-one benzenesulfonate |
Gisadenafil | 334826-98-1 | C23H33N7O5S | 519.62 | 5-[2-ethoxy-5-(4-ethylpiperazin-1-yl)sulfonylpyridin-3-yl]-3-ethyl-2-(2-methoxyethyl)-4H-pyrazolo[4,3-d]pyrimidin-7-one; |
Giripladib | 865200-20-0 | C41H36ClF3N2O4S | 745.25 | 4-[3-[5-Chloro-1-(diphenylmethyl)-2-[2-[[[[2-(trifluoromethyl)phenyl]methyl]sulfonyl]amino]ethyl]-1H-indol-3-yl]propyl]benzoic Acid; 4-(3-[5-Chloro-1-(diphenylmethyl)-2-[2-(((2-(trifluoromethyl)benzyl)sulfonyl)amino)ethyl]-1H-indole-3-yl]propyl)benzoic Ac |
Gipsoside | 15588-68-8 | C80H126O44 | 1791.8 | Gypsoside |
GIP (1-39) | 725474-97-5 | C210H316N56O61S | 4633.21 | Gastric Inhibitory Polypeptide (1-39) |
Ginsenoyne K | 141947-42-4 | C17H24O3 | 276.4 | (-)-Ginsenoyne K;(3R,10S,8E)-10-Hydroperoxy-1,8-heptadecadiene-4,6-diyn-3-ol |
Ginsenosides | 74749-74-9 | C30H52O2 | 444.744 | panaxosides |
Ginsenoside-Rb3 | 68406-26-8 | C53H90O22 | 1079.27 | (3b,12b)-3-[(2-O-b-D-Glucopyranosyl-b-D-glucopyranosyl)oxy]-12-hydroxydammar-24-en-3-yl 6-O-(b-D-glucopyranosyl)-b-D-glucopyranoside; Gypenoside IV |
Ginsenoside Rs3 | 194861-70-6 | C44H74O14 | 827.1 | |
Ginsenoside Ro | 34367-04-9 | C48H76O19 | 957.13 | (3b)-28-(b-D-Glucopyranosyloxy)-28-oxoolean-12-en-3-yl 2-O-(b-D-glucopyranosyl)-b-D-glucopyranosiduronic acid; Chikusetsusaponin; Polysciasaponin P3 |
Ginsenoside Rk3 | 364779-15-7 | C36H60O8 | 620.86 | (2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-6-(hydroxymethyl)oxane-3,4,5-triol; |
Ginsenoside Rh8 | 343780-69-8 | C36H60O9 | 636.86 | |
Ginsenoside Rh7 | 343780-68-7 | C36H60O9 | 636.86 | |
Ginsenoside Rh4 | 174721-08-5 | C36H60O8 | 620.86 | Ginsenoside Rh4 |
Ginsenoside Rg6 | 147419-93-0 | C42H70O12 | 767.00 | (2S,3R,4R,5R,6S)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-4,4,8,10,14-pentamethyl-17-(6-methylhepta-1,5-dien-2-yl)-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxym |
Ginsenoside Rg5 | 186763-78-0 | C42H70O12 | 767.00 | (2S,3R,4S,5S,6R)-2-[(2R,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-2-[[(3S,5R,8R,9R,10R,12R,13R,14R,17S)-12-hydroxy-4,4,8,10,14-pentamethyl-17-[(2Z)-6-methylhepta-2,5-dien-2-yl]-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-3-yl] |
Ginsenoside Rg5 | 74964-14-0 | C42H70O12 | 767.00 | |
Ginsenoside Rg3 | 14197-60-5 | C42H72O13 | 785.01 | 3b-[2-O-b-D-Glucopyranosyl-b-D-glucopyranosyl)oxy]-dammar-24-ene-12b, 20 diol |
Ginsenoside Rg2 | 52286-74-5 | C42H72O13 | 785.01 | (3b,6a,12b)-3,12,20-Trihydroxydammar-24-en-6-yl 2-O-(6-deoxy-a-L-mannopyranosyl)-b-D-glucopyranoside |
Ginsenoside Rg1 | 22427-39-0 | C42H72O14 | 801.03 | (3b,6a,12b)-3,12-Dihydroxydammar-24-ene-6,20-diyl bis-b-D-glucopyranoside; Panaxoside A; Ginsenoside A2; Sanchinoside C1 |
Gibberellin A9 | 427-77-0 | C19H24O4 | 316.39146;g/mol | GibberellinA9; 427-77-0; SCHEMBL3370009; CHEBI:29605; (1R,2R,5R,8R,9S,10R,11R)-11-methyl-6-methylidene-16-oxo-15-oxapentacyclo[9.3.2.1(5,8).0(1,10).0(2,8)]heptadecane-9-carboxylicacid; 1beta-methyl-8-methylidene-13-oxo-4a,1alpha-epoxymethano-4aalpha,4bbet |
GI 254023X | 260264-93-5 | C21H33N3O4 | 391.5 | GI4023; (2R)-N-[(1S)-2,2-Dimethyl-1-[(methylamino)carbonyl]propyl]-2-[(1S)-1-(N-hydroxyformamido)ethyl]-5-phenylpentanamide |
GI 181771 | 305366-98-7 | C34H31N5O6 | 605.22 | GI-181771X; (S)-3-(3-(1-(2-(isopropyl(phenyl)amino)-2-oxoethyl)-2,4-dioxo-5-phenyl-2,3,4,5-tetrahydro-1H-benzo[b][1,4]diazepin-3-yl)ureido)benzoic acid; |
GHRF (1-44), human | 83930-13-6 | 5039.7 | ||
Ghrelin (rat) | 258338-12-4 | C147H245N45O42 | 3314.83 | |
Ghrelin (human) | 258279-04-8 | C149H249N47O42 | 3370.9 | |
Ghatti gum | 9000-28-6 | |||
GGTI-298 | 180977-44-0 | C27H33N3O3S | 479.63 | methyl (2S)-2-[[4-[[(2R)-2-amino-3-sulfanylpropyl]amino]-2-naphthalen-1-ylbenzoyl]amino]-4-methylpentanoate; GGTI 298; GGTI-298; N-4-[2(R)-Amino-3-mercaptopropyl]amino-2-naphthylbenzoyl-(L)-Leucine methyl ester, TFA; (S)-methyl 2-(4-(((R)-2-amino- |
GGTI-297 | 181045-83-0 | C26H31N3O3S | 465.608 | GGTI-297; GGTI297; GGTI 297. |
GGTI-2418 | 501010-06-6 | C23H31N5O4 | 441.532 | GGTI 2418; GGTI-2418; GGTI 2418. |
GGTI-2166 | 478908-51-9 | C25H30N4O3 | 434.531 | GGTI-2166; GGTI2166; GGTI2166. |
GGTI-2154 | 251577-10-3 | C24H28N4O3 | 420.513 | GGTI-2154; GGTI 2154; GGTI2154. |
GGTI 298 (trifluoroacetate salt) | 1217457-86-7 | C27H33N3O3S.CF3COOH | 593.7 | methyl (4-(((R)-2-amino-3-mercaptopropyl)amino)-2-(naphthalen-1-yl)benzoyl)-L-leucinate 2,2,2-trifluoroacetate; GGTI-298 TFA; GGTI-298 trifluoride salt; GGTI-298; GGTI 298; GGTI298 |
GGTI 2133 trifluoroacetate salt | 1217480-14-2 | C27H28N4O3·xCF3COOH | 456.54 | N-[4-[(1H-imidazol-5-ylmethyl)amino]-2-(1-naphthalenyl)benzoyl]-L-leucine, 2,2,2-trifluoroacetate salt |
GGsTop | 926281-37-0 | C13H18NO7P | 331.26 | 3-[[(3-Amino-3-carboxypropyl)methoxyphosphinyl]oxy]benzeneacetic acid; 2-amino-4-[[3-(carboxymethyl)phenoxy]-methoxyphosphoryl]butanoic acid |
GFT505 | 824932-88-9 | C22H24O4S | 384.49 | Elafibranor;(E)-2-(2,6-dimethyl-4-(3-(4-(methylthio)phenyl)-3-oxoprop-1-en-1-yl)phenoxy)-2-methylpropanoic acid;2-(2,6-dimethyl-4-{3-[4-(methylsulfanyl)phenyl]-3-oxoprop-1-en-1-yl}phenoxy)-2-methylpropanoic acid |
GF-109203X | 133052-90-1 | C25H24N4O2 | 412.493 | GF-109203X; GF109203X; GF 109203X; bisindolylmaleimide. |
GERANYL TIGLATE | 7785-33-3 | C15H24O2 | 236.36 | (E)-3,7-dimethyl-2,6-octadienyl 2-methylcrotonate, 2-Butenoic acid, 2-methyl-, (2E)-3,7-dimethyl-2,6-octadienyl ester, (2E)-, GERANYL TIGLATE |
GERANYL PROPIONATE | 105-90-8 | C13H22O2 | 210.32 | 2,6-Octadien-1-ol, 3,7-dimethyl-, propanoate, (2E)-, GERANYL PROPIONATE FCC |
GERANYL PHENYLACETATE | 102-22-7 | C18H24O2 | 272.39 | Benzeneacetic acid, (2E)-3,7-dimethyl-2,6-octadienyl ester, GERANYL PHENYLACETATE FCC |
Gepirone | 83928-76-1 | C19H29N5O2 | 359.48 | 4,4-Dimethyl-1-[4-[4-(2-pyrimidinyl)-1-piperazinyl]butyl]-2,6-piperidinedione; 2,6-Piperidinedione, 4,4-dimethyl-1-(4-(4-(2-pyrimidinyl)-1-piperazinyl)butyl)-; Gepirona |
GERANYL LINALOOL | 68931-30-6 | C20H34O | 290.48 | (* Alt. CAS #) CAS: 1113-21-9; Geranyl linalool, 1,6,10,14-Hexadecatetraen-3-ol, 3,7,11,15-tetramethyl-, GERANYL LINALOOL |
GERANYL ISOVALERATE | 109-20-6 | C15H26O2 | 238.37 | Butanoic acid, 3-methyl-, (2E)-3,7-dimethyl-2,6-octadienyl ester, Geranyl 3-methylbutanoate, Geranyl 3-methylbutyrate, GERANYL ISOVALERATE; GERANYL ISOVALERATE, NO ANTIOXIDANT (special order) |
GERANYL ISOBUTYRATE | 2345-26-8 | C14H24O2 | 224.35 | GERANYL ISOBUTYRATE, Propanoic acid, 2-methyl-, (2E)-3,7-dimethyl-2,6-octadienyl ester; GERANYL ISOBUTYRATE, NO ANTIOXIDANT (special order) |
GERANYL GERANYL BROMIDE | 50848-64-1 | C20H33Br | 353.38 | GERANYL GERANYL BROMIDE |
Geranyl ferulate | 1206615-69-1 | C20H26O4 | 330.424 | [(2E)-3,7-dimethylocta-2,6-dienyl] (E)-3-(4-hydroxy-3-methoxyphenyl)prop-2-enoate |
GERANYL BENZOATE | 94-48-4 | C17H22O2 | 258.36 | 2,6-Octadien-1-ol, 3,7-dimethyl-, benzoate, (2E)-, GERANYL BENZOATE FCC |
Geranyl b-D-glucoside | 22850-13-1 | C16H28O6 | 316.39 | |
Geraniin | 60976-49-0 | C41H28O27 | 952.64 | B-D-GLUCOPYRANOSE; beta-D-Glucopyranose cyclic 2-7:4-5-(3,6-dihydro-2,9,10,11,11-pentahydroxy-3-oxo-2,6-methano-2H-1-benzoxocin-5,7-dicarboxylate) cyclic 3,6-(4,4',5,5',6,6'-hexahydroxy[1,1'-biphenyl]-2,2'-dicarboxylate) 1-(3,4,5-trihydroxybenzoate) stere |
Gepotidacin | 1075236-89-3 | C24H28N6O3 | 448.53 | GSK2140944;GSK-2140944;(2R)-2-[(4-{[(3,4-dihydro-2H-pyrano[2,3-c]pyridin- 6-yl)methyl]amino}piperidin-1-yl)methyl]-1,2-dihydro- 3H,8H-2a,5,8a-triazaacenaphthylene-3,8-dione |
Gepefrine | 18840-47-6 | C9H13NO | 151.2078 | |
Geosmin-d3 | 135441-88-2 | C12H19OD3 | 185.33 | rac Geosmin-d3; (4R,4aR,8aS)-rel-Octahydro-4,8a-dimethyl-4a(2H)-naphthalenol-d3; (+/-)-Geosmin-d3; DL-Geosmin-d3 |
Geoside | 585-90-0 | C21H30O11 | 458.5 | (2S,3R,4S,5S,6R)-2-(2-methoxy-4-prop-2-enylphenoxy)-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol |
GENZ-644282 | 529488-28-6 | C24H22F3N3O7 | 521.44 | GENZ-644282; GENZ644282; GENZ 644282. |
Genz-123346 | 491833-30-8 | C24H38N2O4 | 418.57 | Genz-123346; Genz123346; Genz 123346 |
Genz-123346 | 943344-58-9 | C52H82N4O14 | 987.23 | |
Gentisin | 437-50-3 | C14H10O5 | 258.229 | Gentianin; 1,7-Dihydroxy-3-methoxyxanthone; 1,7-Dihydroxy-3-methoxyxanthen-9-one |
Gentiside J | 1238837-50-7 | C29H50O4 | 462.715 | docosyl 2,3-dihydroxybenzoate |
Gentiside B | 1225022-67-2 | C30H52O4 | 476.742 | [(20S)-20-methyldocosyl] 2,3-dihydroxybenzoate |
Gentiournoside D | 157722-21-9 | C23H28O13 | 512.46 | (1S,4aS,6S,7R,7aS)-6-[(2,3-Dihydroxybenzoyl)oxy]-1-(beta-D-glucopyranosyloxy)-1,4a,5,6,7,7a-hexahydro-7-methylcyclopenta[c]pyran-4-carboxylic acid |
Gentiopicroside | 20831-76-9 | C16H20O9 | 356.33 | Gentiopicrin |
Gentiopentaose | 37796-54-6 | C30H52O26 | 828.72 | |
Gentiohexaose | 37698-89-8 | C36H62O31 | 990.86 | |
Gentioheptaose | 144448-00-0 | C42H72O36 | 1153.00 | |
Gemfibrozil Acyl-beta-D-Glucuronide | 91683-38-4 | C21H30O9 | 426.47 | 1-[5-(2,5-Dimethylphenoxy)-2-dimethylpentanoate] b-D-glucopyranuronic acid |
Gendenafil | 147676-66-2 | C19H22N4O3 | 354.41 | 5-(5-Acetyl-2-ethoxyphenyl)-1,6-dihydro-1-methyl-3-propyl-7H-pyrazolo[4,3-d]pyrimidin-7-one; 5-(5-Acetyl-2-ethoxyphenyl)-1-methyl-3-propyl-1,6-dihydro-7H-pyrazolo[4,3-d]pyrimidin-7-one |
GenapolC-100 | 61791-13-7 | Coceth-10, Coconut oil alcohol, ethoxylated | ||
Gemopatrilat | 160135-92-2 | C19H26N2O4S | 378.49 | Gemopatrilat; BMS 189921; BMS-189921; BMS189921; SCHEMBL1973289; {(6S)-2,2-dimethyl-7-oxo-6-[(3-phenyl-2-sulfanylpropanoyl)amino]azepan-1-yl}acetic acid; 2-[2,2-dimethyl-7-oxo-6-[(3-phenyl-2-sulfanylpropanoyl)amino]azepan-1-yl]acetic acid |
Gemilukast disodium salt | 1232861-64-1 | C36H37F2NO5.2Na | 647.67 | |
Gemilukast 8 hydrate and disodium salt). | 1232873-69-6 | C36H37F2NO5.8H2O.2Na | 601.69 | |
Gemilukast | 1232861-58-3 | C36H37F2NO5 | 601.69 | ONO6950;4,4'-(4-fluoro-7-((4-(4-(3-fluoro-2-methylphenyl)butoxy)phenyl)ethynyl)-2-methyl-1H-indole-1,3-diyl)dibutyric acid;1232861-64-1 (disodium salt); 1232873-69-6 (8 hydrate and disodium salt). |
Gemigliptin | 911637-19-9 | C18H19F8N5O2 | ||
Gemifloxacin Mesylate | 210353-53-0 | C19H24FN5O7S | 485.50 | 7-[(4E)-3-(aminomethyl)-4-methoxyiminopyrrolidin-1-yl]-1-cyclopropyl-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid;methanesulfonic acid 7-(3-aminomethyl-4-methoxyimino-pyrrolidine-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-(1,8)-naphthyridine |
Gemfibrozil | 25812-30-0 | C15H22O3 | 250.33 | CI-719 |
Gemcitabine-13C-15N2 HCl | 1262897-74-4 | C8[13C]H12F2N[15N]2O4Cl | 302.64 | 2'-Deoxy-2',2'-difluorocytidine-13C,15N2 HCl |
Gemcitabine Triphosphate (triethylammonium salt form) | 1035495-84-1 | C9H14F2N3O13P3.C6H15N | 503.141 (free acid) | 2'-Deoxy-2',2'-difluorocytidine 5'-(Tetrahydrogen Triphosphate) triethylammonium |
Gemcitabine monophosphate disodium salt | 1638288-31-9 | C9H12F2N3Na2O8P | 405.158 | Gemcitabine monophosphate disodium salt monohydrate; Gemcitabine monophosphate disodium; GemMP |
Gemcitabine Monophosphate | 116371-67-6 | C9H12F2N3O7P | 343.18 | 2',2'-difluorodeoxycytidine Monophosphate; Gemcitabine 5'-phosphate |
Gemcitabine Impurity C (EP) | 114248-23-6 | C9H10F2N2O5 | 264.19 | 2',2'-Difluoro-2'-deoxyuridine; 2'-Deoxy-2',2'-difluorouridine; 2',2'-Difluorodeoxyuridine |
Gemcitabine hydrochloride | 122111-03-9 | C9H11F2N3O4.HCI | 299.66 | LY188011; LY 188011; LY-188011 |
Gemcitabine elaidate | 210829-30-4 | C27H43F2N3O5 | 527.654 | code name: CO-101; CO101; CO 101; CP-4126; CP4126; CP 4126; Gemcitabine elaidate. |
GDP-L-fucose disodium salt | 15839-70-0 | C16H23N5O15P2Na2 | 633.31 | Guanosine 5-diphospho-b-L-fucose disodium salt; GDP-Fucose |
Gemcitabine Diphosphate Choline | 1643126-46-8 | C14H24F2N4O10P2 | 508.31 | Gemcitabine 5'-Diphosphate Choline |
GDP-D-glucose sodium salt | 103301-72-0 | C16H25N5O16P2 xNa | 605.34 (free acid basis) | Guanosine-5-diphosphoglucose sodium salt; GDP-Glc |
GDP-D-galactose | 41432-88-6 | C16H25N5O15P2 | 589.4 | |
GDP366 | 501698-03-9 | C20H17N5OS | 375.45 | 1-[4-(4-aminothieno[2,3-d]pyrimidin-5-yl)phenyl]-3-(3-methylphenyl)urea; GDP 366; GDP-366; GDP366 |
GDP - lyophilized | 43139-22-6 | C10H15N5O11P2(free acid) | 443.20 (free acid) | Guanosine-5'-diphosphate, Sodium salt |
Guanosine 5'-diphosphate | 146-91-8 | C10H15N5O11P2 | 443.20 | [(2R,3S,4R,5R)-5-(2-amino-6-oxo-3H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methyl phosphono hydrogen phosphate; GDP; ((2R,3S,4R,5R)-5-(2-Amino-6-oxo-1H-purin-9(6H)-yl)-3,4-dihydroxytetrahydrofuran-2-yl)methyl trihydrogen diphosphate |
GDC-0994 | 1453848-26-4 | C21H18ClFN6O2 | 440.863 | GDC-0994; GDC0994; GDC 0994; RG7842; RG-7842; RG 7842. |
GDC-0941 dimethanesulfonate | 957054-33-0 | C25H35N7O9S4 | 705.85 | Pictilisib dimethanesulfonate; GDC-0941 (2 MeSO3H salt) |
GDC0941 | 957054-30-7 | C23H27N7O3S2 | 513.635 | 4-(2-(1H-indazol-4-yl)-6-((4-(methylsulfonyl)piperazin-1-yl)methyl)thieno[3,2-d]pyrimidin-4-yl)morpholine; GDC-0941; GDC 0941; GDC0941; RG7321; RG-7321; RG 7321; GNE0941; GNE-0941; GNE 0941; Pictrelisib; Pictilisib |
GDC-0917 | 1446182-94-0 | C29H36N6O4S | 564.705 | GDC-0917; GDC0917; GDC 0917; CUDC-427; CUDC427; CUDC-427. |
GDC-0879 | 905281-76-7 | C19H18N4O2 | 334.37182 | GDC-0879 |
GD2-Ganglioside | 65988-71-8 | C78H138N4O34 xNa | 1675.94 (free acid basis) | GD2-Ganglioside; Disialoganglioside-GD2 |
GD1b-Ganglioside | 19553-76-5 | GD1b-Ganglioside | ||
GD1a-Oligosaccharide | 1627679-86-0 | C48H79N3O37 | 1290.14 | GD1aSaccharide |
GD1a-Ganglioside | 12707-58-3 | C84H148N4O39 xNa | 1838.08 (free acid basis) | GD1a-Ganglioside |
GCLH | 64308-63-0 | C29H25ClN2O4S | 533.04 | 7-PHENYLACETAMIDE-3-CHLOROMETHYL-3-CEPHEM-4-CARBOXYLIC ACID DIPHENYLMETHYL ESTER; 7-PHENYLACETAMIDO-3-CHLOROMETHYL-3-CEPHEM-4-CARBOXYLIC ACID DIPHENYL METHYL ESTER; 7-PHENYLACETAMIDO-3-CHLOROMETHYL-3-CEPHEM-4-CARBOXYYLIC ACID DIPHENYLMETHYL ESTER; 7-PHENY |
GC376 sodium | 1416992-39-6 | C21H30N3NaO8S | 507.53 | (2S)-1-hydroxy-2-[[(2S)-4-methyl-2-(phenylmethoxycarbonylamino)pentanoyl]amino]-3-(2-oxopyrrolidin-3-yl)propane-1-sulfonate sodium |
GBT-440 | 1446321-46-5 | C19H19N3O3 | 337.37 | Voxelotor; 2-hydroxy-6-[[2-(2-propan-2-ylpyrazol-3-yl)pyridin-3-yl]methoxy]benzaldehyde; Hemoglobin Modulators-1 |
GBR-12935 dihydrochloride | 67469-81-2 | C28H36Cl2N2O | 487.509 | GBR12935 dihydrochloride; GBR-12935 dihydrochloride |
GBR-12935 | 76778-22-8 | C28H34N2O | 414.58 | 1-[2-(Diphenylmethoxy)ethyl]-4-(3-phenylpropyl)piperazine;1-Hydrocinnamyl-4-[2-(diphenylmethoxy)ethyl]piperazine;Piperazine, 1-(2-(diphenylmethoxy)ethyl)-4-(3-phenylpropyl)-;N-[3-tert-Butyl-1-(4-Methylphenyl)-1H-pyrazol-5-yl]-N-[4-[2-(4-Morpholinyl)ethoxy |
GBR 13069 dihydrochloride | 67469-45-8 | C28H30F2N2O.2HCl | 521.48 | (1-(2-(Bis-(4-fluorophenyl)methoxy)ethyl)-4-(3-phenyl-2-propenyl)piperazine dihydrochloride |
GBR 12783 dihydrochloride | 67469-75-4 | C28H32N2O.2HCl | 485.5 | 1-(2-Diphenylmethoxyethyl)-4-(3-phenyl-2-propenyl)-piperazine dihydrochloride |
Gboxin | 2101315-36-8 | C22H33N2O2·Cl | 392.96 | 2-ethyl-1-methyl-3-[2-[[(1R,2S,5R)-5-methyl-2-(1-methylethyl)cyclohexyl]oxy]-2-oxoethyl]-1H-benzimidazolium, monochloride |
GB-2a | 18412-96-9 | C30H22O11 | 558.49 | (2S)-8-[(2S,3R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl]-2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-2,3-dihydrochromen-4-one; [3,8'-Bi-2H-1-benzopyran]-4,4'(3H,3'H)-dione, 2'-(3,4-dihydroxyphenyl)-5,5',7,7'-tetrahydroxy-2-(4-hydroxyphen |
GB-1b | 19360-72-6 | C30H22O10 | 542.49 | (3,8'-Bi-2H-1-benzopyran)-4,4'(3H,3'H)-dione, 5,5',7,7'-tetrahydroxy-2,2'-bis(4-hydroxyphenyl)-, (2S,2'S,3R)-; 3,8''-Binaringenin; (2S)-8-[(2S,3R)-5,7-dihydroxy-2-(4-hydroxyphenyl)-4-oxo-2,3-dihydrochromen-3-yl]-5,7-dihydroxy-2-(4-hydroxyphenyl)-2,3-dihyd |
GB-1a | 220611-41-6 | C30H22O10 | 542.49 | (-)-GB-1a |
GB ACID | 1832-54-8 | C4H11O3P | 138.1 | GB ACID; ISOPROPYL METHYLPHOSPHONIC ACID; ISOPROPYLMETHYLPHOSPHONATE; Isopropyl hydrogen methylphosphonate; Isopropyl methyl phosphonic acid (impa) |
GB 83 | 1252806-86-2 | C32H44N4O4 | 548.72 | GB-83; N-((S)-3-Cyclohexyl-1-((2S,3S)-1-(2,3-dihydrospiro[indene-1,4'-piperidine]-1'-yl)-3-methyl-1-oxopentan-2-ylamino)-1-oxopropan-2-yl)isoxazole-5-carboxamide |
Gaxilose | 14087-31-1 | C11H20O10 | 312.27 | 4-O-Galactosyl-D-xylose; 4-O-Galactosylxylose; 4-Galactosylxylose; Gaxilose;(3R,4R,5R)-5-(((2S,3R,4S,5R,6R)-3,4,5-trihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-2-yl)oxy)tetrahydro-2H-pyran-2,3,4-triol |
Gavestinel | 153436-38-5 | C18H11Cl2N2O3Na | 397.19 | 4,6-Dichloro-3-[(1E)-3-oxo-3-(phenylamino)-1-propenyl]-1H-indole-2-carboxylic acid sodium salt; GV 150526A |
Gaultherin | 490-67-5 | C19H26O12 | 446.40 | Monotropitin; Monotropitoside; Methyl salicylate beta-primeveroside; Monotropitin; Monotropitosid; 2-[(6-O-beta-D-Xylopyranosyl-beta-D-glucopyranosyl)oxy]benzoic acid methyl ester |
GaTx2 | 194665-85-5 | C125H199N39O47S6 | 3192.54 | |
Galocitabine | 124012-42-6 | C19H22FN3O8 | 439.40 | Galocitabine; Ro 09-1390; Galocytabine; N-(3,4,5-Trimethoxybenzoyl)-5'-deoxy-5-fluorocytidine; 5'-Deoxy-5-fluoro-N4-(3,4,5-trimethoxybenzoyl)cytidine; N-[1-(5-Deoxy-beta-D-ribofuranosyl)-5-fluoro-2-oxo-1,2-dihydro-4-pyrimidinyl]-3,4,5-trimethoxybenzamide |
Gatifloxacin sesquihydrate | 180200-66-2 | C19H22FN3O4.1.5H2O | 375.39 | |
Gatifloxacin N-Oxide | 1798008-43-1 | C19H22FN3O5 | 391.40 | |
Gatifloxacin mesylate | 316819-28-0 | C20H26FN3O7S | 471.5 | AM 1155 mesylate; BMS 206584-01 mesylate; PD 135432 mesylate |
Gatifloxacin Impurity 1 | 1335198-95-2 | C19H22FN3O5 | 391.40 | |
Gatifloxacin hydrochloride | 121577-32-0 | C19H23ClFN3O4 | 411.86 | Gatifloxacin hydrochloride |
Gatifloxacin | 112811-59-3 | C19H22FN3O4 | 375.4 | Tequin; Zymar; Gatiflo; 1-cyclopropyl-6-fluoro-8-methoxy-7-(3-methylpiperazin-1-yl)-4-oxoquinoline-3-carboxylic acid |
Ganglioside GD3 Diodium Salt | 497932-19-1 | C70H123N3Na2O29 | 1516.71 | Disialosyllactosylceramide Disodium Salt; GD3 Disodium Salt; Ganglioside D3 Disodium Salt |
Ganetespib | 888216-25-9 | C20H20N4O3 | 364.40 | |
Ganciclovir EP Impurity C | 108436-36-8 | C9H12ClN5O3 | 273.68 | 2'-Monodehydroxy-2'-chloro Ganciclovir; 9-[[2-Chloro-1-(hydroxymethyl)ethoxy]methyl]guanine; 2-Amino-9-[[2-chloro-1-(hydroxymethyl)ethoxy]methyl]-1,9-dihydro-6H-purin-6-one |
Ganciclovir Dipropionate | 86357-20-2 | C15H21N5O6 | 367.36 | Ganciclovir Impurity I; 2-Amino-1,9-dihydro-9-[[2-(1-oxopropoxy)-1-[(1-oxopropoxy)methyl]ethoxy]methyl]-6H-purin-6-one; 2-[(2-AMino-6-oxo-1,6-dihydro-9H-purin-9-yl)Methoxy]propane-1,3-diylDipropanoate |
Ganciclovir | 82410-32-0 | C9H13N5O4 | 255.234 | BW 759; BW759; BW-759; 2'-Nor-2'-deoxyguanosine |
Gancaonin O | 129145-53-5 | C20H18O6 | 354.35 | 2-(3,4-dihydroxyphenyl)-5,7-dihydroxy-6-(3-methylpent-2-enyl)chromen-4-one |
Gancaonin M | 129145-51-3 | C21H20O5 | 352.4 | 5,7-Dihydroxy-3-(4-methoxyphenyl)-8-(3-methyl-2-buten-1-yl)-4H-1-benzopyran-4-one |
Gancaonin I | 126716-36-7 | C21H22O5 | 354.4 | 4-[4,6-Dimethoxy-5-(3-methyl-2-buten-1-yl)-2-benzofuranyl]-1,3-benzenediol |
Gancaonin G | 126716-34-5 | C21H20O5 | 352.38 | 5-hydroxy-3-(4-hydroxyphenyl)-7-methoxy-6-(3-methylbut-2-enyl)chromen-4-one; 5-Hydroxy-3-(4-hydroxy-phenyl)-7-methoxy-6-(3-methyl-but-2-enyl)-1-benzopyran-4-one; 5,4'-Dihydroxy-7-methoxy-6-prenylisoflavone |
GAMMA-UNDECALACTONE | 57084-17-0 | C11H20O2 | 184.28 | GAMMA-HEPTYL-GAMMA-BUTYROLACTONE; GAMMA-UNDECALACTONE; G-N-HEPTYLBUTYROLACTONE; G-UNDECALACTONE; FEMA 3091; ALDEHYDE C-14; 4,5-DIHYDRO-5-HEPTYL-2(3H)-FURANONE; 4-UNDECANOLIDE |
gamma-Secretase modulators | 937812-80-1 | C26H24F3N3O3 | 483.48 | (4R,7E,9aS)-7-[[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]methylidene]-4-(3,4,5-trifluorophenyl)-1,3,4,8,9,9a-hexahydropyrido[2,1-c][1,4]oxazin-6-one; gamma-Secretase Modulators; 937812-80-1; (E)-(4R,9aS)-7-[3-Methoxy-4-(4-methyl-1H-imidazol-1-yl)benzylid |
gamma-secretase modulator 3 | 1431697-84-5 | C24H23FN4OS | 434.53 | 4-(4-fluorophenyl)-N-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]-4,5,6,7-tetrahydro-1,3-benzothiazol-2-amine; gamma-secretase modulator 3; CS-1149; HY-50889; W-6019; 1431697-84-5 |
gamma-secretase modulator 2 | 1093978-89-2 | C25H22F4N6O2 | 514.47 | 6-fluoro-3-[4-[3-methoxy-4-(4-methylimidazol-1-yl)phenyl]triazol-1-yl]-1-(2,2,2-trifluoroethyl)-4,5-dihydro-3H-1-benzazepin-2-one; gamma-secretase modulator 2; 1093978-89-2; SCHEMBL3040102; DTXSID70732149; C25H22F4N6O2; 3374AH; ABP000472; BCP9000905; CS-0 |
gamma-secretase modulator 1 | 1172637-87-4 | C24H24N4OS | 416.54 | |
gamma-oryzanol | 469-36-3 | C41H60O4 | 616.921 | ORYZANOL |
gamma-METHYL DECALACTONE | 7011-83-8 | C11H20O2 | 184.27 | 2(3H)-Furanone, 5-hexyldihydro-5-methyl-, 4-Methyl-4-decanolide, 4-Methyldecanolide, 5-Hexyldihydro-5-methyl-2(3H)-furanone, 5-Hexyldihydro-5-methylfuran-2(3H)-one, Dihydrojasmone lactone, gamma-METHYL DECALACTONE, gamma-Methyldecalactone, Lactone of dihy |
GAMMA-LUMICOLCHICINE | 6901-14-0 | C22H25NO6 | 399.44 | GAMMA-LUMICOLCHICINE; [7S-(7alpha,7balpha,10aalpha)]-N-(5,6,7,7b,8,10a-hexahydro-1,2,3,9-tetramethoxy-8-oxobenzo[a]cyclopenta[3,4]cyclobuta[1,2-c]cyclohepten-7-yl)acetamide; g-Lumicolchicine; (7S-(7alpha,7Balpha,10aalpha))-N-(5,6,7,7B,8,10A-hexahydro-1,2, |
Gamma-L-glutamyl-L-glutamic acid | 1116-22-9 | C10H16N2O7 | 276.245 | gamma-Glutamylglutamate; gamma-glutamylglutamic acid; (S)-2-((S)-4-Amino-4-carboxybutanamido)pentanedioic acid |
gamma-L-Glutamyl-alpha-naphthylamide | 81012-91-1 | C16H18N2O5 | 318.32 | |
gamma-JASMOLACTONE | 63095-33-0 | C10H16O2 | 168.24 | (Z)-5-(3-Hexenyl)dihydrofuran-2(3H)-one, 2(3H)-Furanone, 5-(3Z)-3-hexen-1-yldihydro-, cis-7-Decen-4-olide, cis-gamma-Jasmine lactone, gamma-JASMOLACTONE |
gamma-Ionone | 79-76-5 | C13H20 O | 192.2973 | |
gamma-HEPTALACTONE | 105-21-5 | C7H12O2 | 128.17 | 2(3H)-Furanone, dihydro-5-propyl-, 4-Heptanolide, 4-Hydroxyheptanoic acid, gamma-lactone, 5-Propyldihydrofuran-2(3H)-one, gamma-HEPTALACTONE FCC, gamma-Propiobutyrolactone, gamma-Propylbutyrolactone, Heptan-4-olide |
gamma-DODECALACTONE | 2305-05-7 | C12H22O2 | 198.31 | 2(3H)-Furanone, dihydro-5-octyl-, 4-Dodecanolide, 4-Hydroxydodecanoic acid, gamma-lactone, 5-Octyldihydrofuran-2(3H)-one, gamma-DODECALACTONE FCC, gamma-Octylbutyrolactone |
Gamithromycin | 145435-72-9 | C40H76N2O12 | 777.0 | ML 1709460 |
Gambogic acid | 2752-65-0 | C38H44O8 | 628.75 | beta-Guttiferin; (Z)-4-((1S,3aR,5S,11R,14aS)-8-hydroxy-2,2,11-trimethyl-13-(3-methylbut-2-en-1-yl)-11-(4-methylpent-3-en-1-yl)-4,7-dioxo-2,3a,4,5,7,11-hexahydro-1H-1,5-methanofuro[3,2-g]pyrano[3,2-b]xanthen-3a-yl)-2-methylbut-2-enoic acid |
Gambogenic acid | 173932-75-7 | C38H46O8 | 630.8 | |
Gambogellic acid | 173867-04-4 | C38H44O8 | 628.76 | |
gama-Chloropropyl Methyl Diethoxy Silane | 13501-76-3 | C8H19ClO2Si | 210.77 | 3-Chloropropylmethyldiethoxysilane; gamma-Chloropropylmethyldiethoxysilane |
Gamabufotalin | 465-11-2 | C24H34O5 | 402.52 | Gamabufagin |
Galunisertib | 700874-72-2 | C22H19N5O | 369.428 | LY 2157299; LY-2157299; 4-[2-(6-methylpyridin-2-yl)-5,6-dihydro-4H-pyrrolo[1,2-b]pyrazol-3-yl]quinoline-6-carboxamide |
Galnon | 475115-35-6 | C40H46N4O6 | 678.83 | 3-Cyclohexyl-N-[(9H-fluoren-9-ylmethoxy)carbonyl]-L-alanyl-N-(4-methyl-2-oxo-2H-1-benzopyran-7-yl)-L-lysinamide; 9H-fluoren-9-ylmethyl N-[(2S)-1-[[(2S)-6-amino-1-[(4-methyl-2-oxochromen-7-yl)amino]-1-oxohexan-2-yl]amino]-3-cyclohexyl-1-oxopropan-2-yl]carb |
Galloylpaeoniflorin | 122965-41-7 | C30H32O15 | 632.57 | 6'-O-Galloyl paeoniflorin |
Galloflavin Potassium salt | 1780260-20-9 | C12H5O8K | 316.26 | 3,8,9,10-Tetrahydroxypyrano[3,2-c][2]benzopyran-2,6-dione potassium salt |
Galloflavin | 568-80-9 | C12H6O8 | 278.2 | NSC 107022; 3,8,9,10-tetrahydroxy-pyrano[3,2-c][2]benzopyran-2,6-dione |
Gallocyanine | 1562-85-2 | C15H13N2O5·Cl | 336.7 | IIIC3; Alizarine Navy Blue; Anthracene Blue SWGG; Brilliant Chrome Blue P; C.I. 51030; Fast Violet; Mordant Blue 10; 7-Dimethylamino-4-hydroxy-3-oxo-phenoxazine-1-carboxylic acid |
Gallocatechin gallate | 5127-64-0 | C22H18O11 | 458.37 | Gallocatechin 3-gallate; (-)-Gallocatechin gallate; (2S,3R)-2-(3,4,5-Trihydroxyphenyl)-3,4-dihydro-1(2H)-benzopyran-3,5,7-triol 3-(3,4,5-trihydroxybenzoate); [(2R,3S)-5,7-dihydroxy-2-(3,4,5-trihydroxyphenyl)-3,4-dihydro-2H-chromen-3-yl] 3,4,5-trihydroxybe |
Gallium, trimethyl- | 1445-79-0 | C3H9 Ga | 114.80 | GALLIUM TRIMETHYL; TRIMETHYLGALLIUM; (CH3)3Ga; trimethyl-galliu; TMGa; Trimethylgallium,99+% |
GALLIUM TELLURIDE | 12024-14-5 | GaTe | 197.32 | GALLIUM(II) TELLURIDE; GALLIUM TELLURIDE; galliumtelluride(gate); Gallium(II) telluride, 99.999% (metals basis) |
gallium selenide | 12024-11-2 | GaSe | 0 | GaSe; Gallium (II) selenide, 99.99% (metals basis) |
Gallium maltolate | 108560-70-9 | C18H15GaO9 | 455.03 | |
Gallium hydroxide oxide | 20665-52-5 | GaHO2 | 102.73 g/mol | |
Gallium hydride (GaH3) | 13572-93-5 | GaH3 | 72.7468 g/mol | |
Gallium citrate | 27905-02-8 | C6H5GaO7 | 258.823 g/mol | gallium; 2-hydroxypropane-1,2,3-tricarboxylate; Galliumcitrate; Citricacid,gallium(II)salt; 27905-02-8; EINECS248-721-1 |
GALLIUM ACETATE | 2571-06-4 | C6H9GaO6 | 246.86 | GALLIUM ACETATE; gallium(3+) acetate; Triacetic acid gallium salt; gallium triacetate; gallium triethanoate |
Gallium 2-ethylhexanoate | 67969-68-0 | |||
Galactomannanase | 50812-17-4 | |||
Galactosyl isomaltol | 82756-28-3 | C12H16O8 | 288.25 | 2-Acetyl-3-furyl-b-D-galactopyranoside |
Galantamine-d3 HBr | 2140262-53-7 | C17H19D3NO3Br | 371.29 | |
Galantamine Hydrobromide | 69353-21-5 | C17H22NO3Br | 2,3,3A,8,9,10,11,11B-Octahydro-5-Methoxy-9-Methylbenzofuro[4,3,2-Efg][2]Benzazocin-2-Ol Hydrobromide; 1,2,3,4,6,7,7A,11C-Octahydro-9-Methoxy-2-Methylbenzofuro[4,3,2-Efg]-2-Benzazocin-6-Ol Hydrobromide | |
Fluorescent brightener VBL (C.I.85) | 12224-06-5 | C36H34N12Na2O8S2 | 872.84 | Fluorescent brightener VBL (C.I.85); Fluorescent whitening agent VBL; Optical Brightening Agent VBL |
Fluorescent brightener VBA (C.I.210) | 28950-61-0 | C40H36N12Na4O14S4 | 1129 | c.i. fluorescent brightener 211; Fluorescent Brightener 210; photine btm; Tetrasodium 4,4'-bis[[4-morpholino-6-(p-sulphonatoanilino)-1,3,5-triazin-2-yl]amino]stilbene-2,2'-disulphonate; Tetrasodium 4,4'-bis[[4-morpholino-6-(p-sulphonatoanilino)-1,3,5-tria |
Fluorescent brightener ER-1 | 58449-88-6 | |||
FAD disodium salt | 84366-81-4 | C27H31N9Na2O15P2 | 829.52 | Flavin adenine dinucleotide disodium salt |
FACTOR D, HUMAN | 37213-56-2 | 0 | ADIPSIN; ADIPSIN, HUMAN; COMPLEMENT FACTOR D; FACTOR D, HUMAN; C3 ACTIVATOR CONVERTASE; C3 ACTIVATOR CONVERTASE, HUMAN; complement factor D from human plasma | |
Dynamin inhibitory peptide, myristoylated | 251634-22-7 | C61H107N19O14 | 1330.64 | |
Edrophonium chloride | 116-38-1 | C10H16NOCl | 201.69 | ETHYL[M-HYDROXYPHENYL]-DIMETHYLAMMONIUM CHLORIDE;EDROPHONIUM CHLORIDE;antirex;dimethylethyl(m-hydroxyphenyl)-ammoniuchloride;ethyl(m-hydroxyphenyl)dimethyl-ammoniuchloride;n-ethyl-3-hydroxy-n,n-dimethyl-benzenaminiuchloride;tensilon;ethyl(3-hydroxyphenyl |
Edrophonium | 312-48-1 | C10H16NO+ | 166.24 | N-Ethyl-3-hydroxy-N,N-dimethyl-benzenaminium Chloride |
dupilumab | 1190264-60-8 | C6512H10066N1730O2052S46 | 146900 | Dupixent |
Galanolactone | 115753-79-2 | C20H30O3 | 318.5 | 8,17-Epoxy-12-labden-16,15-olide |
Galanin (porcine) | 88813-36-9 | C146H213N43O40 | 3210.55 | |
Galanin (2-29) (rat) | 141696-11-9 | C144H210N42O39 | 3153.519 | 2-29-Galanin(rat)(9ci) |
Galanin (1-30) (human) | 119418-04-1 | C139H210N42O43 | 3157.41 | Galanin human; Galanin-1-30 |
Galanin (1-29) (rat, mouse) | 114547-31-8 | C141H211N43O41 | 3164.48 | Galanin (mouse, rat) |
Galanin (1-15) (porcine, rat) | 112747-70-3 | C72H105N19O20 | 1556.74 | Galanin (1-15); 1-15-Galanin(cattle)(9ci) |
Galactosyl diglyceride - 10 mg/ml solution in chloroform/methanol | 41670-62-6 | C45H86O10 | 787.16 | Monogalactosyl diglyceride |
Galactostatin bisulfite | 1196465-02-7 | C6H13NO7S | 243.24 | Galactonojirimycin bisulfite; 5-Amino-5-deoxy-D-galactopyranose; 6-(Hydroxymethyl)-2,3,4,6-peperidinetetrol hydrogensulfite |
Galactostatin | 107537-94-0 | C6H13NO5 | 179.17 | 5-Amino-5-deoxy-D-galactopyranose; 6-(Hydroxymethyl)-2,3,4,6-peperidinetetrol; Galactonojirimycin |
Galacto-RGD | 922175-70-0 | C34H52N10O12 | 0 | CYCLO(-ARG-GLY-ASP-D-PHE-LYS((2S,3R,4R,5R,6S)-6-AMINOMETHYL-3,4,5-TRIHYDROXY-TETRAHYDRO-PYRAN-2-CARBONYL)); CYCLO(RGDFK(SAA)); GALACTO-RGD |
galacto-Dapagliflozin | 1408245-02-2 | C21H25ClO6 | 408.9 | (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-D-galactitol |
Galactoarabinan | 9036-66-2 | ([C5H8O4][C6H10O5]6)x | D-Galacto-L-arabinan | |
Galactinol hydrate | 3687-64-7 | C12H22O11 xH2O | 342.30 (anydrous basis) | 1-O-a-D-Galactopyranosyl-L-myo-inositol hydrate; myo-Inositol galactoside |
Galactan - from gum arabic | 39300-87-3 | |||
Gala3Galb4GlcNAcb3Galb4Glc | 443660-52-4 | C32H55NO26 | 869.77 | Gala-3Galb-4GlcNAcb-3Galb-4Glc |
Gadolinium(III) sulfate oCtahydrate | 13450-87-8 | Gd2(SO4)3.8(H2O) | 746.81 | gadolinium(3+); trisulfate; octahydrate; Gadolinium(III)sulfateoctahydrate; 13450-87-8; Gd2H16O20S3 |
Gadolinium(III) 2-ethylhexanoate | 19189-19-6 | C24H45GdO6 | 586.86 | GADOLINIUM(III) 2-ETHYLHEXANOATE; GADOLINIUM 2-ETHYLHEXANOATE; 2-ethyl-hexanoicacigadolinium(3++)salt; Gadolinium 2-ethylhexanoate (25% in toluene); Gadolinium(III) 2-ethylhexanoate (25% in toluene); Gadoliniumethylhexanoateintoluene |
Gabapentin Enacarbil | 478296-72-9 | C16H27NO6 | 329.39 | Horizant; Regnite; XP-13512; XP 13512; XP13512 |
G-5555 | 1648863-90-4 | C25H25ClN6O3 | 492.96 | 8-[(5-amino-1,3-dioxan-2-yl)methyl]-6-[2-chloro-4-(6-methylpyridin-2-yl)phenyl]-2-(methylamino)pyrido[2,3-d]pyrimidin-7-one 59T 8-(((2r,5r)-5-amino-1,3-dioxan-2-yl)methyl)-6-(2-chloro-4-(6-methylpyridin-2-yl)phenyl)-2-(methylamino)pyrido[2,3-d]pyrimidin |
G-36 | 1392487-51-2 | C22H22BrNO2 | 412.33 | (±)-(3aR,4S,9bS)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-8-(1-methylethyl)-3H-cyclopenta[c]quinoline |
G3335 | 36099-95-3 | C16H19N3O5 | 333.3 | L-Tryptophyl-L-glutamic acid; WE |
G3130 | 848952-37-4 | C14H14N4O2 | 270.287 | G3130; G-3130; G 3130 |
G244-LM | 1563007-08-8 | C18H22N4O3S2 | 406.5 | 3,5,7,8-tetrahydro-2-[4-[2-(methylsulfonyl)phenyl]-1-piperazinyl]-4H-thiopyrano[4,3-d]pyrimidin-4-one |
G-1 | 881639-98-1 | C21H18BrNO3 | 412.29 | (±)-1-[(3aR*,4S*,9bS*)-4-(6-Bromo-1,3-benzodioxol-5-yl)-3a,4,5,9b-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone; rel-1-[4-(6-bromo-1,3-benzodioxol-5-yl)-3aR,4S,5,9bS-tetrahydro-3H-cyclopenta[c]quinolin-8-yl]-ethanone |
G007-LK | 1380672-07-0 | C25H16ClN7O3S | 529.96 | G007 LK; G007LK |
G 28UCM | 1094451-90-7 | C24H16O10 | 464.38 | 3-(3,4,5-Trihydroxybenzoyloxy)naphthalen-1-yl 3,4,5-trihydroxybenzoate; 1,3-Bis[(3,4,5-Trihydroxybenzoyl)Oxy]Naphthalene |
FY26 (complex) | 1255143-82-8 | C23H28F6IN4OsP | 822.60 | |
FX1 | 1426138-42-2 | C14H9ClN2O4S2 | 368.82 | SCHEMBL16323186; CHEBI:133537; AKOS015865677; CS-7688; HY-102027; 3-[(5Z)-5-(5-chloro-2-oxo-1H-indol-3-ylidene)-4-oxo-2-sulfanylidene-1,3-thiazolidin-3-yl]propanoic acid |
FW1256 | 117089-08-4 | C12H10NOPS | 247.25 | 2-phenyl-3H-benzo[d][1,3,2]oxazaphosphole 2-sulfide |
Fuziline | 80665-72-1 | C24H39NO7 | Aconitane-1,8,14,15-tetrol, 20-ethyl-6,16-dimethoxy-4-(methoxymethyl)- , (1alpha,6alpha,14alpha,15alpha,16beta)-; 15-Epinagarine; 15-Hydroxyneoline; Senbusine C | |
Futoquinol | 28178-92-9 | C21H22O5 | 354.4 | (4S)-4-[(E)-2-(1,3-Benzodioxol-5-yl)-1-methylethenyl]-4,5-dimethoxy-2-(2-propenyl)-2,5-cyclohexadien-1-one; 4-[(E)-1-(1,3-benzodioxol-5-yl)prop-1-en-2-yl]-4,5-dimethoxy-2-prop-2-enylcyclohexa-2,5-dien-1-one |
Futokadsurin C | 852459-91-7 | C21H24O5 | 356.42 | 5-[(2R,3R,4S,5S)-5-(3,4-dimethoxyphenyl)-3,4-dimethyloxolan-2-yl]-1,3-benzodioxole |
Futoenone | 19913-01-0 | C20H20O5 | 340.37 | (2alpha,4alpha,5beta,5aalpha)-(-)-4-(1,3-Benzodioxol-5-yl)-2,3,4,5-tetrahydro-7-methoxy-5-methyl-8H-2,5a-methano-1-benzoxepin-8-one |
Fustin | 20725-03-5 | C15H12O6 | 288.26 | Dihydrofisetin |
Fusidic acid acyl glucuronide | 13013-66-6 | C37H56O12 | 692.83 | Fusidic acid b-D-glucopyranuronosyl ester |
Fusidic acid | 6990-06-3 | C31H48O6 | 516.72 | |
Fuscin | 83-85-2 | C15H16O5 | 276.28 | 9,10-dihydro-5-hydroxy-4,8,8-trimethyl-2H,4H-benzo[1,2-b:4,3-c']dipyran-2,6(8H)-dione |
Fuscaxanthone C | 15404-76-9 | C26H30O6 | 438.5 | 3,6-Dimethylmangostin |
Fusarisetin A | 1300041-53-5 | C22H31NO5 | 389.5 | (+)-Fusarisetin A |
Fusapyrone | 156856-31-4 | |||
Fusafungine | 1393-87-9 | |||
Fursultiamine | 804-30-8 | C17H26N4O3S2 | 398.55 | ((tetrahydrofurfuryl)dithio)-1-butenyl)-; adventan; alinaminf; diteftin; fursultiamin; judolor; linamin; retar-b(sub1) |
Furowanin A | 911004-72-3 | C25H26O7 | 438.47 | 6-(3,4-Dihydroxyphenyl)-2,3-dihydro-4-hydroxy-2-(1-hydroxy-1-methylethyl)-9-(3-methyl-2-buten-1-yl)-5H-furo[3,2-g][1]benzopyran-5-one |
Furosine | 19746-33-9 | C12H18N2O4 | 254.28 | Epsilon-N-(2-furoyl-methyl)-L-lysine; Epsilon-N-(2-furoyl-methyl)-L-lysine; (S)-2-amino-6-(2-(furan-2-yl)-2-oxoethylamino)hexanoic acid |
Fura PE-3 potassium salt | 172890-83-4 | C37H39N5O17 | 825.73 | |
Fupenzic acid | 119725-20-1 | C30H44O5 | 484.7 | 2,19-Dihydroxy-3-oxoursa-1,12-dien-28-oic acid |
Funoran | 9083-24-3 | 0 | funoran; Gloiopeltis furcata gum | |
Functional soya protein conc | 68153-28-6 | |||
Funapide | 1259933-16-8 | C22H14F3NO5 | 429.35 | UNII-A5595LHJ2L; A5595LHJ2L; XEN-401-S; TV-45070; (7S)-1'-[[5-(trifluoromethyl)furan-2-yl]methyl]spiro[6H-furo[2,3-f][1,3]benzodioxole-7,3'-indole]-2'-one |
Funalenone | 259728-61-5 | C15H12O6 | 288.3 | 3,4,7,9-tetrahydroxy-2-methoxy-6-methyl-1H-phenalen-1-one |
Fumonisin B3 | 1422359-85-0 | C34H59NO14 | 705.8 | FB3; (2R)-2-[2-[(5R,6R,7S,9S,11R,18S,19S)-19-amino-6-[(3R)-3,4-dicarboxybutanoyl]oxy-11,18-dihydroxy-5,9-dimethylicosan-7-yl]oxy-2-oxoethyl]butanedioic acid |
Fumitremorgin C | 118974-02-0 | C22H25N3O3 | 379.45 | fumitremorgin C; tryproquivaline D (2'S-(2'alpha,9'alpha(4R*(S*)),9'abeta))-isomer; tryproquivaline L (9'R-(9'alpha(R*),9'abeta))-isomer; tryproquivaline L (9'R-(9'alpha(S*),9'abeta))-isomer; tryproquivaline M (2'S-(2'alpha,9'alpha(4R*(S*)),9'abeta))-isom |
Fumitremorgin B | 12626-17-4 | C27H33N3O5 | 479.577 | Lanosulin |
Fumiquinazoline D | 140715-86-2 | C24H21N5O4 | 443.5 | (1'R,2S,3'S,5'S,9aS)-1,4',5',9a-tetrahydro-1',2-dimethyl-spiro[9H-imidazo[1,2-a]indole-9,3'-[1,5](iminomethano)[3H][1,4]oxazepino[3,4-b]quinazoline]-3,7',13'(1'H,2H)-trione |
FUMARPROTOCETRARIC ACID | 489-50-9 | C22H16O12 | 472.36 | FUMARPROTOCETRARIC ACID; [(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dioxepin-9-yl)methyl] hydrogen fumarate; (E)-2-Butenedioic acid hydrogen 1-[(7-carboxy-4-formyl-3,8-dihydroxy-1,6-dimethyl-11-oxo-11H-dibenzo[b,e][1,4]dio |
Fumarate hydratase-IN-1 | 1644060-37-6 | C27H30N2O4 | 446.54 | |
Fumagillol | 108102-51-8 | C16H26O4 | 282.38 | Gelcohol; NSC9665; Alcohol-I from Fumagillin; (3R,4S,5S,6R)-5-methoxy-4-[(2R,3R)-2-methyl-3-(3-methylbut-2-enyl)oxiran-2-yl]-1-oxaspiro[2.5]octan-6-ol |
Fumagillin | 23110-15-8 | C26H34O7 | 458.54 | Amebacilin; NSC9168 |
Fulvic acid | 479-66-3 | C14H12O8 | 308.24 | 4,10-dihydro-3,7,8-trihydroxy-3-methyl-10-oxo-1h,3h-pyrano[4,3-b][1]benzopyran-9-carboxylic acid; Fulvic acid; FULVIC ACID PURITY 95%; 1H,3H-Pyrano4,3-b1benzopyran-9-carboxylic acid, 4,10-dihydro-3,7,8-trihydroxy-3-methyl-10-oxo- |
Fulvestrant-3-Glucuronide | 261506-27-8 | C38H55F5O9S | 782.90 | (7a,17b)-17-Hydroxy-7-[9-[(4,4,5,5,5-pentafluoropentyl)sulfinyl]nonyl]estra-1,3,5(10)-trien-3-yl b-D-glucopyranosiduronic acid |
Fulvestrant Side Chain Impurity | 148757-89-5 | C14H24BrF5S | 399.31 | 9-Bromononyl 4,4,5,5,5-pentafluoropentyl Sulfide; 1-Bromo-9-[(4,4,5,5,5-pentafluoropentyl)thio]-nonane |
Fulvestrant Impurity 4 | 1621885-82-2 | C30H44O6S | 532.75 | |
Fulvestrant Impurity 3 | 1621885-81-1 | C30H44O7S | 548.74 | |
Fulvestrant Impurity 2 | 1621885-80-0 | C30H46O6S | 534.76 | |
FUCHSELIN | 83513-68-2 | 0 | RESORCIN FUCHSIN; PHENOL FUSCHSIN; WEIGERT'S ELASTIN STAIN; WEIGERT'S RESORCIN FUCHSIN; WEIGERT'S RESORCINOL FUCHSIN STAIN; FUCHSELIN; ELASTIN STAIN WEIGERT | |
Fubridazole | 3878-19-1 | C11H8N2O | 184.19 | 2-(furan-2-yl)-1H-benzimidazole; BAY 33172; |
FTY720 Phosphate | 402615-91-2 | C19H34NO5P | 387.5 | FTY720P; 2-amino-2-[2-(4-octylphenyl)ethyl]-1,3-propanediol, 1-(dihydrogen phosphate) |
FTY720 (S)-Phosphate | 402616-26-6 | C19H34NO5P | 387.5 | (S)-FTY 720P; (2S)-amino-2-[2-(4-octylphenyl)ethyl]-1-(dihydrogen phosphate)-1,3-propanediol |
FTY720 (R)-Phosphate | 402616-23-3 | C19H34NO5P | 387.5 | (2R)-amino-2-[2-(4-octylphenyl)ethyl]-1-(dihydrogen phosphate)-1,3-propanediol |
FTY720 | 162359-56-0 | C19H33NO2.HCl | 343.9 | Fingolimod hydrochloride |
FTIDC | 873551-53-2 | C18H23FN6O | 358.41 | 4-[1-(2-Fluoro-3-pyridinyl)-5-methyl-1H-1,2,3-triazol-4-yl]-3,6-dihydro-N-methyl-N-(1-methylethyl)-1(2H)-pyridinecarboxamide |
FTI-277 | 170006-73-2 | C22H29N3O3S2 | 447.612 | FTI-277; FTI 277; FTI277. |
FTI-276 | 170006-72-1 | C21H27N3O3S2 | 433.585 | FTI-276; FTI276; FTI 276. |
FTI-249 | 161721-65-9 | C15H23N3O3S2 | 357.491 | FTI-249; FTI 249; FTI249 |
FTI-2153 | 344900-92-1 | C25H30N4O3S | 466.6 | FTI-2153; FTI 2153; FTI2153 |
FTI-2148 | 251577-09-0 | C24H28N4O3S | 452.573 | FTI-2148; FTI 2148; FTI2148. |
Fluvastatin sodium salt | 93957-55-2 | C24H25FNNaO4 | 433.45 | Canef; Fluindostatin; Lescol XL; Lipaxan; Vastin; XU-62-320; XU62320; XU 62 320; |
Fluvastatin Methyl Ester | 786710-21-2 | C25H28FNO4 | 425.50 | |
Fluvastatin | 93957-54-1 | C24H26FNO4 | 411.47 | Cranoc;Lescol;(+)-(3R,5S)-fluvastati;(E,3R,5S)-7-[3-(4-fluorophenyl)-1-propan-2-ylindol-2-yl]-3,5-dihydroxyhept-6-enoic acid;6-Heptenoic acid,7-[3-(4-fluorophenyl)-1-(1-methylethyl)-1H-indol-2-yl]-3,5-dihydroxy-,[R*,S*-(E)]- |
Flutropium bromide | 63516-07-4 | C24H29BrFNO3 | 478.39 | |
Flutroline | 70801-02-4 | C27H25F3N2O | 450.50 | CP-36,584; Flutrolino; Flutrolinum; CP36,584; flutroline; flutroline, (+-)-isomer;(+-)-8-Fluoro-alpha,5-bis(p-fluorophenyl)-1,3,4,5-tetrahydro-2H-pyrido(4,3-b)indole-2-butanol;4-[8-fluoro-5-(4-fluorophenyl)-3,4-dihydro-1H-pyrido[4,3-b]indol-2-yl]-1-(4-flu |
Flutriafol Impurity D | 110933-21-6 | C16H13F2N3O | 301.30 | |
Flutriafol Impurity A | 124774-27-2 | C16H13F2N3O | 301.30 | |
Flutonidine | 28125-87-3 | C10H12FN3 | 0 | Flutonidine; 2-(5-Fluoro-o-toluidino)-2-imidazoline; N-(5-Fluoro-2-methylphenyl)-4,5-dihydro-1H-imidazol-2-amine; ST-600 |
Fluticasone propionate-d5 | 1093258-28-6 | C25H26D5F3O5S | 505.61 | |
Fluroxypyr | 69377-81-7 | C7H5Cl2FN2O3 | 255.03 | ((4-amino-3,5-dichloro-6-fluoro-2-pyridinyl)oxy)-aceticaci; 4-amino-3,5-dichloro-6-fluoro-2-pyridyloxyaceticacid; ff4014; ADVANCE; ((4-amino-3,5-dichloro-6-fluoro-2-pyridinyl)oxy)acetic acid; ef-689; FLUROXYPYR; 2-(4-Amino-3,5-dichloro-6-fluoropyrin-2-yl) |
Fluorofelbamate | 726-99-8 | C11H13FN2O4 | 256.23 | Fluorofelbamate |
fluoroethyne | 2713-09-9 | C2HF | 44.0277 g/mol | |
fluoro-Dapagliflozin | 1181681-43-5 | C21H24ClFO5 | 410.9 | flouro-DAPA; (1S)-1,5-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-4-deoxy-4-fluoro-D-glucitol |
Fluorescein diacetate | 596-09-8 | C24H16O7 | 416.38 | 3,6-Diacetoxyfluoran; Di-O-acetylfluorescein |
Fluoro 2-Deoxy-2-fluoro-3,4,6-tri-O-acetyl-D-mannopyranoside | 24679-92-3 | C12H16F2O7 | 310.25 | |
Fluoroclebopride | 154540-49-5 | C20H23ClFN3O2 | 391.87 | Fluoroclebopride |
Fatty acids, tall-oil, reaction products with tetraethylenepentamine | 68953-36-6 | |||
Famotidine Impurity I | 1020719-36-1 | C8H14N6O4S3 | 355.44 | 3-[2-(Diaminomethyleneamino)-1,3-thiazol-4-ylmethylsulphinyl]-N-sulphamoyl propanamide |
Famotidine Impurity H DiHCl | 88046-01-9 | C6H10N6S2. 2 HCl | 230.31 2 36.46 | S-(2-Guanidino-4-thiazolyl)methylisothiourea Dihydrochloride; |
Exalamide | 53370-90-4 | C13H19NO2 | 221.3 | 2-(Hexyloxy)benzamide; 2-hexoxybenzamide; |
EX-527 S-enantiomer | 848193-68-0 | C13H13ClN2O | 248.71 | Selisistat S-enantiomer |
Ethyl 5-amino-1-phenyl-1H-pyrazole-3-carboxylate | 866837-96-9 | C12H13N3O2 | 231.25 | |
FTI 277 trifluoroacetate salt | 1217447-06-7 | C22H29N3O3S2.C2HF3O2 | 561.64 | N-[4-[2(R)-Amino-3-mercaptopropyl]amino-2-phenylbenzoyl]methionine methyl ester trifluoroacetate salt |
FTI 277 HCl | 180977-34-8 | C22H30ClN3O3S2 | 484.07 | |
FTI 276 trifluoroacetate salt | 1217471-51-6 | C21H27N3O3S2.C2HF3O2 | 547.61 | N-[4-[2(R)-Amino-3-mercaptopropyl]amino-2-phenylbenzoyl]methionine trifluoroacetate salt |
FTBMT | 1358575-02-6 | C19H16F4N4O | 392.35 | 4-[3-[[3-Fluoro-5-(trifluoromethyl)phenyl]methyl]-5-methyl-1H-1,2,4-triazol-1-yl]-2-methylbenzamide |
Ftaxilide | 19368-18-4 | C16H15NO3 | 269.295 | 2-[(2,6-dimethylphenyl)carbamoyl]benzoic acid Ftaxilide 2',6'-Dimethylphthalanilic acid Histanorm 19368-18-4 Ftaxilide [INN:DCF] Ftaxilidum [INN-Latin] Ftaxilida [INN-Spanish] Phthalic 2,6-dimethylanilide UNII-7Z71845H3F MP-12-P MP 12 NSC 1611 |
FTase Inhibitor II | 156707-43-6 | C15H21N3O4S2 | 371.5 | Farnesyltransferase Inhibitor II; FTI-II; N-[4-[[(2R)-2-amino-3-mercapto-1-oxopropyl]amino]benzoyl]-L-methionine |
FTase Inhibitor I | 149759-96-6 | C22H38N4O3S2 | 470.7 | Farnesyltransferase Inhibitor I; B581; N-[(2S)-2-[[(2R)-2-amino-3-mercaptopropyl]amino]-3-methylbutyl]-L-phenylalanyl-L-methionine |
FSLLRY-NH2 | 245329-02-6 | C39H60N10O8 | 796.97 | |
FSL 1 | 322455-70-9 | C84H140N14O18S | 1666.16 | |
FSB | 760988-03-2 | C24H17FO6 | 420.4 | 3,3'-[(2-fluoro-1,4-phenylene)di-(1E)-2,1-ethenediyl]bis-6-hydroxy-benzoic acid; 1-Fluoro-2,5-bis(3-carboxy-4-hydroxystyryl)benzene |
Fruquintinib | 1194506-26-7 | C21H19N3O5 | 393.39 | Fruquintinib; HMPL013; HMPL 013; HMPL-013. |
Fructosyl-lysine | 21291-40-7 | C12H24N2O7 | 308.33 | |
Fructose-tryptophan (mixture of diastereomers) | 25020-15-9 | C17H22N2O7 | 366.37 | N-(1-Deoxy-D-fructos-1-yl)-L-tryptophan; (S)-1-[[1-Carboxy-2-(1H-indol-3-yl)ethyl]amino]-1-deoxy-D-fructose; D-Fructose-tryptophan; Fructose-L-tryptophan |
Fructose-proline (mixture of diastereomers) | 29118-61-4 | C11H19NO7 | 277.27 | 1-(1-Deoxy-D-fructos-1-yl)-L-proline; (S)-1-(2-Carboxy-1-pyrrolidinyl)-1-deoxy-D-fructose; 1-Deoxy-1-L-proline-D-fructose; 1-Deoxy-1-L-prolino-D-fructose |
Fructose-leucine (mixture of diastereomers) | 34393-18-5 | C12H23NO7 | 293.31 | N-(1-Deoxy-D-fructos-1-yl)-L-leucine; (S)-1-[(1-Carboxy-3-methylbutyl)amino]-1-deoxy-D-fructose; D-1-[(L-1-Carboxy-3-methylbutyl)amino]-1-deoxy-fructose; 1-Deoxy-1-L-leucino-D-fructose; Fructoseleucine |
Fructoheptasaccharide | 62512-20-3 | C42H72O36 | 1153.00 | Fructo-oligosaccharide DP7; 1,1,1,1,1-Kestoheptaose; Frub2-1[Frub2-1]5a2-1Glc |
Fructose-asparagine (Mixture of diastereomers) | 34393-27-6 | C10H18N2O8 | 294.26 | N2-(1-Deoxy-D-fructos-1-yl)-L-asparagine; (S)-1-[(3-Amino-1-carboxy-3-oxopropyl)amino]-1-deoxy-D-fructose; 1-[(2-Carbamoyl-1-carboxyethyl)amino]-1-deoxy-fructose; 1-Deoxy-1-L-asparagino-D-fructose; N-(1-Deoxy-D-fructosyl)-L-asparagine |
Fructose-alanine (mixture of diastereomers) | 16124-24-6 | C9H17NO7 | 251.23 | N-(1-Deoxy-D-fructos-1-yl)-L-alanine; (S)-1-[(1-Carboxyethyl)amino]-1-deoxy-D-fructose; 1-Alanino-1-deoxy-D-fructose; 1-Deoxy-1-L-alanine-D-fructose; N-(1-Deoxy-D-fructosyl)-L-alanine |
Fructose-1,6-bisphosphatase-1 Inhibitor | 883973-99-7 | C13H7Cl3N2O3S | 377.6 | F1,6BPase-1 Inhibitor; FBP1 Inhibitor; FBPase-1 Inhibitor; 2,5-dichloro-N-(5-chloro-2-benzoxazolyl)-benzenesulfonamide |
Fructose Valine (mixture of diastereomers) | 10003-64-2 | C11H21NO7 | 279.29 | N-(1-Deoxy-D-fructos-1-yl)-L-valine; D-1-[(L-1-Carboxy-2-methylpropyl)amino]-1-deoxy-fructose; 1-Deoxy-1-L-valino-D-fructose; 1-L-Valine-1-deoxy-D-fructose; Fructosyl-valine; N-Fructosyl Valine |
Fructose L-Arginine Adduct | 25020-14-8 | C12H24N4O7 | 336.34 | (S)1-[[4-[(Aminoiminomethyl)amino]-1-carboxybutyl]amino]-1-deoxy-D-fructose; D-1-[(1-Carboxy-4-guanidinobutyl)amino]-1-deoxy-fructose |
Fructose 2,6-bisphosphate | 79082-92-1 | |||
Fructosazine | 13185-73-4 | C12H20N2O8 | 320.30 | D-Arabino-1,1-(2,5-pyrazinediyl)di-1,2,3,4-butanetetrol; Tagatosazine |
FRUCTOOLIGOSACCHARIDES | 308066-66-2 | 0 | FOS; FRUCTOOLIGOSACCHARIDES; FRUCTOOLIGOSACCHARIDE, 80%-90%; FructooIigsacccharids; Oligolevulose; Beneo p 95; Fortifeed; Fos-p power 300 | |
Fructo-oligosaccharide DP9/GF8 | 143625-74-5 | C54H92O46 | 1477.3 | |
Fructo-oligosaccharide DP8/GF7 | 62512-21-4 | C48H82O41 | 1315.1 | |
Fructo-oligosaccharide DP10/GF9 | 118150-64-4 | C60H102O51 | 1639.4 | |
Fructooligosaccharide | 223122-07-4 | |||
FR-234938 | 256461-79-7 | C19H21N3O2 | 323.39 | 1-[(3R,4S)-4-hydroxy-1-naphthalen-1-ylpentan-3-yl]imidazole-4-carboxamide; FR-234938; FR 234938; FR234938 |
Frovatriptan succinate hydrate | 158930-17-7 | C14H17N3O·C4H6O4·H2O | 379.41 | SB 209509; VML 251; butanedioic acid, compd. with (R)-2,3,4,9-tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide, hydrate (1:1:1); R-(+) 3-Methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole monosuccinate monohydrate |
Frovatriptan Succinate | 158930-09-7 | C18H23N3O5 | 361.40 | (3R)-2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide butanedioate; 1H-Carbazole-6-carboxamide, 2,3,4,9-tetrahydro-3-(methylamino)-, (3R)-, butanedioate (1:1); Sb-209509ax; Vml 251 |
Frovatriptan Racemate | 147009-08-3 | C14H17N3O | 243.31 | (RS)-3-(Methylamino)-2,3,4,9-tetrahydro-1H-carbazole-6-carboxamide; 3-Methylamino-6-carboxamido-1,2,3,4-tetrahydrocarbazole; 2,3,4,9-Tetrahydro-3-(methylamino)-1H-carbazole-6-carboxamide |
Frovatriptan Impurity 5 | 473927-51-4 | C7H9N3O | 151.17 | 3-Hydrazinobenzamide; Benzamide, 3-hydrazino-; 3-Carboxamidophenyl hydrazine |
FR-233074 | 262596-45-2 | C36H32N2O4S | 588.72 | N-benzylsulfonyl-3-[[(1S)-2-(4,5-diphenyl-1,3-oxazol-2-yl)cyclohex-2-en-1-yl]methyl]benzamide; FR-233074; FR 233074; FR233074 |
FR-229934 | 799841-02-4 | C21H23Cl2N3O3S | 468.40 | 1-((3,4-dichlorophenyl)methyl)-2-methyl-N-(pentylsulfonyl)-1H-Benzimidazole-6-carboxamide |
FR-221647 | 256461-28-6 | C14H17N3O2 | 259.3 | 1-(1-hydroxy-4-phenylbutan-2-yl)imidazole-4-carboxamide; FR-221647; FR 221647; FR221647 |
FR-218944 | 233264-02-3 | C28H30N4O6S | 550.63 | methanesulfonic acid;2-methoxy-N-(2-methyl-1H-benzimidazol-4-yl)-4-(2,3,4,5-tetrahydro-1-benzazepine-1-carbonyl)benzamide; FR-218944; FR 218944; FR218944 |
FR-217840 | 848444-16-6 | C16H18FN3O6S3 | 463.52 | (2S)-1-((5-(4-fluorophenyl)-2-thienyl)sulfonyl)-N-hydroxy-4-(methylsulfonyl)-2-Piperazinecarboxamide |
FR-202306 | 342785-41-5 | C10H12O5 | 212.20 | 3-methoxy-7-methyl-1,3-dihydro-2-benzofuran-4,5,6-triol; |
FR-198248 | 197316-54-4 | C9H10O5 | 198.17 | 2,3,4-trihydroxy-6-(hydroxymethyl)-5-methylbenzaldehyde; FR-198248; FR-198248; FR-198248 |
FR-194921 | 202646-80-8 | C23H23N5O | 385.46 | 2-(1-methylpiperidin-4-yl)-6-(2-phenylpyrazolo[1,5-a]pyridin-3-yl)pyridazin-3-one; FR-194921; FR 194921; FR194921; 2-(1-methyl-4-piperidinyl)-6-(2-phenylpyrazolo(1,5-a)pyridin-3-yl)-3(2H)-pyridazinone |
FR-193879 | 194928-82-0 | C20H18N4O5S3 | 490.58 | (6R,7R)-3-[[4-(2-amino-2-oxoethyl)-1,3-thiazol-2-yl]sulfanyl]-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid; FR-193879; FR193879; FR 193879 |
FR-193262 | 187992-22-9 | C31H29N2NaO4 | 516.56 | sodium;2-[[(5R)-5-[(2R)-2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetate; FR-193262; 187992-22-9(FR-193262); 314289-63-9 (FR-193262 Free Base) |
FR-193262 | 314289-63-9 | C31H30N2O4 | 494.59 | 2-[[(5R)-5-[(2R)-2-(4,5-diphenyl-1,3-oxazol-2-yl)pyrrolidin-1-yl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetic acid; |
FR-190809 | 215589-63-2 | C29H34FN3O6S2 | 603.73 | 1-cycloheptyl-1-[[4-(4-fluorophenoxy)phenyl]methyl]-3-[6-methyl-2,4-bis(methylsulfonyl)pyridin-3-yl]urea; FR 190809; FR-190809; N-cycloheptyl-N-(4-(4-fluorophenoxy)-benzyl)-N'-(2,4-bis(methylsulfonyl)-6-methylpyridin-3-yl)urea |
FR-188582 | 189699-82-9 | C16H13ClN2O2S | 332.8 | 3-chloro-5-(4-methylsulfonylphenyl)-1-phenylpyrazole; FR 188582 |
FR-186054 | 179053-90-8 | C26H27N5OS2 | 489.66 | FR-186054; FR 186054; FR186054; 1-benzyl-3-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]-1-[[3-(1H-pyrazol-5-yl)phenyl]methyl]urea |
FR-182980 | 179054-51-4 | C29H34FN3O2S2 | 539.73 | FR-182980; FR182980; FR 182980; 1-cycloheptyl-1-[[4-(4-fluorophenoxy)phenyl]methyl]-3-[6-methyl-2,4-bis(methylsulfanyl)pyridin-3-yl]urea |
FR-182024 | 179034-83-4 | C18H16N4O4S3 | 448.53 | FR-182024; 9031SV3FWE; (6R,7R)-3-[(5-methyl-1,3,4-thiadiazol-2-yl)sulfanyl]-8-oxo-7-[(2-phenylacetyl)amino]-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid |
FR-181877 | 172936-99-1 | C30H28N2O4 | 480.56 | FR-181877; (-)-FR-181877; 2-[[(6S)-6-[(3-benzhydryl-6-oxopyridazin-1-yl)methyl]-5,6,7,8-tetrahydronaphthalen-1-yl]oxy]acetic acid |
FR-181157 | 200433-03-0 | C30H26NNaO4 | 487.52 | sodium;2-[3-[[(1S)-2-(4,5-diphenyl-1,3-oxazol-2-yl)cyclohex-2-en-1-yl]methyl]phenoxy]acetate; FR 181157; FR181157; 200433-03-0 (FR-181157 Free Base) |
FR-181157 | 171046-15-4 | C30H26NNaO4 | 487.52 | FR-181157; (S)-FR-181157; SCHEMBL8057380; sodium;2-[3-[[(1S)-2-(4,5-diphenyl-1,3-oxazol-2-yl)cyclohex-2-en-1-yl]methyl]phenoxy]acetate |
FR-181074 | 184147-65-7 | C23H25ClN2O2 | 396.91 | 1-[(2-chlorophenyl)methyl]-3-(2-methylpropanoyl)-2-propylindole-6-carboxamide; FR-181074 |
FR180204 | 865362-74-9 | C18H13N7 | 327.351 | FR180204; FR-180204; FR 180204 |
FR-168888 Free Base | 168620-45-9 | C13H14N4O2 | 258.28 | FR-168888 free base; SCHEMBL1388039; SCHEMBL8300855; Benzamide, N-(aminoiminomethyl)-3-(hydroxymethyl)-5-(1H-pyrrol-1-yl)- |
FR-168888 | 168620-46-0 | C14H18N4O5S | 354.38 | FR-168888; FR 168888; FR168888; Benzamide, N-(aminoiminomethyl)-3-(hydroxymethyl)-5-(1H-pyrrol-1-yl)-, methanesulfonate (1:1) |
FR-167653 | 158876-66-5 | C24H20FN5O6S | 525.511 | FR-167653 |
FR-167653 | 158876-65-4 | C24H18FN5O2 | 427.43 | |
FR-167356 | 174185-16-1 | C19H17Cl2NO3 | 378.25 | FR-167356; FR167356; DSSTox_CID_28148; DSSTox_RID_82712; 2,6-dichloro-N-[3-(2-hydroxypropan-2-yl)-2-methyl-1-benzofuran-7-yl]benzamide |
FR 901537 | 161162-21-6 | C23H29N3O6S2 | 507.62 | FR 901537; FR-901537; AC1L4IQN; DTXSID10167072; (R)-N-(3-((2-((2,3-Dihydro-6-hydroxy-2-oxo-1H-naphtho(2,1-b)(1,4)thiazin-5-yl)thio)ethyl)amino)-3-oxopropyl)-2,4-dihydroxy-3,3-dimethylbutanamide |
FR 901235 | 124190-19-8 | C18H16O7 | 344.32 | (-)-2,4,9-trihydroxy-6-methoxy-7-methyl-2-(2-oxopropyl)-1H-phenalene-1,3(2H)-dione |
FR 76830 | 113243-75-7 | C25H26N4O4 | 446.5 | 2-methyl-N-(4-morpholinylethyl)-4-(3-nitrophenyl)-6-phenyl- 3-Pyridinecarboxamide |
FR 75513 | 127975-78-4 | C19H19NO7 | 373.36 | 3-O-methyl 1-O-propan-2-yl 4-hydroxy-6-methyl-2-(2-nitrophenyl)benzene-1,3-dicarboxylate |
FR 236924 | 28399-31-7 | C20H36O2 | 308.5 | Dcp-LA; 2-[(2-Pentylcyclopropyl)methyl]cyclopropaneoctanoic acid |
FR 179642 | 168110-44-9 | C35H52N8O20S | 936.89 | FR-179642; Pneumocandin M1; 1-[(4R,5R)-4,5-Dihydroxy-L-ornithine]-4-[(4S)-4-hydroxy-4-[4-hydroxy-3-(sulfooxy)phenyl]-L-threonine]pneumocandin A0; UNII-44677O2TDO |
FR 171113 | 173904-50-2 | C19H11Cl3N2O4S | 469.73 | 2-[3-(4-Chlorophenyl)-2-[(2,4-dichlorobenzoyl)imino]-4-oxo-5-thiazolidinylidene]-acetic acid methyl ester |
Fosamprenavir Calcium Salt | 226700-81-8 | C25H34CaN3O9PS | 623.67 | GW 433908G; Lexiva; GW433908G; GW-433908G |
Fosinoprilat-d7 | 1279220-43-7 | C23H27D7NO5P | 442.55 | (4S)-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl-d7)phosphinyl]acetyl]-L-proline; trans-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl-d7)phosphinyl]acetyl]-L-proline; Fosfenopril-d7; Fosinoprilic-d7 Acid; SQ 27519-d7 |
Fosinoprilat acyl-b-D-glucuronide | 113411-09-9 | C29H42NO11P | 611.62 | trans-4-Cyclohexyl-1-[[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline b-D-glucopyranuronosyl ester |
Fosinoprilat | 95399-71-6 | C23H34NO5P | 435.50 | (4S)-4-Cyclohexyl-1-[2-[hydroxy(4-phenylbutyl)phosphinyl]acetyl]-L-proline Disodium Salt; Fosfenopril Disodium Salt; Fosinoprilat Disodium Salt; Fosinoprilic Acid Disodium Salt; SQ 27519 Disodium Salt; L-Proline, 4-cyclohexyl-1-hydroxy(4-phenylbutyl)phosp |
Fosinopril sodium salt | 88889-14-9 | C30H45NO7P·Na | 585.64 | Monopril; Staril; Dynacil; Fosinil; Tenso Stop; Tensocardil; Sodium, Fosinopril; SQ 28,555; SQ 28555; SQ-28,555; SQ-28555; SQ28,555; SQ28555 |
Fosinopril Related Compound C | 1217600-34-4 | C30H45NO7PNa | 585.66 | (4S)-4-Cyclohexyl-1-[(RS)-1-hydroxy-2-methylpropoxy](4-phenylbutyl)phosphinyl]-acetyl-L-proline Propionate (Ester) Sodium Salt |
Fosinopril Impurity G | 46348-61-2 | C10H15O3P | 214.20 | 4-phenylbutylphosphonic acid; P-(4-phenylbutyl)phosphonic Acid; USP Fosinopril Related Compound H |
Fosaprepitant Impurity 3 | 287930-75-0 | C21H19F6NO3 | 447.38 | (2R)-2-[(1R)-1-[3,5-Bis(trifluoromethyl)phenyl]ethoxy]-4-(phenylmethyl)-3-morpholinone |
Fosamprenavir | 226700-79-4 | C25H36N3O9PS | 585.62 | [(3S)-oxolan-3-yl] N-[(2S,3R)-4-[(4-aminophenyl)sulfonyl-(2-methylpropyl)amino]-1-phenyl-3-phosphonooxybutan-2-yl]carbamate; 3-(((4-aminophenyl)sulfonyl)(2-methylpropyl)amino)-1-(phenylmethyl)-2-(phosphonooxy)propyl)carbamic acid C-(tetrahydro-3-furanyl) |
Fortuneine | 87340-25-8 | C20H25NO3 | 327.424 | |
Fortimicin | 55779-06-1 | C17H35N5O6 | 405.4897;g/mol | 2-amino-N-[(1S,2R,3R,4S,5S,6R)-4-amino-3-[(2R,3R)-3-amino-6-[(1S)-1-aminoethyl]oxan-2-yl]oxy-2,5-dihydroxy-6-methoxycyclohexyl]-N-methylacetamide; Fortimicin; Astromicin; 55779-06-1; C17H35N5O6 |
Forsythoside I | 1177581-50-8 | C29H36O15 | 624.59 | Isoforsythoside A |
Forsythoside H | 1178974-85-0 | C29H36O15 | 624.59 | |
Forsythoside F | 94130-58-2 | C34H44O19 | Arenarioside | |
Forsythoside E | 93675-88-8 | C20H30O12 | 2-(3,4-Dihydroxyphenyl)Ethyl 6-O-(6-Deoxy-Alpha-L-Mannopyranosyl)-Beta-D-Glucopyranoside | |
Forsythoside B | 81525-13-5 | C34H44O19 | 756.7 | Forsythoside B; (E)-O-D-Apio-beta-D-furanosyl-(1-6)-O-[6-deoxy-alpha-L-mannopyranosyl-(1-3)]-beta-D-glucopyranoside 2-(3,4-dihydroxyphenyl)ethyl 4-[3-(3,4-dihydroxyphenyl)-2-propenoate] |
Forsythin | 96420-61-0 | C27H34O11 | 534.55 | PHILLYGENIN-O-BETA-D-GLUCOPYRANOSIDE; Phillyrin,Forsythin. Phillyroside |
Forsythin | 487-41-2 | C27H34O11 | 534.55 | 4-[(1S,3aR,4R,6aR)-4-(3,4-Dimethoxyphenyl)tetrahydro-1H, 3H-furo[3,4-c]furan-1-yl]-2-methoxyphenyl b-D-glucopyranoside; Forsythin |
Forsythenside A | 202721-09-3 | C22H26O10 | 450.44 | [(2R,3S,4S,5R,6R)-3,4,5-trihydroxy-6-[2-(1-hydroxy-4-oxocyclohexa-2,5-dien-1-yl)ethoxy]oxan-2-yl]methyl 2-(4-hydroxyphenyl)acetate |
Forskolin J | 81873-08-7 | C24H36O8 | 452.5 | (3R,4aR,5S,6S,6aS,10S,10aR,10bS)-10,10b-Dihydroxy-3,4a,7,7,10a-pe ntamethyl-1-oxo-3-vinyldodecahydro-1H-benzo[f]chromene-5,6-diyl d iacetate |
Forskolin G | 473981-11-2 | C24H36O7 | 436.6 | (3R,4aS,5S,6S,6aS,10S,10aS,10bR)-10-Hydroxy-3,4a,7,7,10a-pentamet hyl-1-oxo-3-vinyldodecahydro-1H-benzo[f]chromene-5,6-diyl diaceta te |
Forskolin | 66575-29-9 | C22H34O7 | 410.507 |